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Neurotoxicity is defined as “an adverse change in the structure or function of the 
nervous system that results from exposure to a chemical, biological or physical 
agent”1. This is a very general term that includes the wide variety of adverse effects 
elicited by an external agent acting directly on the central nervous system (brain, 
spinal cord, optic nerves), and/or on the peripheral nervous system (motor, sensory 
and/or autonomic components and end organs), and/or indirectly via peripheral 
organs1. The objective of the research project I pursued during my PhD training was 
the study of possible molecular targets and mechanisms involved in two specific 
cases of neurotoxicity, widely documented but not completely understood: 1) the 
potential neurotoxicity induced by Silica Nanoparticles (SiO2) and 2) the Oxaliplatin 
(OHP)-induced neurotoxicity. 
 
1.1 Nanoparticles and potential neurotoxicity 
 
Nanomaterials (NMs) are defined as materials having at least one dimension in the 
range of 1–100 nm. Based on their structure, nanomaterials can be categorized 
into: 1) zero-dimensional (nanoparticles and quantum dots); 2) one-dimensional 
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(nanofibers, nanotubes, and nanowires); 3) two-dimensional (graphene and 
graphene oxide); and 4) three-dimensional nanomaterials, generally known as bulk 
nanomaterials, which consist of equiaxed nanometer sized grains, and 
characterized by three arbitrary dimensions which are not confined to the 
nanoscale. In this context, it should be noted that these categories are not so 
restrictive and some materials can be positioned on the margin of two of these 
categories2.  
The International Organization for Standardization (ISO) has defined Nanoparticles 
(NPs) as nano-objects with all three external dimensions in the nanoscale 
(https://www.iso.org/standard/51240.html). These NPs can differ in sizes and shapes 
(such as spheres, cylinders, cubes, triangles, rings, or disks with various dimensions) 
and for nature (organic, inorganic and carbon based).  
At the nanoscale, the inorganic matter present chemical and physical properties 
that are not present when the same materials are analyzed at a micro-macroscopic 
scale. The increased surface area, optical properties (such as quantum effects and 
increased absorption efficiency), uniformity, quantum confinement (a 
phenomenon that causes spontaneous properties of semi-conductivity) and 
increased reactivity are just some example of the most important properties 
acquired2.  
These findings are the reason of the increasing applications of engineered NPs. NPs 
have been successfully applied not only to traditional manufacturing (i.e. catalysis, 
energy, electronics, cosmetics and personal care products), but also to emerging 
pharmaceutical and biomedical fields (I.e. imaging, diagnosis, drug delivery, and 
cancer immunology)3.  
However, the expansion of the use of NPs has raised great public attention because 
of potential toxicity concerns in animals and humans. Being their dimensions 
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comparable to those of common subcellular and molecular structures from 
biological material, this fact allows NPs to interact with tissues and cells and to 
induce unknown and/or not always well understood alterations of their functions4. 
The main cellular entrance routes are endocytosis based, and usually these require 
the activation of a trigger according to the cellular machinery involved in the 
internalization processes 5. However, recent reports are available regarding a direct 
permeation of NPs through plasma membrane6,7. 
The plasma membrane represent the first site of interaction between nanoobjects 
and the cell before any internalization process is initiated. Therefore, the highly 
organized lipids and proteins of which it is composed are likely targets. In neurons 
(and glial cells),  the main modulators of neuronal activity and of its changes in 
responses to external stimuli are located in the plasma membrane. It is therefore 
to be expected that in these tightly regulated and highly responsive cells, NPs can 
induce significant and potentially damaging effects by interfering with transporters 
and channels, receptors for neurotransmitters and neurohormones 4. 
While a significantly expanded literature, especially in the last decade, on potential 
toxicity induced by NPs on living beings is available, the amount of data about 





Amorphous silica powders, conversely to crystalline forms, are considered 
biocompatible and thus they are widely used in a large range of industrial 
applications, from food to catalysis. Depending on which kind of application is 
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considered, the size range of the powder particles can vary and, in some cases, may 
also include a fraction of nanometric particles8.  
Stober was the pioneer in developing a system of chemical reactions for the 
synthesis of spherical monodisperse micron size silica particles. From then on, the 
method is known as “Stober synthesis”. Many modifications have constantly been 
added to the Stober synthesis to yield monodisperse, ordered, nanosized silica 
particles. Manipulating the reaction parameters resulted in particles with different 
shapes and sizes, produced ad hoc to be used in various fields, including 
nanomedical applications ranging from drug delivery to cell tracking and subcellular 
imaging. On the basis of the performances required, they can be used as either 
produced or functionalized at the surface of the object8,9.  
The control of Ca2+ homeostasis is a key point for neuronal physiological and 
pathological processes. Any single step in neuronal function is linked to a tight 
control of intracellular Ca2+ levels and all the mechanisms involved in the regulation 
of this parameter. For several kinds of nanomaterials, such as Ag, ZnO, TiO2, 
hydroxyapatite, quantum dots (QDs), Au and PM10, alterations of intracellular Ca2+ 
concentration [Ca2+]i have been reported9.  
Although the data for SiO2 NPs are still more scarce9, oscillatory and reversible 
changes in [Ca2+]i have been observed following perfusion of neuronal cells with the 
silica NPs10. In the same work, even if the NPs could be internalized, and so the 
intracellular organelles could represent potential targets, the Ca2+ imaging data 
supported the hypothesis of the existence of an influx from the extracellular 
medium as, apparently, the exclusive Ca2+ pathway (Fig. 1). This work suggests that 
target(s) that mediate the interaction with neurons should also be searched on the 







Figure 1. Upper panel. Time course of incorporation of cyanine-doped fluorescent silica NPs 
into GT1–7 cells. 3D reconstructions of XYZ confocal stacks. Cells were stained with a FITC 
conjugated with an anti-β-Tubulin III antibody. Lower panel. A) Perfusion with an extracellular 
Ca2+-free solution completely and reversibly abolished the NPs-induced Ca2+ signals B) 







1.2 Chemotherapy-induced peripheral neuropathy (CIPN) 
 
Cancer presents an enormous global disease burden. However, the availability of 
sensitive tests and diagnostic methods to detect cancer at an early stage and the 
use of increasingly effective treatments (including chemotherapeutic agents), are 
improving the cancer survival rates11.  
The antineoplastics commonly used for the treatment of many types of cancers, 
alone or in combination with surgery and radiation therapy, belong to platinum-
based antineoplastics (particularly oxaliplatin (OHP) and cisplatin), vinca alkaloids 
(particularly vincristine and vinblastine), epothilones (ixabepilone), taxanes 
(paclitaxel, docetaxel), proteasome inhibitors (bortezomib) and 
immunomodulatory drugs (thalidomide) (Tab. 1) . However, despite their efficacy, 
these agents are associated with significant, debilitating and sometimes even 
devastating side effects. The reduction of chemotherapy doses or even their 
cessation may be necessary thereby limiting its effectiveness11,12.  
One of the most relevant side effects caused by platinum-based antineoplastic 
agents is a condition known as chemotherapy-induced peripheral neuropathy 
(CIPN). Predominant CIPN is characterized by sensory symptoms, which usually 
develop first, characterized by paresthesias, dysesthesias, tingling and numbness 
especially in the hands and feet. Pain and sensory abnormalities may persist after 
the cessation of chemotherapy, in some cases even for years. Frequently, then 
sensory symptoms, motor and autonomic symptoms (including weakness, cramps, 
gait dysfunction, sweating abnormalities, constipation, and light-headedness) can 
also be encountered. The life quality of cancer patients developing CIPN can be 
profoundly affected. In the most severe cases, CIPN can lead to paresis, complete 




Table 1. Cancer therapy, mechanism of action and side effects of antineoplastic drugs 
that induce CIPN, as reviewed in 11,13,14. 





(see Tab. 2) 
mitochondrial damage, 
altered expression and 
function of ion channels 
(Na+, K+, TRP), activation of 
microglia and astrocytes 
neuroinflammation, 








testicular cancer and 
non–small cell lung 
cancer 
microtubule disruption, 
induction of changes of 
large axons and DRG 
neurons, attraction and 
activation of immune cells 
neuroinflammation, 







small cell lung 




altered expression and 
function of ion channels 
(Na+, K+, TRP), activation of 
microglia and astrocytes 
neuroinflammation, 







attraction and activation of 
T-lymphocytes and 
monocytes, mitochondrial 









multiple myeloma downregulation  of TNF-α, 
inhibition of NF-kB, 
antiangiogenic effects 
(inhibition of b-FGF and 
VEGF) 





Oxaliplatin-induced peripheral neuropathy 
 
Platinum-based chemotherapeutics are third generation agents widely used for the 
treatment of several types of solid tumors (Tab. 2) . Among these, OHP is indicated 
for the treatment of the digestive tract tumor (advanced colorectal, esophageal, 
stomach, liver and pancreatic cancers)11. 
Essentially, OHP toxicity is associated to the ability of the drug to interact with DNA 
and to induce alterations able to stop DNA replication and cell cycle, as well as to 
inhibit the mechanisms of DNA repair and, finally, to induce cell death through 
apoptosis. In particular, the PlatinumII atom center, released by the drug hydrolysis 
together with other metabolites (i.e. oxalate), is able to form DNA adducts, 
intra/inter-strand DNA cross-links and also DNA-protein cross-links. Thus, the DNA 
double helix structure is completely distorted and the replication is prevented 
causing an inhibition of proliferation15.  
It is necessary remember that the metal-based molecules, such as OHP and, in 
general, all platinum-based drugs, are biologically active molecules and, for this 
reason, they can bind, not only nucleic acids, but also to other important biological 
entities such as proteins, enzymes and hormones. Thus, they can interfere with the 
functionality of normal intracellular organelles (particularly mitochondria); 
influence signalling and neurotransmission by altering intracellular homeostasis 
and affecting the activity of membrane receptors and ion channels; or cause 
neuroinflammation by inducing the release of pro-inflammatory cytokines and 
activating apoptosis11,15.  
Despite OHP shares the typical chronic syndrome with others platinum compounds, 
during or immediately after its administration, the onset of an acute syndrome has 
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been observed in the majority of patients (85%–95%). This acute peripheral 
neurotoxicity, which appears to be unique for OHP treatments, is characterized by 
an altered cold sensitivity and by a neuronal hyperexcitability that can be resolved 
in hours or days after the onset12,16. Since the acute neurotoxicity rarely causes an 
early discontinuation of the treatment, mechanistic studies are usually directed to 
elucidate the chronic form of neurotoxicity. Despite no solid proof of a relationship 
between the two kinds of neurotoxicity has been given yet, it has been reported 
that patients with more complicated acute symptoms usually show a more severe 
type of chronic neurotoxicity15. 
The pathomechanism by which OHP damages the nervous system structures seems 
to be multifactorial, but the hypothesis concerning its effect on ion channels and 
Ca2+ signalling remains mainly related to the acute form of OHP neurotoxicity. A 
dysregulation of voltage-gated Na+ channels and the alteration of Ca2+ signalling 
seems to be the most accepted explanation. However, the mechanisms at the basis 
of ion channel dysfunction are not sufficiently clarified15. The understanding of the 
pathogenesis of the acute form OHP neuropathy can not be longer considered a 














Table 2. Cancer therapy, side effects and main mechanisms of neurotoxicity of Platinum-
based antineoplastics, as reviewed in 11,12,15. 
Platinum-based 
antineoplastics 
Cancer therapy Side effects Main Mechanisms 
of neurotoxicity 
Cisplatin  testicular, ovarian, bladder, 
lung (small-cell and non-
small-cell) cancer, sarcomas,  




numbness in a 
stocking and glove 
distribution, sensory 
ataxia in the most 
severe cases),  
nephrotoxicity, 
ototoxicity, severe 
nausea and vomiting, 
mild hematologic 
toxicity 
nuclear DNA damage, 
mitochondrial DNA 
damage and 
oxidative stress  






frequent and less 
severe) 
nuclear DNA damage, 
mitochondrial DNA 
damage and 
oxidative stress  
Oxaliplatin advanced and metastatic 
colorectal cancer (in 
combination with 5-
fluorouracil/leucovorin),eso










nuclear DNA damage, 
mitochondrial DNA 
damage and 








1.3 Features facilitating neurotoxicity 
 
The nervous system is organized in networks in which different cell types of many 
anatomic locations can communicate via electric and chemical signals. The sheer 
complexity of the system makes it highly vulnerable.  
Despite the nervous system is armed with compensating mechanisms, a 
widespread lesion induced by a given toxicant may correspond to a leak of 
functional capacity. Especially during development when the basic structures of the 
brain are forming, a chemical disruption of this tightly regulated process can have 
profound structural and functional (including behavioral) consequences for life17. 
For this reason, the nervous system is protected by the blood–brain barriers (BBBs). 
These barriers act effectively to retard the transfer of charged and large molecular 
weight compounds from circulation to nervous tissue, but do not provide 
protection to the BBB against lipid soluble agents or toxins that may damage and 
render porous. Furthermore, there are some regions that are not completely 
protected by BBB, including areas involved in the neuroendocrine activity (i.e. 
hypothalamus, pineal), as well as motor and sensory nerve terminals, and thus may 
represent potential points of entry for toxins18. 
 
Metabolism and Neuronal Structure 
 
To maintain this extraordinary complexity, the highly differentiated cells of the CNS 
need a large amount of energy. More in detail, the high metabolic rate required 
includes the maintaining of the synapses, the restoring of ion gradients across the 
cell membranes for the generation of action potentials, the synthesis and packaging 
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of neurotransmitters in vesicles, the axonal transport, and, of course, all the 
“normal” cell requirements19. 
In comparison to other cell types, neurons have an exceptional cellular morphology 
with long projections called axons. Whereas most cells are measured in 
micrometers, neurons can extend their axons and dendrites for millimeters, 
centimeters, and, in the case of human peripheral nerves up to a meter (their length 
can exceed the diameter of the cell body by a factor of >100,000)20,21. 
Reflecting the functional heterogeneity presented in neuronal segments, each part 
of a neuron (dendrites, soma, axon, presynaptic segment) might have quite 
different energy demands. For this reason, mitochondria, that are thought to arise 
from the cell soma, are distributed along the cellular body in a more orderly way 
than in other cells, adapting to the local requirement of energy.  
As for others organelles, anterograde and retrograde mitochondrial trafficking is 
supported by cytoskeletal transport mechanisms primarily by microtubule-based 
motors—kinesins and dynein20. This process, together with the maintaining of 
neuronal excitability, covers about the 60–80% of the ATP consumption in the CNS. 
The remaining 10–20% is invested in the neurotransmission, which includes 
synthesis and packaging of neurotransmitters in vesicles and the transport to 
presynaptic endings19. The high dependence of neurons on oxidative 
phosphorylation, as the major source of energy, makes them extremely vulnerable 
to substances that are able to interfere with the mitochondrial respiratory chain19.  
The capacity of some platinum-based chemotherapeutic, such as OHP and 
cisplatin15,22, to bind mitochondrial DNA (mDNA) and form mDNA adducts may 
affect the replication and transcription of mDNA, resulting in the synthesis of 
abnormal proteins and the following damage on the mitochondrial activity. 
17 
 
Otherwise, the interruption of the respiratory chain function can also derived in an 
abnormal accumulation of substances inside the mitochondria, as in the case of NPs 
after the interaction with cells23–25. In any case, the impairment of the 
mitochondrial physiological function is followed by a decrease in the cellular 
metabolism and, thus, an increase in the production of ROS (reactive oxygen 
species) that, most likely, reaches the oxidative stress condition, often 
accompanied by the degeneration of the organelle itself and the inevitable cell 
death4,11,26.  
Furthermore, neurons are susceptible to any, direct or indirect, impairment to the 
normal cytoskeleton structure. The stress on the axonal transport system is so high 
that non-critical perturbations for other cell types can cause degeneration in 
neurons. It has been reported the role of several kinds of NPs in perturbing the 
cytoskeletal architecture in cells of the CNS, as observed, for example, for Ag NPs, 
which affect key cytoskeletal proteins β-tubulin and F-actin in rat cortical neurons 
27. 
 
Ion Channels and Neurotrasmission 
 
The proper functioning of ion channels in the membrane is necessary for preserving 
the neuronal excitability. An elevated active transport maintains unequally 
distributed the ions on each side of the axonal membrane. In this way, the axonal 
membrane separates areas of unequal electrochemical potential, generating a 
resting potential. In this condition, the internal compartment results negative 
because the majority of Na+ selective channels are closed and the K+ selective 
channels open and close occasionally. However, this situation completely changes 
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in the presence of a stimulation, during which voltage-dependent Na+ selective 
channels start to open making the membrane permeable to mainly Na+  ions and 
thus the internal compartment of the cells more positive (depolarization). Right 
after, Na+ selective channels start to inactivate and voltage-dependent K+ selective 
channels to open, bringing the membrane back to resting levels, ready to restart 
the generation of another electrical signal. In order to avoid the accumulation of 
Na+ (but also Ca2+ and Cl-) in the neuronal cytosol, and of K+ to the extracellular 
space, the combination of ATPase (Na+-K+ ATPases and Ca2+ ATPases) activity and 
K+ buffering of astrocytes acts to restore and maintain neuronal excitability. When 
a nerve impulse reaches a terminal branch of an axon, it depolarizes the synaptic 
boutons. Here, a second type of transmission by means of the cellular release of 
special messenger chemicals (neurotransmitters) initiates. The amount of secretion 
is related to the degree of depolarization, which, in turn, is a function of the number 
of nerve impulses that reach a synaptic bouton17. Thus, any disturbance in the 
neuronal and glial functioning affects the membrane excitability and, as 
consequence, the release of neurotransmitters. 
Before any internalization process is initiated, the plasma membrane represents 
the first site of interaction between nanoobjects and cell. Thus, receptors for 
neurotransmitters and neurohormones, transporters, channels and lipids that 
composed the plasma membrane, may represent possible targets of this 
interaction4. Large amounts of data support the hypothesis that ionic channels can 
be modulated in different ways by several kinds of NPs. Among these, there are 
Na+, K+, Ca2+ voltage operated channels 28–30, but also members of the highly 
heterogeneous family of Transient Receptors Potentials channels (TRP)10, as well as 




In a similar way, the hyperexcitability observed following a single administration of 
OHP may be partially induced by the altered action of Na+  channels (NaV)32,33, TRP 
channels34,35 and members of the two-pore domain potassium channels K2P 
subfamily36,37, as main players in the transduction of the thermal, chemical and 





The physical BBB has evolved for preventing the entrance of various toxic 
compounds in the brain and thus preserving its homeostatic microenvironment. 
The BBB comprises three parts: 1) the arachnoid barrier, composed by three 
layers of connective tissue that are collectively termed the meninges (dura mater, 
arachnoid mater and pia mater) and are present in the brain as well as in the spinal 
cord; 2) the blood–cerebrospinal fluid barrier (BCSFB), which comprises the 
epithelial cells that surround the specialized vascular tissue (choroid plexus) 
present in each lateral ventricles of the brain, where the cerebrospinal fluid (CSF) 
originates; and 3) the BBB itself, which is the closest to the neurons. The BBB is 
formed by brain microvessel endothelial cells (BMECs), which separate the blood 
in the capillaries from the interstitial fluid (ISF) in the brain compartment. Tight 
junctions, adherent junctions, apicobasal polarity, and a luminal surface-bound 
glycocalyx provide to BBB with unique properties that make it a physically 
imposing gateway that control the penetration of any molecule to brain. Different 
types of cells (i.e. neurons, BMECs, vascular smooth muscle cells, astrocytes, 
microglia, pericytes, oligodendrocytes, mast cells), constituting all together the 
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neurovascular unit (NVU), are in constant cross-talk to each other. They create a 
very complex interdependence that dynamically regulates the permeability of the 
BBB and, thus, preserves the optimal functioning of the CNS38. 
However, it is not completely impermeable for all substances since there is directed 
transport by diffusion of lipophilic substances through cell membranes, and 
paracellular passage of water-soluble substances across tight junctions21. 
Furthermore, not all the neurons in the body are protected. In the peripheral 
nervous system the lack of the BBB, that is supplied by capillaries with fenestrated 
walls, allows the free passage of molecules between the bloodstream and the 
extracellular fluid. This explains, in part, why sensory neurons located in the dorsal 
and trigeminal root ganglion (DRG and TG) may represent the main target of 
chemotherapeutic agents like platinum-based drugs. Moreover, many studies have 
shown a new neuropsychological syndrome associated with cancer 
treatment/chemotherapy-induced cognitive impairment.  
A direct action of chemotherapeutics on BBB endothelial cells (EC) has not been 
demonstrated. However, in vitro administration of OHP induces significant changes 
in the junctional and cytoskeletal apparatus of endothelial cells, and these 
alterations in the BBB may be associated with higher concentrations of OHP in the 
brain, what probably contributes to the development of a chronic form of pain11 . 
A consistent set of data, both in vivo and in vitro assays, confirms that many types 
of NPs can reach the CNS by two main pathways: 1) by crossing the BBB when either 
orally administered or injected (transcellular diffusion, paracellular diffusion, 
receptor-mediated transcytosis, adsorptive-mediated transcytosis), 2) or through 
the nasal epithelium to the olfactory bulb and the brain, when inhaled3. The initial 
uncertainty about the accessibility of NPs to the central CNS is probably because of 
the lower amount of data on potential NP-induced neurotoxicity, respect to 
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literature dedicated to describe the interaction between NMs on other tissues and 
cells4. 
 
1.4 Mechanisms of Neurotoxicity 
 
Among the possible mechanisms by which external agents can trigger a neuronal 
damage, the oxidative stress, the dysregulation of Ca2+ and pH homeostasis have a 
high impact on the functional modulation of the proteins that govern the resting 
membrane potentials, that set the threshold for firing action potential, that 
influence the duration and/or shape of an action potential and that synchronize 
neuronal activity. Even small perturbations in these regulatory pathways can lead 
to serious pathological events, including apoptosis and cell death. Even more, all 
these mechanisms appear to be mutually interconnected to each other39.  
 
Formation of ROS 
 
The term ROS is used to describe a variety of molecules and free radicals derived 
from molecular oxygen. The main sources of intracellular ROS are mitochondria, 
endoplasmic reticulum (ER), peroxisomes, microsomes, and a family of cell 
membrane enzymes namely nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidases (NOX).  
MITOCHONDRIAL ROS SOURCES Mitochondrial electron-transport system 
represent the main intrinsic source of ROS. During the generation of ATP 
and water, the individual complexes of the respiratory chain mediate the 
transfer of the electrons from the reducing equivalents NAD(P)H and FADH2 
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(Flavin adenine dinucleotide) to molecular oxygen. Since mitochondria are 
not thermodynamically perfect machines, some of these electrons 
inevitably escape the physiological default pathway40,41. The one-electron 
reduction of molecular oxygen operated by complex I (NADH ubiquinone 
oxidoreductase) and complex III (co-enzyme Q, bc1complex, and 
uniquinone/cytochrome c reductase) activity in the mitochondrial matrix 
and intermembrane space, respectively, generate the first ROS element: the 
superoxide anion (O2−). Once in the intermembrane space, O2− can be 
converted, spontaneously or by the catalysis of an enzyme family known as 
SOD (superoxide dismutase), into a more stable form, hydrogen peroxide 
(H2O2). However, further reactions may lead to the formation of hydroxyl 
radicals (OH), through the Fenton or Haber-Weiss reactions42,43.  
NON-MITOCHONDRIAL ROS SOURCES In addition to the mitochondrial 
electron transport, other cellular systems are able to generate ROS, 
including NADPH oxidases, xanthine oxidase, nitric oxide synthases, 
cyclooxygenases and lipoxygenases. Among them, NADPH oxidases, 
originally discovered in neutrophils, which play a key role in the microbicidal 
activity, are a distinct ROS producing family of enzymes. They are multi-
subunit membrane-bound enzymes, expressed at the cell surface and 
intracellular organelles, that catalyze the reduction of oxygen into 
superoxide (O2-) by using NADPH as an electron donor and oxygen as an 
electron acceptor. Thus, whereas the other oxidoreductases, mentioned 
above, only produce ROS as by-products along with their specific catalytic 
pathways, NADPH oxidases can be considered as “professional” ROS 
producers. Recently, seven different homologues have been identified in 
mammalian cells44. It should be noted that in many tissues their expression 
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is not constitutive (i.e. neurons), but Nox-dependent ROS generation can be 
stimulated by a large collection of chemical, physical, environmental, and 
biological factors. These findings suggest that NADPH oxidase is an 
important component of the cellular stress signal transduction network, a 
sort of cellular “alarm system”, that can alert and prime the cells either to 
be adapted to the stress or to undergo apoptosis40. 
 
For most organ systems, including the CNS, only uncontrolled levels of ROS are 
deleterious. Regulated ROS generation has key functions in physiology and 
intracellular signaling pathways, such as inhibition of protein tyrosine 
phosphatases, activation of certain redox-sensitive transcription factors, and 
modulation of the functions of some ion channels45. Therefore, to maintain the 
concentration of these oxidants at non-toxic levels, many enzymatic mechanisms, 
as well as nonenzymatic components with antioxidant capacity that derive directly 
from the dietary (i.e. β-carotene, ascorbate (vitamin C), α-tocopherol (vitamin E)), 
are present 42.  
SOD enzyme removes superoxide ions to form hydrogen peroxide. The cytosolic 
form of this enzyme contains Cu+ and Zn+ (CuZn–SOD), while the mitochondrial 
form contains Mn (Mn–SOD). H2O2 produced this way can be removed by 
glutathione peroxidase or catalase, both of which are haem-containing enzymes42. 
Due to the close proximity to the electron transport chain, the major locus for free 
radical production, and the lack of protective histones, the mitochondrial DNA 
(mtDNA) is, therefore, the principal cellular target of oxidative stress. Although the 
presence of DNA-repairing enzymes, ROS can impair the mtDNA that, in turn, may 
induce a decrease of cellular metabolism through the disruption of electron 
transport (many electron carriers are synthetized from mitochondrial 
24 
 
chromosome), mitochondrial membrane potential, ATP generation and an 
increased production of ROS46. 
The stimulation of lipid peroxidation is another important factor that may 
contribute to the suppression of mitochondrial metabolism. The uncontrolled 
formation of lipid peroxides exerts its toxic effect through two general mechanisms: 
first, affecting the composition, structure and dynamics of cellular membranes, 
since they are important for the maintaining of the membranes integrity; second, 
being highly reactive compounds that may react with proteins and DNA, 
contributing, in this way, to the propagation and generation of new ROS47.  
Mitochondria are one of the internal organelles involved in the regulation of Ca2+ 
homeostasis. A tight correlation between the oxidative stress and calcium signal 
disruption is markedly evidenced by the Ca2+-dependent mitochondrial 
permeability transition (MPT). When intracellular Ca2+ rise and the retention 
capacity of the mitochondria is exceeded, the protein channels, commonly known 
as the permeability transition pores (PTP), open. The efflux of Ca2+ causes drastic 
changes in mitochondrial ultrastructure and functional activity. The result is a 
mitochondrial failure, which can lead to necrosis due to ATP depletion, or, if MPT 





Ca2+ regulates many divergent cellular processes, including, but not limited to, 
muscle contraction, exocytosis and gene transcription. Signals that have a widely 
different spatial and temporal profiles, from microseconds, for Ca2+ triggering 
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exocytosis at the synaptic junction, to hours, for gene transcription and cell 
proliferation.  
This versatility emerges from the use of an heterogenous molecular array of 
components that constitute the complex toolkit of Ca2+ signalling. Pumps, channels, 
exchangers and binding proteins tightly control changes in free cytosolic Ca2+ 
concentration [Ca2+]c, that in resting conditions is maintained around the value of 
10-100 nM (Fig. 2). While internal and external sources of Ca2+ are used by the cells 
to generate Ca2+ signals 48,49.  
Ca2+-entry mechanisms When the permeability of the plasma membrane to 
Ca2+ changes, the ions enter the cell from the outside, where the [Ca2+] is 
around 2 mM. The large electrochemical gradient across the plasma 
membrane is guaranteed by the activity of the Ca2+-ATPase (PMCA) and of 
the Na+/Ca2+ exchanger (NCX), that removes Ca2+ from the cytoplasm in 
order to restore the resting state50.  
There are various entry channels, each of them characterized by widely 
different properties. Voltage-operated Ca2+ channels (VOCCs), found mainly 
in excitable cells, generate rapid Ca2+ fluxes that mediate fast cellular 
responses such as muscle contraction or exocytosis at the synaptic endings. 
Furthermore, there are also channels modulated by ligands, that can be 
external ligands, as in the case of NMDA (N-methyl-D-aspartate) receptors 
(NMDARs) that respond to glutamate and, for this reason, belonging to the 
class of Receptor-operated channels (ROCs); or they can be internal ligands, 
as in the case of channels gated by cyclic-nucleotides, found mainly in 




Moreover, other types of stimuli are translated by different channels. Many 
of them belong to the superfamily of TRP channels, composed by 28 
members, encoded by up to 28 different genes and one pseudogene 
generally characterized by a low conductance that allow them to operate 
over much longer time scales without swamping the cell with too much Ca2+ 
48.  
 
Ca2+ release from internal stores Other important sources for Ca2+ signalling 
are represented by the internal stores. The principal organelle responsible 
to rapid rise of Ca2+ is the ER, or its muscle equivalent, the sarcoplasmatic 
reticulum (SR). The release from such store is controlled principally by Ca2+ 
itself, but also, by several other messengers, such as inositol-1,4,5-
trisphosphate (Ins(1,4,5)P3), cyclic ADP ribose (cADPR), nicotinic acid 
adenine dinucleotide phosphate (NAADP) and sphingosine-1-phosphate 
(S1P)48. Since little is known about the channels opened by NAADP and S1P, 
in this section, the focus will be on Ryanodine (RYR) and Inositol (1,4,5) 
trisphosphate (Ins (1,4,5) P3R) receptors. These two channels are often 
mediators of Ca2+ signal amplification. In general, at low concentrations of 
Ins (1,4,5) P3, they have a bell-shaped Ca2+ dependence. Therefore, at low 
concentrations of cytosolic Ca2+ (100-300 nM) they take part to the so-called 
Ca2+-induced Ca2+ release (CICR) process, but, when the concentration of 







Figure 2. Overview of the calcium homeostasis and signaling mechanisms. Ca2+ signalling 
can be divided into “on” and “off” reactions. During the “on” reactions, the [Ca2+]i increases as a 
consequence of Ca2+ entry from the external environment or through the release from 
intracellular stores. Most of this Ca2+ (shown as red circles) is bound to buffers and effectors. 
During the “off” reactions, Ca2+ leaves the effectors and buffers and is removed from the cell by 
various exchangers and pumps. The Na+/Ca2+ exchanger (NCX) and the plasma-membrane Ca2+-
ATPase (PMCA) extrude Ca2+ to the outside, whereas the sarco(endo)plasmic reticulum Ca2+-
ATPase (SERCA) pumps Ca2+ into the ER. Mitochondria also have an active function: they rapidly 
sequester Ca2+ through a uniporter, and then slowly release it back into the cytosol (adapted 
from Berridge, Bootman, et al. 2003). 
 
A unique array of channels can be found in each cell type, in order to create a 
perfect “toolkit” able to generate a Ca2+ signalling systems that differ in terms of 
spatial and temporal properties.  
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The cytosolic buffers proteins are essential for shaping the amplitude, as well as the 
duration of Ca2+ signals. They are molecules that serve as Ca2+ ion chelators that 
present appropriately spaced acidic side-chain residues (i.e. glutamate, aspartate) 
and/or backbone carbonyl groups, in which a Ca2+ ion may fit in. This evolutionarily 
well-conserved protein families differ in the way the Ca2+ ions are bound52.  
In the neurons, for example, high concentration of buffers like parvalbumin and 
calbindin, belonging to the EF-hand cytosolic protein family, limits the spatial 
spreading of local Ca2+ signals. This is particularly important to maintain confined 





The intracellular pH represents another fundamental parameter that can affect a 
wide range of biological processes, including membrane excitability, intercellular 
communication, signal transduction and vesicle trafficking. The ionization state 
and, therefore, the structure and function of virtually all proteins of the cells 
depend on pH. Not surprisingly, dynamic and sustained mechanisms have been 
evolved to maintain long-term pH homeostasis53.  
Under physiological conditions, the extracellular pH is slightly alkaline (~7.3–7.4), 
while the cytosolic pH is slightly more acidic (7.2). The tendency of cells to acidify 
can be explained by 1) the electrical potential across the membrane and 2) the acid 
equivalents produced during metabolic reactions. Being more negative inside, the 
cells promote the uptake of the positively charged protons and, at the same time, 
the efflux through specific pathway of the negatively charged bases. Furthermore, 
the continuous generation of acid equivalents during metabolic reactions, like ATP 
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production by glycolysis and oxidative phosphorylation in the cytoplasm and in the 
mitochondria, respectively, can boost the gradual accumulation of free H+ 54. 
Although the cells have a high buffer capacity, characterized by various intracellular 
weak acids and bases that protect them from rapid and localized pH changes, active 
processes are needed to promote the protons extrusion from the cytosol across the 
plasma membrane in sustained stress situations. A steady state condition is 
maintained when a balance between the rate of acid loaders (JL, i.e., rate of acid 
influx/generation or alkali efflux/consumption) and the rate of acid extrusion (JE, 
i.e., rate of acid efflux/consumption or alkali influx/generation) is achieved55,56 (Fig. 
3).  
ACID LOADERS Mammalian cells are continuously exposed to CO2, which 
being uncharged, can cross the biological membrane and enter into the 
cells. Once inside, CO2 can combine with H2O to form H2CO3, most of which 
dissociates very slowly to form HCO3- and H+. Most cells have a specific 
enzyme, carbonic anhydrase, that catalyzes the conversion of CO2+H2O to 
H2CO3, accelerating the acidification process of the cell. Although HCO3- is an 
effective proton buffer, it is negatively charged and, as well as OH-, can 
passively exit to the cell and then contribute to the instauration of a chronic 
intracellular acid load53.  
The main acid loader that is involved in the JL is the Cl-/HCO3- exchanger 
(Anion Exchanger AE, encoded by the SLC4A gene). AE3 is the most 
expressed exchanger in the CNS and, as the other members of the family, 
mediates the electroneutral exchange of one Cl− for one HCO3-. Generally, 
Cl− concentration inside the cells is lower than extracellularly, so the inward 
gradient of Cl− provides the driving force for a net efflux of HCO3- 54. Thus, 
since acid loaders, at least in theory, work without the direct input of energy, 
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if the gradient driving transport reverses, the acid-base transporters can 
switch the direction of net transport53. 
Finally, the electrogenic Na+/HCO3- cotransporter will be explained in the 
next paragraph in detail since this same protein can either operate as acid 
loader and acid extruder. 
ACID EXTRUDERS The extrusion of acid equivalents is an active process that 
tends to raise the intracellular pH an to restore it after an acid loading, for 
example, after an intense neuronal activity55. The membrane associated 
vacuolar H+-ATPase (V-ATPase), firstly found in association with endosomal 
membranes, but also distributed in the plasma membrane of specialized cell 
types (i.e. phagocytes and osteoclasts54), is a pump that uses the energy of 
ATP hydrolysis to extrude cytosolic H+ into the extracellular space.  
The net extrusion of H+ or the influx of HCO3- can be also accomplished by a 
secondary active transport. In this context, the main acid extruders are the 
Na+-H+ antiporters or exchangers (NHE) from the SLC9 family of solute 
carriers and the Na+-coupled HCO3- transporters (NCBTs) in the SLC4 family. 
NHEs use, in an electro-neutral manner, the inwardly directed 
electrochemical Na+ gradient generated by Na+/K+-ATPases to export H+. 
Until now, nine different isoforms of NHE exchangers have been identified 
and all of them are broadly expressed in the CNS.  
Among the acid-extruding HCO3- transporters, the six mammalian NBCTs are 
the predominant. They translocate Na+ and HCO3– both in the same 
direction, but the coupling stoichiometry varies among members of this 
family. In particular, several Na+-driven HCO3- (or CO32-) operate as acid 
extruders (NBCn1 and NCBn2), with a Na+: HCO3- stoichiometry of 1:2, while 
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others, as acid loaders (NCBe1 and NCBe2), if Na+:HCO3- stoichiometry is 
1:353,54.  
NBCn1 and NCBn2 are electroneutral isoforms, what means that they are 
unaffected by the transmembrane potential, and perhaps the magnitude 
and directionality of transport is dependent solely of the combined chemical 
gradients of Na+ and HCO3–. 
Conversely, for the electrogenic NBCe1 and NBCe2, the driving force depend 
of the electrical potential, as well as the concentration of HCO3- and Na+ on 
either side of the membrane. Therefore, for example in the case of renal 
proximal tubule, in which the electrical component outstrips the driving 
force of the concentration gradients, the net direction of transport is 
outward, resulting in a cytosolic acidification.  
Finally, the Na+-driven Cl-/HCO3- exchanger that mediates the electroneutral 
exchange of one Na+ plus two HCO3− equivalents for one Cl−. This was the 
first transporter ever to be studied as a pHi regulator53. 
 
A straight correlation between the excitability of the neurons and pH changes 
exists. Membrane proteins, such as channels, transporters, receptors and even 
ATPase pumps have intracellular and extracellular moieties that result in pH 
sensitivity. The direction of the responses evoked by pH changes depends on the 
individual components that are responsible for dictating overall excitability in each 
neuron. For this reason, there are neurons that exhibit hyperexcitability following 
an acidification of the cytosol (i.e. chemosensitive neurons), while others could 





Figure 3. pH regulation in the CNS. (A) pHi dependence on the balance between the rate of 
acid extrusion (JE) and the rate of acid loading (JL). Steady-state of pHi is achieved when JE = JL 
(intersection of dark-blue and dark-red lines: point A). A shift to a more alkaline value 
(intersection of light-blue and dark-red lines: point B) follows an JE increase (J’E). Conversely, a 
shift to a more acidic value (intersection of dark-blue and light-red lines: point C) follows an JL 
increase (J’L). If the rise in JE is matched by an equal increase in JL (J’E = J’L) there will be no net 
change in pHi (red circle). (B) Acid loaders (red) and acid extruders (dark blue) in neurons, 















The TRP superfamily is a very heterogenous class of ion channels displaying a great 
diversity of ion selectivity, modes of activation, and physiological functions57. 
Despite this variability, all the members of this family share a typical protein 
structure consisting of six putative transmembrane segments (S1 to S6) that 
assemble in tetramers (homo- or heterotetramers) to form the functional channel. 
Each subunit contributes to selectivity filter and to ion-conducting pore with a 
reentrant loop located between S5 and S6. They also have an intracellular amino 
and carboxyl termini that result variable in length and in domains.  
From protein homology, TRP channels can be divided into seven subfamilies: TRPA, 
TRPC, TRPM, TRPML, TRPN, TRPP and TRPV58. They are expressed in all cellular 
membranes, with the exception of the nuclear envelope and mitochondria, of 
virtually all cell types. The majority are located in the plasma membrane, where 
they mediate the transport of ions59. Although they are defined as non selective 
Ca2+-permeable cation channels, the variety of homo/heteromultimerizations that 
can be achieved, makes the overall picture of TRP channel ion selectivity more 
complex. Most TRPs show little preference for Ca2+ over Na+, some others (i.e. 
TRPC1, TRPM1 and TRPP2) are completely non-selective cation channels, and both 
Ca2+-selective (i.e. TRPV5 and TRPV6) and Na+-selective (i.e. TRPM4 and TRPM5) are 
present in the superfamily57. 
Regarding the regulation of their activity, a lot of mechanisms have been described. 
The mechanism(s) through which a given TRP is activated and regulated cannot be 
predicted reliably on the basis of its subfamily assignment. Members of this family 
that are considered sensors for the temperature, are also sensitive to a large 
34 
 
number of exogenous and endogenous ligands. The heat-sensitive TRPV1 can be 
also activated by capsaicin (the pungent extract of hot peppers), as well as the cold 
receptor TRPM8 by menthol (derived from the mint plant Mentha piperita), and 
TRPV4 directly by bisandrographolide (derived from the plant Andrographis 
paniculata)59. The recurring topic is that most TRP channels are activated through a 
diversity of mechanisms60.  
Initially considered as rather insensitive to voltage, it is well documented now, that 
the mid-point activation of TRPs, evoked for example by temperature or ligands, 
can undergo to a voltage-dependent shift of even several millivolts magnitude61. 
This intrinsic voltage dependence regards mainly TRPs involved in sensory 
perception59. However, in some cases there are similarities among subfamily 
members, as all TRPC channels that are sensitive to membrane phospholipids, like 
phosphatidylinositol (4,5) bisphosphate (PtdIns (4,5) P2).  
The modulation by phospholipids can be direct or indirect. The great number of 
membrane-associated proteins sensitive to the levels of PtdIns (4,5) P2 can, in turn, 
affect the activity of TRP channels62. The hydrolysis of PtdIns (4,5) P2 operated by 
phospholipases C (PLCs) can be activated by two different pathways: 1) G protein–
coupled receptors (GPCRs) and 2) tyrosine kinases receptors. Once the hydrolysis 
of PtdIns (4,5) P2 is obtained, two important signaling molecules are produced: 1) 
diacylglycerol (DAG) and 2) inositol (1,4,5) trisphosphate (IP3)58,59. DAG can affect 
the TRP channel opening directly or indirectly, by producing several metabolites of 
(i.e.). While IP3, which activates IP3 receptors (IP3R) on the ER membrane, evokes a 
release of Ca2+ from intracellular stores responsible of the activity modulation of 
TRP (store-operated Ca2+ entry (SOCE) or capacitative Ca2+ entry (CCE))57. Additional 
activation mechanisms include phosphorylation by PKA, PKC and PKG, that sensitize 
them by other stimuli; changes in extracellular and intracellular pH; ROS 
production; mechanical stimuli and changes in osmolarity58,63–67.  
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Detecting and responding to this wide variety of external environment stimuli make 
their contribution essential for several physiological processes, ranging from pure 
sensory (chemosensation, thermosensation, nociception, mechanosensation and 
photoreception) and homeostatic (such as reabsorption and osmoregulation of Ca2+ 
and Mg2+) functions to many other motile functions, such as muscle contraction and 
vasomotor control. Thus, an increasing number of evidences suggest the 
implication of several TRP channels in a wide range of diseases in humans, following 
either mutations in the encoding gene or an acquired mechanism.  
Genetically and pharmacological evidences have confirmed the involvement of 
these channels in the generation and transduction of pain (TRPV1,TRPA1,TRPM8); 
in the activation of central and peripheral reflex responses, including cough, mucus 
secretion and bronchospasm, in the mammalian respiratory tract following the 
interaction with irritant and/or inflammatory stimuli (TRPV1, TRPA1, TRPM8, 
TRPV4, TRPC6); in the skin, where they control a variety of biological processes such 
as itch, regulation of barrier function, keratinocyte differentiation, hair growth, 
inflammation and wound healing, being expressed both on neuronal and non-
neuronal cells (TRV1, TRPV3, TRPA1); in CNS disorders, like learning and memory 
formation through regulation of synaptic plasticity (TRPC6), or neurodegenerative 
disorders, Guamanian amyotrophic lateral sclerosis (ALS-G) and Parkinsonism 
dementia (TRPM2, TRPM7), or in axonal and neuronal degeneration in Multiple 
Sclerosis (MS, TRPM4) and in cardiac hypertrophy associated with arrythmias, 






Large conductance channels: Connexins and Pannexins  
 
Gap junctions (GJs) were primarily known as mediators of direct intracellular 
communication. When two hemichannels (HCs), belonging of two neighboring cells, 
interact together, a GJ is formed. These junction put directly in contact the cytosolic 
compartments of adjacent cells allowing the flux of several small molecules, such 
as ATP, glutamate and prostaglandins, as well as ions, including Ca2+. Each 
hemichannel is composed of 6 connexin (Cx) proteins, all of which consist of 4 
transmembrane domains, 2 extracellular loops (EL), 1 cytoplasmic loop (CL), 1 
cytoplasmic C-terminal tail (CT) and 1 cytoplasmic N-terminal tail. Now, it is clear 
that Cx HCs are not only structural precursors of GJs but themselves, alone, can 
provide a circuit for communication, albeit between the cytosol and the 
extracellular environment69. Although Cx- based GJC and hemichannels share 
similar structure, they differ in their localization (inside or outside the contacting 
zone with others cells), opening and closing regulation and their roles in cellular 
processes70. Usually, while the GJs are open in physiological conditions, Cx HCs are 
typically closed, because of their low open probability, which would be enough to 
participate in several cellular processes. For example, Cx46 and Cx50 hemichannels 
openings seem to have a crucial role in the lens, an avascular tissue in which the 
microcirculatory homeostasis depends on nutrient, electrolyte and water flow 
through these plasmalemmal channels. In human CNS, where 11 out 21 Cx isoforms 
have been identified, are differently distributed between astrocytes, 
oligodendrocytes, microglia and neurons. Here, hemichannels activity has been 
correlated to release of precursor or signaling molecules such as Nicotinamide 
adenine dinucleotide (NAD+), ATP, adenosine, IP3 and glutamate. The opening of 
Cx43 hemichannels, which represents also the most abundantly expressed 
connexin in the human body, and the following release of ATP have been observed 
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in astrocytes in which it seems to be involved in the Ca2+ wave propagation 
mediated by an extracellular paracrine signaling component 71. 
However, in the presence of several type of stimuli such as increases in membrane 
depolarization, an increase in intracellular Ca2+ concentration or a decrease in 
extracellular Ca2+ concentration, mechanical stimulation, changes in the Cx 
phosphorylation status, oxidative stress, pH, ischemia/reperfusion insults, fatty 
acid overload and in the inflammatory conditions the Cx- hemichannels open 
probability increases. When the hemichannel activity becomes too high and 
uncontrolled, cell viability diminishes. In this cases, they form “leaky hemichannels” 
and/or their number at the plasma membrane increase dramatically up to enhance 
cell membrane permeabilization, enough to cause an accelerated cell death70. In 
addition of a possible abnormal connexin hemichannel activity that could be 
considered as a gain-of-function mutation, many connexins undergo to loss of gap 
junction function owing to trafficking deficiencies (i.e. gap junction plaque 
formation), channel malformation (non-functional or communication-deficient 
channels) or the genesis of aberrant hemichannel activity. At least the half part of 
the total human connexin genes identified can be linked to inherited human 
diseases including neuropathies, deafness, skin diseases, oculodentodigital 
dysplasia (ODDD) and cardiac arrhythmias 69,70,72. 
In 2000, a novel class of Cx-like proteins, with similar membrane topology to the 
connexins but without forming GJs, has been identified. The Panx family consists of 
three members, namely Panx1, Panx2, Panx3. Panx1 is the most widely represented 
one in diverse tissues and cell types, while the other two are mainly expressed 
respectively in the CNS and, in skin and skeletal tissues. Similar to Cx hemichannels, 
Panx ones are implicated in a wide variety of physiological and pathological 
contexts. Although Panx channels are opened at positive potential, a wide number 
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of triggers that promote their opening at membrane resting potential, has been 
identified69,73. Large amount of data refers their activation following the 
intracellular Ca2+ increments, the phosphorylation mediated by Src family kinase or 
by other types of kinases (i.e. c-Jun NH2-terminal kinase (JNK); protein kinase G), 
the ATP binding to purinergic P2 receptors (such as P2Y receptors), the oxygen 
deprivation (in erythrocytes and neurons), the elevation of extracellular potassium 
or a mechanical stress (in various cell types)74.  
Both reversible (i.e. G-protein-coupled receptor) and irreversible (caspase- 
mediated cleavage) forms of channel activation induce a progressive channel 
opening, characterized by a robust macroscopic currents across the plasma 
membrane of individual cells (ion- and large-molecule transport) that presents at 
least five open substates (corresponding to 5, 25, 30, and 90% of the fully open 
unitary conductance, ranging from ∼300 pS to >500 pS)74.  
The involvement of pannexins in the induction of inflammation has been reported 
in multiple publications. There are many evidences that support the idea that Panx1 
and its associated P2X receptors are essential for upstream regulation of 
inflammasomes and proteolytic activation of Casp1 and Casp11. This has been 
reported in many cell types, however a strong demonstration has been only 







Two-pore domains (K2P) channels 
 
The two- pore domain are the third major family of K+ channels, along with voltage-
gated (KV) and inwardly rectifying (Kir). They are structurally different to the others 
K+ channels. While voltage-gated KV channels and inwardly rectifying Kir channels 
assemble as tetramers and each subunit symmetrical contribute to the ion 
permeation pathway through a single copy of P-domain, the K2P have two pore 
domains (P1 and P2) in tandem per subunit and four transmembrane domains 
(TM1–TM4). A large extracellular cap-domain linked to the P1 from TM1, stabilized 
by an apical disulphide bridge, can be considered as the most prominent structural 
motif of K2P. The steric hindrance created by the specific position of the cap-domain 
seems to modulate the gating of the K2P channels, rendering them less sensitive to 
classical toxin peptides and pore blocking molecules like tetraethyl-ammonium ions 
that, instead, act on other classes of K+ selective channels. 
In mammals, K2P derive from 15 genes and can be classified in six subfamilies: TWIK 
(weak inward rectifiers), TREK (lipid and mechanosensitive channels), TASK 
(acidification-inhibited), TALK (alkalinization-activated), THIK (inhibited by halo- 
thane), and TRESK (spinal cord channels)76. They are called leak or background 
channels for their primary function, which is to maintain hyperpolarized resting the 
membrane potential of virtually every excitable and non-excitable eukaryotic cell. 
Increasing evidence suggests that the activity of these ion channels can be also 
modulated by a great variety of stimuli, including changes in membrane tension, 
voltage, temperature, oxygen-tension, extracellular and intracellular pH, 
phospholipids, and other signaling molecules arising from G-protein–coupled 
receptor activation76,77. Although they do not have a conventional voltage-sensor, 
a voltage-dependence has been shown in most K2P channels, except for TWIK-1. A 
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recent work provides a possible explanation of the voltage-dependence of K2P78. 
The intriguing hypothesis relies crucially on the movement of the permeant ion, 
along the selectivity filter (SF), and therefore on its electrochemical potential 
difference. Only a depolarization would push ions into the SF, otherwise empty. 
Once fully occupied, it become permeant in outward direction. High occupancy 
would not be reached by forcing ion movement in the inward direction; under these 
conditions, the SF would become inactive. Many stimuli including intracellular 
acidification , lipids, membrane tension can affect the voltage- dependence78. 
K2P channels are expressed throughout the body and each type of channels have a 
different expression profile. It is well established that several members of this 
family are highly expressed in DRG and TG neurons77. Therefore, an increasing 
number of evidences is revealing their central role in the transduction of noxious 
stimuli by modulating the somatosensory excitability. The painful stimuli activate 
various classes of cationic ion channels like ASIC, TRPV1 and TRPA1 in the peripheral 
nerve terminals, in which they induce a depolarization of the membrane potential. 
Voltage-dependent Na+ channels generate an action potential when the threshold 
is reached. The leak K+ channels are able to prevent the generation of an action 
potential hyperpolarizing the membrane potential. Thus, these channels operate a 
counteraction by decreasing conduction fidelity across the axon or by limiting the 
release of neurotransmitter79. Further evidences are provided, for example, by less 
amplitude current required to elicit an action potential in cells derived by TRESK-1 
knockout mice; or the mechanical and thermal hypersensitivity showed by both 
TREK-1- and TRAAK-deficient mice in response to a chronic inflammation. On the 
contrary, the overexpression of TRESK channels reduces mechanical and thermal 
hypersensitivity in response to nerve injury80. 
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The implication of these channels in the regulation of multiple types of pain, such 
as inflammatory, neuropathic, mechanical and thermal, migraine and cancer pain, 
make them possible molecular targets for the development of pain therapeutic 
strategies. However, the pharmaceutical design is restrained by 1) the broad range 
of transcript processing and post-translational modification mechanisms 
(phosphorylation, SUMOylation, glycosylation) and 2) the high capacity of 
heterodimerization of specific pairs of subunits. The result of these mechanisms is 
a high rate of diversification of channels, with completely distinct physiological and 
pharmacological properties by combining the functional properties of single 
constituent. However, the lack of structural data remains the first most prominent 
bottleneck in the development of drugs that act at K2P channels77,80,81. 
 
1.6 Neurotoxicity screening  
 
Traditionally, the paradigms for hazard identification and risk assessment requires 
an animal-based experimental approach. In the last years, a change towards new 
approaches using integrate in silico and in vitro testing to identify the mechanisms 
of toxicity is occurring. Many practical and scientific considerations support this 
evolution, first of all the increase of safety testing reliability by reducing the need 
for animals and by lowering the costs with the implementation of high-throughput 
methods82. 
The endpoints commonly used for in vitro neurotoxicity testing can be divided into 
three categories: 1) viability read-outs, 2) morphological read-outs and 3) 
functional read-outs. The first step is, essentially, to identify which are the 
compounds that cause toxicity in one or more cell types and to individuate which is 
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the lower concentration that can affect the viability of the cells. Thus, biochemical 
assays are usually chosen for monitoring the irreversible cell damage by measuring 
the level of energy metabolism, using ATP as indicator83; by quantifying the 
reduction in resazurin or tetrazolium salts (i.e. MTT, MTS, XTT or WST ) in viable 
cells84; by evaluating the level of lactate dehydrogenase (LDH) from dead cells85; or 
by measuring markers of the apoptosis, such as cleaved caspase-3 or the 
accumulation of p53, for the evaluation of the degree of proliferation of cells 
exposed to neurotoxicants86.  
Once established the sub-cytotoxic concentrations that can be used, morphological 
and functional read-outs are evaluated. At this point, the common endpoints 
considered are neuronal differentiation (i.e. by measuring neurite outgrowth and 
biomarker expression), spontaneous electrical activity of neuronal networks, cell 
communication, migration and synaptogenesis.  
The distinction between morphological and functional read-outs is often not so 
evident. Largely, it depends on the analytical method used for measuring the 




The perturbation of neuronal excitability induces substantial and rapid disruption 
of the nervous system functions. For this reason, the physiological assessment is a 
key factor when potentially-neurotoxic compounds are considering. To monitor and 
evaluate the eventual disruption of ion channels, receptors and other critical 
determinants of neuronal electrical activity, highly optimized analytical methods 
are needed87.  
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Multielectrode arrays (MEAs), recently developed, are a useful tool for functional 
neurotoxicity screening. By interfacing microelectrodes with neurons, MEA 
platforms provide non-invasive, spatio-temporal information of the network 
activity of a population of neurons during development, as well as any functional 
effects of acute and chronic treatment paradigms. One of the major advantages of 
this technology is the possibility of long-term monitoring (up to weeks and/or 
months) of a cell population electrical behavior88,89. Moreover, the availability of 
multiwell MEA plates has allowed increased throughput, offering the ability to 
perform complete concentration-effect curves of several compounds on cell 
populations exposed to the same culture conditions87,90. 
Developed by Neher and Sakmann over 40 years ago, the patch-clamp technique 
remain the gold standard for the study of ion channel activity at the single molecule 
level (microscopic current) and at the cellular level (macroscopic current)91. 
Actually, automated patch-clamp (APC) systems has been developed, but they have 
not replaced the traditional patch-clamp technique, rather represent a very useful 











Outline of the Project 
 
The objective of this thesis project was focused on the study of the possible 
molecular targets and mechanisms involved in two specific cases of neurotoxicity, 
widely documented but not completely understood: 1) the potential neurotoxicity 
induced by Silica Nanoparticles (SiO2) and 2) the Oxaliplatin (OHP)-induced 
neurotoxicity. 
This Ph.D. thesis comes out in the form of collection of papers. They are presented 
progressively, each one corresponding to a single chapter (those from 2 to 4). In 
turn, in chapter 5 it is described a concluded set of experiments partially conducted 
during my visiting period in the Laboratory of Molecular and Cell Biology at the 
Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de 
Elche (IDIBE) (Spain), coordinated by Prof. Antonio Ferrer Montiel. All together, this 
is the scientific production, strictly related to my Ph.D. research program, I 
contributed to during the “Chemistry and Biology” Ph.D. three years course: The 
studies were conducted in the Laboratory of Cellular Physiology and Biophysics at 
the Department of Pharmaceutical Sciences of the University of Piemonte Orientale 
"A. Avogadro", under the supervision of my tutor Prof. Carla Distasi.  
This research was conducted in collaboration with the Laboratory of Pharmacology 
at the Department of Pharmaceutical Sciences of the University of Piemonte 
Orientale "A. Avogadro", coordinated by Prof. Armando Genazzani, and the 
Laboratory of Physiology, coordinated by Prof. Davide Lovisolo..  
During these last 3 years Prof. Carla Distasi has been active within different research 
lines in the field of neurophysiology. Among the most important ones, to highlight 
the study of the impact of chemical agents on the Central Nervous System from an 
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electrophysiological perspective in order to characterize the molecular targets and 
the mechanisms underlying the toxicity induced by different types of engineered 
nanoparticles, i.e. TiO2 and SiO2 NP, and by the administration of platinum-based 
chemotherapeutic agents. 
Before starting my Ph.D. studies, it had been already described that amorphous 50 
nm SiO2 nanoparticles (NPs), developed by the group of Prof. Gianmario Martra, 
(Dept. of Chemistry, University of Turin) and tested by Prof. Lovisolo and his team 
(Dept. of, University of Turin), can be made fluorescent by hybridization with 
cyanine dyes and safely incorporated into neurons and other cell types10. At non-
toxic doses (20 µg mL-1), 50 nm SiO2 NPs elicit increases in the intracellular Ca2+ 
concentration in a neuroendocrine cell line GT1-7. These signals are fully dependent 
on Ca2+ influx by means of different types of Ca2+ permeable channels, and are 
completely reversible even in the continuous presence of NPs.  
My role in this field consisted in assessing 1) the possible molecular targets 
correlated with cytosolic Ca2+ signals observed following the administration of 50 
nm SiO2 NPs and 2) investigating the Ca2+ mobilizing mechanisms involved in these 
processes (see section 1.4 and 1.5). 
Under the supervision of Prof. Carla Distasi and Prof. Lovisolo, I performed patch 
clamp measurements, which combined with long-term recordings of electrical 
activity with multielectrode arrays, provided evidence that these SiO2 NPs evoke a 
transient depolarization of the membrane potential, leading to a modulation of 
action potential firing without any change in gene expression. These results were 
published in 2018 in the journal Scientific Reports (quoted in full in Chapter 2) as: 
 
C. Distasi, F. A. Ruffinatti, M. Dionisi, S. Antoniotti, A. Gilardino, G. Croci, B. 
Riva, E. Bassino, G. Alberto, E. Castroflorio, D. Incarnato, E. Morandi, G. 
Martra, S. Oliviero, L. Munaron & D. Lovisolo (2018) "SiO 2 nanoparticles 
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modulate the electrical activity of neuroendocrine cells without 
exerting genomic effects." Sci. Rep. 8, 1–12 
 
In view of a safe and effective use of these tools in biomedical applications, the next 
step was to provide a detailed electrophysiological characterization of the 
responses elicited by NPs in GT1-7 neuronal cells. Ca2+ imaging data on cell 
populations and electrophysiological recordings pointed out three classes of 
channels as the major components of the observed Ca2+ signals following the 
administration of 50 nm SiO2 NPs: TRPV4, Cx and Panx-like channels. All these 
channels are known to be involved in a wide spectrum of physiological and 
pathological processes and characterized by multiple activation mechanisms (see 
Section 1.5 and 1.6). In this specific case, the most relevant mechanism is likely 
related to the production of reactive species, since we have shown that lipid 
peroxidation is significantly increased after 30 min of NP exposure and that 
preincubation with the antioxidant N-acetyl-L-cysteine (NAC) strongly reduced the 
increase in NP-induced [Ca2+]i . Furthermore, a relevant issue in the interpretation 
of these data is the finding that their activation has been observed also in excised 
membrane patches (outside out configuration) suggesting the implication of a 
direct membrane-delimited pathway. This fact does not exclude the coexistence of 
more than one mechanism, being all the three group of channels involved, for 
example, in the transduction of cell stretch and mechanical pressure. 
These results were published in 2019 in the journal Nanomedicine as: 
Carla Distasi*, Marianna Dionisi*, Federico Alessandro Ruffinatti, 
Alessandra Gilardino, Roberta Bardini, Susanna Antoniotti, Federico 
Catalano, Eleonora Bassino, Luca Munaron, Gianmario Martra & Davide 
Lovisolo (2019) “The interaction of SiO2 nanoparticles with the 
neuronal cell membrane: Activation of ionic channels and calcium 




where * means that these two authors contributed equally to this work. In 
particular, I contributed by performing and analyzing  whole cell and inside-out 
patch patch clamp experiments. Chapter 3 quotes in full this article 
In parallel I also addressed the problem of OHP induced peripheral neurotoxicity 
(OIPN). In particular, given that intracellular Ca2+ related-events appears to play an 
important role in the onset of OIPN, we focused on the TRP family members (TRPV1, 
TRPA1, TRPM8) that are known to participate in the transduction of noxious stimuli. 
Ca2+ imaging experiments, performed by Dr. Beatrice Riva (Dept. Pharmaceutical 
Sciences, University of Piemonte Orientale "A. Avogadro"), showed that an acute 
treatment with OHP (6 h, 0,1 µg/mL) reduced the responses to capsaicin (TRPV1 
agonist), but significantly enhanced the responses to icilin (TRPA1-M8 agonist). By 
using specific antagonist (BCTC, TRPV1-M8 antagonist; HC-030031, TRPA1 
antagonist), we demonstrated that these increased responses in treated neurons 
exerted by icilin were mediated by a TRPA1-dependent mechanism. In parallel, we 
observed a significant OHP-induced acidification of intracellular pH (pHi) in DRG 
cells both in vitro and in vivo. Since in our conditions, no changes in the levels of 
channel expression can be correlated with such enhanced responses, we 
investigated a pH-dependent hyperactivation of the channel. The 
electrophysiological patch clamp experiments in the cell attached mode, performed 
and analyzed by my supervisor and me, demonstrated that. In particular, we 
observed that when  pHi is restored in treated DRG neurons the hyperactivity of 
TRPA1 is normalized. All these results were published in 2018 in the journal 
Scientific Reports (quoted in full in Chapter 4) as: 
Beatrice Riva, Marianna Dionisi, Alberto Potenzieri, Alessia Chiorazzi, Celia 
Cordero-Sanchez, Roberta Rigolio, Valentina Alda Carozzi, Dmitry Lim, 
Guido Cavaletti, Paola Marmiroli, Carla Distasi & Armando A. Genazzani 
(2018) “Oxaliplatin induces pH acidification in dorsal root ganglia 
neurons.” Sci. Rep. 8, 1–12  
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Being pHi an essential parameter in cellular homeostasis, it is likely that OHP-
induced intracellular pHi changes do not affect solely TRPA1 but also other types of 
channels. Several evidences of this hypothesis are presented in Chapter 5. In 
particular, I combined electrophysiological recordings at both single cell level (patch 
clamp technique) and at population level (multielectrode arrays, MEAs), as well as 
quantitative real-time polymerase chain reaction (qRT-PCR), to investigate the 
potential involvement of K2P channels. Indeed, these channel proteins are known 
to play a key role in preserving and maintaining the neuronal excitability. Transient 
increments of expression levels, observed at 6 h post OHP-treatment, and the 
hyperactivity recorded in cell attached configuration of TREK-family members, 
confirmed the effective involvement of these channels in the OIPN. In this regard, 
the resultant hyper-excitability observed in OIPN could be interpreted as the effect 
of multiple adjustments on different molecular targets whose activity is altered by 
changes in the pH induced by chemotherapeutic agent. 
Concluding remarks are drawn in Chapter 6 by joining information from all the 
previous works in order to provide an integrated view about the ionic channels and 
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Engineered silica nanoparticles (NPs) have attracted increasing interest in several 
applications, and particularly in the field of nanomedicine, thanks to the high 
biocompatibility of this material. For their optimal and controlled use, the 
understanding of the mechanisms elicited by their interaction with the biological 
target is a prerequisite, especially when dealing with cells particularly vulnerable to 
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environmental stimuli like neurons. Here we have combined different 
electrophysiological approaches (both at the single cell  and at the population level) 
with a genomic screening in order to analyze, in GT1-7 neuroendocrine cells, the 
impact of SiO2 NPs (50  3 nm in diameter) on electrical activity and gene 
expression, providing a detailed analysis of the impact of a nanoparticle on 
neuronal excitability. We find that 20 µg mL-1 NPs induce depolarization of the 
membrane potential, with a modulation of the firing of action potentials. 
Recordings of electrical activity with multielectrode arrays provide further evidence 
that the NPs evoke a temporary increase in firing frequency, without affecting the 
functional behavior on a time scale of hours. Finally, NPs incubation up to 24 hours 




The fast development of nanoparticles (NPs) designed and engineered to be 
employed as tools for targeting to specific cells and tissues and for drug delivery 
has opened an entire new field in both basic science and medical applications. A 
preliminary, albeit essential, phase was devoted at addressing the concerns about 
their potential toxicity in vitro and, more relevantly, in vivo. A huge amount of 
papers1-3 has evidenced the parameters (size, concentration, surface properties, 
etc.) that can determine the presence or absence of toxic effects, thus providing 
the rational background for designing safe and biocompatible nanotools. The next 
step is to switch the focus on the more subtle effects that can arise from a 
prolonged presence of NPs in contact with cells, and to understand the mechanisms 
that underlie the interaction between objects at the nanoscale and their cellular 
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and molecular targets. This task is particularly relevant when the target is 
represented by single nerve cells or by complex neuronal networks.  
Engineered silica NPs have encountered a rapid diffusion in several applications in 
the last decade4, specifically in nanomedicine, thanks to the high biocompatibility 
of this material5. We have reported that amorphous 50 nm SiO2 NPs can be made 
fluorescent by hybridization with cyanine dyes and can be safely incorporated into 
neurons6 and other cell types7. In a previous paper, we have shown that 50 nm SiO2 
NPs, at non-toxic doses, elicit increases in the intracellular calcium concentration, 
[Ca2+]i, in a neuroendocrine cell line, GT1-7 cells8. These signals are fully dependent 
on calcium influx, carried through different types of calcium permeable channels, 
and are completely reversible even in the continuous presence of NPs. A few other 
papers3, 9-11 have reported that NPs of different composition can elicit changes in 
neuronal [Ca2+]i. This is a relevant topic, since perturbations of intracellular calcium 
homeostasis, even if reversible, can significantly affect neuronal excitability. 
Electrical activity is the most distinctive functional feature of neuronal cells, and the 
issue of the potential effects of NPs on the electrical behaviour of neurons and on 
the ionic channels that underlie it, while still only partially investigated, has 
attracted increasing interest in recent years, particularly in the light of their value 
as tools for nanoneuromedicine. Most of these studies deal with the effects of NPs 
on the properties of a specific channel (see e.g. Refs 12,13). Recently, a few 
excellent reviews, focused on the potential medical applications of NPs14-16, have 
provided a comprehensive picture of the available knowledge about NPs and 
neuronal ionic channels; some of them also report the effects on action potential 




A further level of complexity that needs to be addressed stems from the finding 
that changes in the pattern of neuronal electrical activity may have effects on the 
expression of relevant genes, particularly when calcium influx is involved20,21. In the 
perspective of using SiO2 NPs, both in vitro and in vivo, for applications such as drug 
delivery22 or cell tracking23 in neuronal cells and tissues, it is of the outmost 
importance to analyze at the cellular level the functional changes induced by the 
interaction with the NPs, and to investigate whether these changes have stable and 
long-lasting outcomes on the neuronal phenotype. We have addressed this issue 
by means of an integrated approach, combining patch-clamp recordings from single 
neuroendocrine cells and sensory neurons in culture with population recordings by 
means of multielectrode arrays (MEAs), spanning a time scale from early responses 
(min) after acute NPs application to hours. In addition, by means of a genomic 
approach, we have investigated the potential effects of the changes in neuronal 
activity on gene expression. 
 
2.2 Materials and Methods 
 
Materials. Unless otherwise specified, materials were obtained from Sigma Aldrich. 
Synthesis of silica NPs. Synthesis and characterization of the SiO2 nanoparticles 
have been described in previous papers6, 8. Briefly, bare silica nanoparticles were 
synthesized by the reverse microemulsion technique; in particular, a reverse 
microemulsion was prepared by mixing 75.0 mL of cyclohexane, 18.85 g of Triton 
X-100, 18.0 mL of n-hexanol and 5.4 mL of deionized H2O in a round bottom flask. 
After 30 min of equilibration at room temperature and continuous gentle magnetic 
stirring, 1.0 mL of tetraethylorthosilicate (TEOS) was added; after further 10 min of 
equilibration, reaction was started by the addition of 0.7 mL of NH3 (28-30%) and 
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continued overnight at room temperature under magnetic stirring. After 16 hrs, 
reaction was interrupted by the addition of acetone; then particles were extracted 
by centrifugation at 10,000 rpm for 20 min and finally washed twice with ethanol 
and several times with deionized water until complete removal of surfactant. The 
nanoparticles were stored in water suspension (1 mg mL-1) at room temperature.  
High resolution transmission electron microscopy (HRTEM). Micrographs of 
nanoparticles were acquired using a 3010 Jeol instrument operated at 300 kV. 
Samples were prepared by spreading a droplet of the corresponding suspensions in 
MilliQ H2O (1.0 mg mL-1) on a copper grid coated with a lacey carbon film and then 
letting water to slowly evaporate to limit particle agglomeration. The mean particle 
diameter was calculated as dm = Σdini/Σni (ni= number of particles of diameter di) by 
measuring the size of ca. 300 particles. 
Dynamic Light Scattering (DLS). DLS measurements were performed in a 90Plus 
Particle Size Analyzer (Brookhaven Instruments) at a laser wavelength of 660 nm, a 
detection angle of 90°, and 293 K. Samples were prepared by suspending NPs in 
Milli-Q water (pH 5.5, concentration: 0.1 mg mL-1). DLS plots are reported in number 
distribution. 
GT1-7 cell cultures. GT1-7 cells, an immortalized line derived from highly 
differentiated mouse gonadotropin-hormone releasing hormone (GnRH) neurons 
(generously donated by Prof. P.L. Mellon), were maintained in Dulbecco’s Modified 
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Lonza), 
gentamycin (50 µg mL-1), and glutamine (2 mM) at 310 K, in a humidified 
atmosphere of 5% CO2 in air. For patch-clamp experiments, cells were plated at the 
density of 9,000 cells cm-2 on uncoated plastic dishes (Corning). After 24 hrs, 
medium was changed to 0.5% FBS supplemented with 1/50 of B27 (Invitrogen) to 
63 
 
improve survival and differentiation, then switched to 0.5% FBS alone for 4-6 days 
for patch-clamp experiments (a protocol similar to that described in Ref. 25) or 8-
15 days for multielectrode arrays (MEAs) experiments. Plating density was 
increased to 20,000-30,000 cells/cm2 both for genomic experiments, in order to 
have a sufficient amount of cells for RNA extraction, and for recordings on MEAs, 
to reach a higher surface of microelectrodes covered by cells. 
Isolation and Primary Cell Culture of Mouse Dorsal Root Ganglion Neurons. Mice 
were purchased from Charles River (Segrate, Italy). The care and husbandry of mice 
were in conformity with the institutional guidelines in compliance with national (D. 
L.vo 26/2014, Gazzetta Ufficiale della Repubblica Italiana, n.61, March 14th 2014) 
and international laws and policies (European Union directive 2010/63/UE; Guide 
for the Care and Use of Laboratory Animals, U.S. National Research Council, 1996). 
Adult Balb-C mice (5/10-wk-old) were euthanized under deep isoflurane-induced 
anaesthesia. The procedures were approved by the local animal-health and ethical 
committee (Università del Piemonte Orientale) and were authorized by the national 
authority (Istituto Superiore di Sanità; authorization number N. 22/2013). 
DRG were aseptically removed and collected in a dish containing cold F12 (Nutrient 
Mixture F12 Ham) medium. Working under a dissecting microscope and using fine 
forceps, the surrounding membrane was gently teased away from each DRG; nerves 
and sheath were cut. All desheathed DRG were then transferred into a sterile 35 
mm dish containing collagenase from clostridium hystoliticum 0.125% and DNase 
in F12 medium and incubated at 310 K for 1 hour. After incubation, DRG were 
triturated using a tip p1000. Myelin and nerve debris were eliminated by 
centrifugation trough a bovine serum albumin (BSA) cushion. Cell pellet was re-
suspended in Bottenstein and Sato medium (BS) (30% F12, 40% DMEM (Dulbecco’s 
Modified Eagle’s medium, 30% Neurobasal A medium (Life Technologies, Italy), 100 
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X N2 supplement (Life Technologies, Italy), penicillin 10 U/mL and streptomycin 100 
mg/mL, supplemented with Recombinant Human -NGF, Recombinant Murine 
GDNF and Recombinant Human NT3 (Peprotech, USA) and plated onto 35 mm Petri 
dish pre-coated with laminin. Two days after, electrophysiological patch clamp 
measurements were performed on DRG neurons of all soma sizes. 
Exposure to NPs. Prior to the experiments, cells were switched to the appropriate 
extracellular medium (either DMEM or standard physiological solution, both 
serum-free). NPs, stored in a stock solution (1 mg mL-1 in water) were sonicated for 
20 min before final dilution. For all protocols except patch-clamp, the NPs were 
administered by substituting the extracellular solution with an identical one 
containing a stable suspension of NPs at the final desired concentration.  
Incorporation of nanoparticles. For conventional transmission electron microscopy 
(TEM), GT1-7 cells were treated for 1 and 2 hours with NPs and then fixed with 1.2 
% glutaraldehyde in 66 mM sodium cacodylate buffer, post-fixed in 1% OsO4, 1.5% 
K4Fe(CN)6, 0.1 M sodium cacodylate, en bloc stained with 1% uranyl acetate, 
dehydrated, and flat embedded in epoxy resin (Epon 812, TAAB). After baking for 
48 hrs, the glass coverslip was removed from the Epon block by thermal shock. Cells 
were identified by means of a stereomicroscope, excised from the block and 
mounted on a cured Epon block for sectioning using an EM UC6 ultramicrotome 
(Leica Microsystem, Vienna). Ultrathin sections (70-90 nm thick) were collected on 
copper mesh grids and observed with a JEM-1011 microscope (Jeol, Tokyo, Japan) 
operating at 100 kV and equipped with an ORIUS SC1000 CCD camera (Gatan, 
Pleasanton, CA). For each experimental condition, at least 100 images were 




Si2+ uptake was quantified by using inductively coupled plasma mass spectrometry 
(ICP-MS; element-2; Thermo-Finnigan, Rodano (MI), Italy). GT1-7 cells were seeded 
at the initial density of 20.000 cells cm-2 in DMEM 10% FCS. The following day, the 
medium was changed with DMEM 0.5% FCS supplemented with B27 to improve 
survival and differentiation. Afterward, cells were incubated with SiO2 NPs (20 µg 
mL-1) added to DMEM 0.5% FCS for 1 and 24 hrs. After the treatments cells were 
washed for three times with PBS solution, detached with Trypsin, recounted and 
collected into an appropriate conical tube and centrifuged (5 minutes at 1000 rpm). 
The supernatant was discarded and the pellet was analyzed with ICP-MS. Sample 
digestion was performed with concentrated HNO3 (70%, 1 mL) under microwave 
heating at 433 K for 20 minutes (Milestone MicroSYNTH Microwave labstation). 
Control measurements were performed as above but omitting nanoparticles; 
values were below the sensitivity of the instrument.  
Electrophysiology - Patch-clamp. Conventional whole cell patch-clamp recordings 
were performed in the current clamp mode at 295-298 K. Cells were continuously 
superfused with a standard physiological solution of the following composition (in 
mM): NaCl, 154; KCl, 4; CaCl2, 2; MgCl2, 1; 4-(2-hydroxyethyl)-1-piperazine ethane 
sulfonic acid (HEPES), 5; glucose, 5.5; and NaOH (pH 7.35). Composition of the 
pipette solution was (in mM): KCl, 15; CaCl2, 3; MgCl2, 3; Hepes, 5; KAsp, 118; EGTA, 
5; Na2ATP, 5; pH to 7.3 with KOH. Pipettes had a resistance of 2-5 MΩ. NPs were 
dispersed in the solutions at the required concentration. Solutions were applied by 
means of a microperfusion system connected to a set of five syringes containing 
the control and test solutions; the perfusion pipette was located at several tens of 
microns away from the cell to be recorded, in order to minimize mechanical 
perturbations. Correction for junction potential was performed analogically. Data 
were collected with an Axopatch 200B amplifier (Molecular Devices, USA) using 
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Clampex 10.2 and Axoscope 10.2 software. Step protocols, in the voltage clamp 
mode, were applied to check cell functionality. In the presence of NPs, whole cell 
recordings lasted from 5 to 30 min, durations comparable to those obtained in 
control experiments in the absence of NPs. 
Electrophysiology - Multielectrode Arrays (MEAs). Extracellular GT1-7 action 
potentials were recorded by means of a commercial 60-channel multi-electrode 
array (MEA) setup. A description of the experimental apparatus is provided in 
Supplementary Methods online. An external T-control unit (TC02) kept the 
temperature of the socket surface at 310 K. The digitalized output-data coming 
from the USB-ME64 unit were acquired, monitored and recorded on a PC through 
MC_Rack software (Version 4.6.2, Multi Channel Systems MCS GmbH). To reduce 
the data file size, only upward (positive) and downward (negative) spike cutouts 
from each of the available recording electrodes were stored. These waveforms 
consisted of 1 ms pre-spike and 2 ms post-spike fragments respect to the point of 
threshold crossing. Threshold was fixed at ±6 standard deviations from baseline 
noise (typically around 15 µV peak-to-peak). A channel was considered active if it 
recorded at least 30 spikes in 5 hrs. In general, according to the technical 
specifications of the device, one electrode does not correspond to a single cell. 
Rather, each electrode can detect all the electrical signals originating in the spatial 
region surrounding it, within a radius of tens of micrometers. Waveforms drawn 
from each active channel were finally transformed into time stamps using 
NeuroExplorer (Nex Technologies, USA). The same software was used also to make 
raster plots and rate histograms. 
Survival assay. Cytotoxicity was evaluated by counting cells with a Burker chamber 
at 24 hours after incubation in DMEM medium supplemented with B27 without FBS 
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either in the presence or in the absence of the NPs. Data are expressed as number 
of cells/cm2.  
RNA-Seq analysis. GT1-7 cells, plated in 10 cm Petri dishes and kept in 0.5% FBS for 
4 days, were shifted to DMEM without FBS to prevent adsorption of serum proteins 
to NPs and either treated or not (control cells) with 20 µg L-1 NPs for 30 min, 1, 6 
and 24 hrs. Cells were then washed with ice cold PBS and lysed with TriReagent 
(Sigma), 1 mL per dish, harvested with a scraper and stored at 193 K until RNA 
extraction. RNA was purified as previously described38. RNA integrity 
measurements were performed using Fragment Analyzer™ (Advanced Analytical). 
All samples had RNA Quality Number (RQN) greater than 9.8. RT-qPCR was 
performed using the SuperScript III Platinum One-Step Quantitative RT-PCR System 
(Invitrogen) following the manufacturer’s instructions. Library preparation was 
performed using Illumina TruSeq RNA prep-kit following manufacturer’s 
instructions. Reads were mapped using TopHat239 and RPKM were calculated using 
cuffdiff tool from Cufflinks software package40. Data analysis and plotting was 
performed using custom R scripts41. RNA-seq data has been deposited on Gene 
Expression Omnibus database under the accession GSE98032. 
Statistical analysis. Particle size evaluated by TEM is given as mean ± SD. Unless 
otherwise specified, all other data are expressed as means ± SEM. For analysis of 
NP-cell internalization, differences were assessed by a Mann-Whitney U test; for 
ICP-MS measurements and cell survival assays, differences were checked by a t-test 
(after normality had been verified through a Shapiro-Wilk test); in the analysis of 
MEAs recordings, to compare the differences in firing rate, a paired-samples sign 
test was used. 
Data availability. The RNA-seq data has been deposited on Gene Expression 
Omnibus database under the accession GSE98032. All other datasets generated and 
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SiO2 NPs interact with the cell membrane and are incorporated in 
endocytic compartments 
 
In agreement with previous studies5, 6 TEM and DLS analysis (Fig. 1) indicated that 
the lab made SiO2 were in the form of nanospheres with a narrow size distribution 
(mean diameter 50  3 nm). When suspended in water they mainly exhibited a 
hydrodynamic diameter similar to what observed in TEM images, indicating that 
they suffered a very limited aggregation. 
In order to analyze the distribution of nanoparticles on the cell membrane, we 
imaged by electron microscopy GT1-7 cells exposed for 1 or 2 hours to 20 µg mL-1 
NPs. Ultrastructural analysis (Fig. 2a,b) reveals that the NPs were present on the 
plasma membrane (NP density for 1 hour treated cells: 2.60 ± 0.61 NPs µm-2; 2 
hours treated cells: 9.20 ± 0.39 NPs µm-2; Fig. 2c) suggesting that they can interact 
with membrane channels at times shorter than 1 hour. Following the interaction 
with the plasma membrane, nanoparticles could be internalized inside the cell. 
Intriguingly, free nanoparticles were never imaged either in the cytoplasm of the 
GT1-7 cells or inside mitochondria, Golgi apparatus, endoplasmic reticulum or 
nucleus, but always inside membranous endocytic-like structures, indicating a 
possible induction of endocytosis after the interaction with the plasma membrane. 
A quantitative assessment of NPs incorporation in GT1-7 cells was performed by 
means of the ICP-MS technique (Fig. 2d). It can be seen that at 1 hour of incubation, 
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a detectable amount of NPs could be measured (0.43 ± 0.16 pg/cell), that was 





Fig. 1. Characterization of the lab-made silica NPs. Left: representative TEM image (original 
magnification: 50k). Right: related particle size distribution by TEM data (histogram; values on the 
left Y and bottom X axes) and hydrodynamic diameters by DLS in water (dashed-dotted line; values 




Fig. 2. Interaction with the plasmamembrane of GT1-7 cells and internalization of 50 nm SiO2 NPs. 
(a) Low magnification TEM image of a GT1-7 cell with NPs on the plasmamembrane and in a vescicle 
(2 hours incubation). Scale bar: 500 nm. (b) After either 1 or 2 hours of incubation, small 
agglomerates of NPs could be observed in association with the plasmamembrane; some of them 
were already incorporated into endocytic vesicles. Scale bars: 100 nm. (c) NPs density obtained by 
TEM images at 1 and 2 hrs of incubation. Mann-Whitney U test; *** p < 0.0001 two-tailed, n = 3. (d) 
Quantitative assessment of internalization at 1 and 24 hours of incubation by means of ICP-MS. t-
test, * p = 0.037 two-tailed, n = 4. 
 
SiO2 NPs elicit depolarizing responses in GT1-7 cells and adult mouse 
sensory neurons 
 
When bathed in physiological Tyrode solution, GT1-7 cells showed different 
patterns of electrical activity as recorded in patch clamp experiments, in current 
clamp mode. Out of 32 cells, 19 had a stable resting potential (Fig. 3a,b), 10 cells 
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showed small oscillations (Fig. 3d); in three cells firing of full-sized action potential 
was detected (Fig. 3c). Average Vm was -69.7 ± 2.2 mV.  
The 50 nm SiO2 NPs were used at the concentration of 20 µg mL-1, that in previous 
experiments had been shown to be non-toxic6 and to elicit strong and long-lasting 
but reversible [Ca2+]i oscillations7. When NPs were added to the extracellular Tyrode 
solution, they elicited a depolarizing response (average ∆V = 40.1 ± 3.1 mV) in 28 
out of 32 cells. In most cells, after transient firing of one or few full action potentials, 
the membrane potential either showed oscillatory activity with small spikes  
(Fig. 3a) or was stabilized at the depolarized value (Fig. 3b,c), without showing 
further oscillations and/or spikes, probably because of a strong inactivation of 
voltage dependent Na+ and Ca2+ channels. In two cells firing activity was markedly 
increased for longer times (Fig. 3d). 
The depolarizing response was in general irreversible, at least for the duration of 
the recordings (up to 20 min). The functional state of the cells, checked by 
transiently switching to the voltage clamp mode and recording responses to voltage 
stimulation protocols appeared to be preserved (an example, related to the 
response of Fig 3b, is shown in Supplementary Fig. S1 online).  
In 2 experiments, cells were first challenged with a lower dose (0.5 µg mL-1) and 
subsequently with 20 µg mL-1. Supplementary Fig. S2 online shows that the lower 
dose induced a small and reversible depolarization, while the response to the 






Fig. 3. Four examples of the changes in electrical activity recorded from single cells in response to 
20 µg mL-1 SiO2 NPs. Insets show expanded segments at the times indicated. Traces were blanked in 















These findings were confirmed by recordings from another neuronal model, 
primary cultures of DRG sensory neurons from adult mice. DRG neurons had a 
stable resting potential of -60.7 ± 1.5 mV (n=20), ranging from -72.0 mV to -47.0 
mV. Only 30% of neurons generated sporadic spontaneous activity. In all cells 
challenged with 20 µg mL-1 50 nm SiO2 NPs (n=8), we recorded a depolarizing 
response (average ∆V = 37.8 ± 3.0 mV, ranging from 27.5 to 53.8 mV). In most cells, 
the membrane potential shifted to a depolarized value without firing any action 
potential, as shown in Fig. 4a. The remaining two neurons, prior to the Vm 
stabilization at the depolarized value, fired one or a few action potentials in 
response to fast and transient Vm changes above threshold (Fig. 4b). 
 
SiO2 NPs transiently increase the electrical activity of GT1-7 cells in long 
lasting recordings 
 
To provide further information on the electrical activity elicited by the NPs on a 
longer time scale, comparable to the duration (several hours) of the calcium 
imaging experiments reported in a previous paper7 and at a population level with a 
non-invasive approach, we performed extracellular recordings from GT1-7 cells 
cultured on MEAs.  
Full recordings sampled at 25 kHz (Fig. 5a) were filtered using a voltage threshold 
(see Methods) in order to extract extracellular action potential (EAP) waveforms 
from raw data (Fig.5b), and build raster plots (Fig. 5c, lower) and rate histograms 
(Fig. 5c, upper). Rate histograms represent the time course of the firing rate and 





Fig. 4 Current clamp recordings from mouse DRG neurons. (a,b) Two examples of changes in Vm 








In our experiments, both under control condition and in presence of NPs, GT1-7 
cells exhibited a characteristic firing pattern, in which active and resting phases 
alternated with an irregular period ranging from 5 to 15 min (Fig. 5c). This is in good 
agreement with the reported behavior of GT1-7 cells described in literature24. 
Over 24 different MEAs, just 7 (about 30% of the total) showed a sustained 
electrical activity in at least one MEA electrode. For each of these experiments, an 
average of 3 out of 59 electrodes (5%) recorded non-sporadic activity, resulting in 
a total of 21 independent long duration recordings. Half of them were silent 
channels under control conditions (standard physiological solution) that started to 
show electrical activity only after 20 µg mL-1 NPs administration (Fig. 5e, e.g. Exp7, 
Ch71+). Conversely, the other half presented some degree of spontaneous activity 
already under control conditions and the effect of NPs on these channels 
apparently consisted in a modulation of the number of EAPs recorded (Fig. 5e, e.g. 
Exp4, Ch82–), confirming the heterogeneity already observed in current clamp 
experiments. 
In order to quantify the overall effects of NPs on GT1-7 firing rate, distinguishing 
between early and long lasting effects, we firstly decided to measure the average 
number of EAPs within two temporal windows of equal length (200 s), placed just 
before (Δtpre) and immediately after (Δtpost, Fig. 5e) NPs administration. Within 





Fig. 5. MEA recordings. (a) A representative raw signal featuring many EAPs, as displayed by the 
acquisition software MC_Rack (sampling frequency: 25 kHz). (b) 7 superimposed waveforms 
consisting of upward EAPs extracted from raw data. Each cutout extends from 1 ms before to 2 ms 
after the point where the signal crosses the threshold (horizontal dashed line) with a negative slope. 
Threshold was fixed at ±6 standard deviations from the baseline noise. (c) A representative raster 
plot (lower trace) and the corresponding rate histogram (upper trace) of an active channel (the same 
shown in (e): Exp6, Ch43+). Bin size: 60 s. 10 spikes/bin ≈ 0.17 Hz. Dashed line is the time of NPs 
administration. (d) Schematic overview of the early changes induced by 20 µg mL-1 SiO2 NPs in GT1-
7 EAP rate. Table refers only to the short temporal window (Δtpre+Δtpost) as shown in (e). (e) 8 
complete raster plots (representative of 21) from the 7 experiments featuring the active channels 
used for the analysis. On the left side of each raster are the experiment number and the channel 
reference. Symbols + and – represent the direction (upward or downward respectively) of the EAPs 
detected. Dashed line is the time of medium change. (f) Global rate histogram resulting from the 
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average of the rate histograms of all the 21 active units. Here, too, the dashed line is the time of 
medium change and NPs administration. (g) Low magnification image of GT1-7 cells pated on MEAs. 
 
 
Overall, the average firing rate under control conditions (average spontaneous 
activity) was <fpre> = 0.014 ± 0.011 Hz, that increased to <fpost> = 0.095 ± 0.038 Hz 
after NPs addition. The maximum value for GT1-7 firing rate we recorded (using a 1 
min binning) was fmax = 1.02 Hz, but both fmax and <fpost> are possibly 
underestimated because of the blind spot (about 15 seconds) in MEA recording due 
to medium substitution. To compare the differences in firing rate in the two 
conditions, a paired-samples sign test was used. The sign test is a non-parametric 
alternative to the paired-samples t-test and Wilcoxon signed-rank test, being our 
distribution of differences Δf = fpost – fpre neither normal nor symmetrical.  
NPs elicited a statistically significant median increase in firing rate compared to the 
spontaneous electrical activity (p = 4.883·10-4 two-tailed, n = 21). Different choices 
for window length (e.g. Δt = 400 s, Δt = 500 s) led to the same conclusions, even 
though p-values showed a clear increasing trend as window length increased (p = 
0.002 for Δt = 400 s; p = 0.013 for Δt = 500 s), thus confirming the transient nature 
of the effect on the firing rate elicited by NPs. 
In particular, after about 10 min from NPs administration, this effect on GT1-7 firing 
rate was no more detectable in any of the channels taken into account, even if 
nearly half of them still showed some kind of electrical activity after 1 hour or more. 
The late firing rate of this portion of channels, such as their percentage respect to 
the total of the active channels used for the analysis, were comparable to the ones 
measured under control condition. A global firing rate histogram (Fig. 5f) was drawn 
by averaging the full rate histograms from all the 21 active channels. It shows that, 
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after the short and early phase already discussed, electrical activity indeed 
recovered to control levels and was preserved in time, thus providing evidence that 
50 nm SiO2 NPs, at the concentration of 20 µg mL-1, do not exert long lasting effects 
on neuronal function. Fig. 5g shows an image of the GT1-7 cells plated onto the 
MEAs. 
 
Incubation with NPs up to 24 hours does not affect gene expression 
 
To further characterize the effect of SiO2 NPs treatment, and evaluate whether it 
could induce a transcriptional response, we performed RNA-Seq in GT1-7 cells at 
various time points following treatment with 20 µg mL-1 NPs. RNA-Seq analysis of 
the samples at 30 min, 1, 6 and 24 hrs showed very high correlation (R > 0.99, 
Pearson Correlation Coefficient) between treated and untreated cells for the entire 
timescale of the analysis (Fig. 6), revealing that the SiO2 NPs do not induce a 
detectable transcriptional response. 
Since these experiments were performed in the absence of FBS, and since the lack 
of toxicity of the concentration of 20 µg mL-1 has been tested in a previous paper6 
in the presence of 0.5% FBS, we repeated the survival assay at 24 hours on cells 
cultured in DMEM without FBS. Supplementary Fig. S3 online shows that also under 





Fig 6. Lack of detectable transcriptional responses to incubation with SiO2 NPs. Scatter plot with 
heat density of pairwise expression level comparison between treated and untreated (20 µg mL-1 of 
50 nm SiO2 NPs) cells at 30 minutes, 1, 6 and 24 hrs post-treatment. Gene expression values (per kb 




The data presented in this paper show that our nanoparticle model, 50 nm SiO2 
NPs, non-toxic at the size and concentration employed, induces fast changes in 
membrane potential and modulates the electrical activity of GT1-7 cells. MEAs 
recordings provide evidence for a transient increase in the firing rate of action 
potentials, without inducing long lasting alterations on the time scale of a few hrs. 
This is in agreement with previous observations8 that the increases in [Ca2+]i 
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induced by the presence of these NPs were transient and reversible. These findings 
are not limited to a specific experimental model. We have observed similar 
responses to 50 nm SiO2 NPs with single cell recordings from primary adult neurons 
that have electrical properties quite different from GT1-7 cells: the latter, in varying 
percentages according to culture conditions, are able to generate spontaneous 
electrical activity, either sporadic or in bursts25; DRG neurons, on the other hand, 
even if representing an heterogeneous population of different sensory cells, have a 
very limited and sporadic spontaneous electrical activity26. 
Interestingly, ultrastructural and ICP-MS data provide evidence for an interaction 
with the plasma membrane followed by the activation of an endocytic process. It is 
of relevance that in the culture medium, NPs form very small agglomerates, as 
reported by dynamic light scattering (DLS) data in a previous paper8. 
A very recent paper27, combining a complex set of experimental approaches with 
numerical simulations, has reported that different kinds of nanoobjects (Quantum 
Dots, Quantum Rods, Fe2O3 NPs of different shape) elicit an increase in electrical 
activity in cultured rat hippocampal neurons. The most relevant and novel findings 
are: i) the responses are size-and shape independent; ii) electrical charge is the 
crucial parameter: negative NPs adhere to the neuronal plasmamembrane, cause a 
depolarization and increase firing, neutral and positive ones do not; iii) NPs interact 
only with active neurons. While in the present paper we did not characterize the 
dependency of the responses from these parameters, in a previous paper we have 
shown that SiO2 NPs with a negative ζ potential elicited increases in [Ca2+]i, while 
positively charged (aminated) ones had no effect. In the above paper, we reported 
a size dependency; however the size range (50-200 nm) was broader than the range 
(5-75 nm) tested in Ref. 25. While the issue of dependency of interaction with the 
plasmamembrane from the negative surface charge of NPs finds support in the data 
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from several other laboratories (see e.g. Refs. 28, 29), the independency from size 
needs further investigation. Finally our experiments show that, in both GT1-7 and 
DRG neurons, the firing activity is not a requisite for SiO2 NPs-neuronal membrane 
interaction. 
The fact that electrical activity in neurons may have effects on gene transcription 
(the “excitation-transcription” paradigm14,15), mainly because of its link to changes 
in [Ca2+]i, were the rational for carrying out the analysis of the whole transcriptome. 
Interestingly, we found that the treatment with SiO2 NPs does not induce a 
detectable transcriptional response at all time points analyzed, and this deserves 
further comments.  
The issue of the effects of NPs on the target cell genome has attracted increasing 
interest in the last decade, the main focus being on potential genotoxic effects. 
Several comprehensive reviews are available30-32; in general, evidence for DNA 
damage induced by SiO2 NPs is limited, and confined to relatively high doses (in 
most cases over 100 µg mL-1). Most of the reported effects are cell- and 
nanoparticle size specific (the smaller being in general more genotoxic), thus 
requiring great caution when trying to derive general conclusions. Data based on 
neuronal models are more scarce, and limited to the pheocromocytoma cell line, 
PC12 cells. Here the reports are conflicting: it has been found33 that 20 nm SiO2 NPs 
at the concentration of 500 µg mL-1 did not alter chemokine and NF-ĸB levels in 
microglial cell, but only induce a small increase in the secretion of inflammatory 
chemokines; the supernatant from these cells, when applied to PC12 cells, did not 
induce cytotoxicity nor changes in a few marker genes. On the other hand, with 50 
µg mL-1 of 25 nm NPs, other Authors34 found activation of reactive oxygen species 
(ROS) and aggregation of α–synuclein, a potential early Parkinsons’ Disease marker. 
Finally another group35, using 20 and 50 nm NPs, report that they affect viability in 
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a time dependent way at concentrations starting from 50 µg mL-1 for the former 
and  from 100 µg mL-1 for the latter; both induced significant increases of ROS 
starting from 25 µg mL-1. A likely explanation for these discrepancies can be based 
on the different sizes employed, and, more relevantly, from the different 
experimental protocols: in the first two cases the NPs were administered to PC12 
cells in the presence of 10% FBS, while in the latter stimulation was performed on 
cells in 0.1% FCS. This comparison points to another key issue in analyzing toxicity 
and genotoxicity induced by NPs: it has been reported that the toxic doses can 
change even of a few orders of magnitude when evaluated in the presence or in the 
absence of serum32. The finding that in our experimental conditions, the lack of 
genomic effects is paralleled by a lack in reduction of cell survival, even in the 
absence of FBS, strengthens the conclusion that the use of these particles is 
particularly safe and opens to the possibility of employing them as markers for cell 
tracking and/or carriers for drug delivery. This is, to our knowledge, the first 
detailed description of the changes in electrical activity of neurons following 
exposure to a nanoparticle, and of its evolution in time. The transient nature of 
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Aim: To clarify the mechanisms of interaction between SiO2 nanoparticles (NPs) and 
the plasmamembrane of GT1–7 neuroendocrine cells, with focus on the activation 
of calcium-permeable channels, responsible for the long lasting calcium influx and 
modulation of the electrical activity in these cells. Materials & methods: Non-toxic 
doses of SiO2 NPs were administered to the cells. Calcium imaging and patch clamp 
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techniques were combined with a pharmacological approach. Results: TRPV4, 
Connexins and Pannexin-like channels are the major components of the NP-induced 
inward currents. Pre-incubation with the antioxidant N-acetyl-L-cysteine strongly 
reduced the [Ca2+]i increase. Conclusion: These findings suggest that SiO2 NPs 
directly activate a complex set of calcium-permeable channels, possibly by 
catalyzing free radicals production.  
 
Keywords: Neuronal cells, silica nanoparticles, TRPV4, connexin, pannexin, free 





SiO2 nanoparticles (NPs) are among the most promising tools in the field of 
nanomedicine because of their good biocompatibility [1,2] and have already been 
employed in several applications from drug delivery [3,4] to cell tracking and 
imaging [5,6]. A previous research [7] provided evidence for the possibility to 
incorporate at nontoxic doses dye-doped fluorescent silica NPs, displaying high 
yield and extremely stable photoemission, into neuronal cells. These properties are 
particularly attractive for imaging application in nanoneuromedicine, that deals 
with highly sensitive and delicate biological material, both at the cell and at the 
organ level. In this context, the understanding of the mechanisms of interaction 
between the NPs and their targets as well as of the cellular and molecular responses 
elicited by these interactions is a prerequisite to the rational design of safe and 
efficient nanotools for both laboratory and clinical applications. At the nanoscale, 
the exploration of the laws that govern the interaction between inorganic particles 
and biological structures such as membrane proteins is still moving its first steps. A 
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lot of information has to be gathered to set on solid ground the generalized use of 
nanoparticles in basic and applied biology, and specifically in the highly sensitive 
field of neuroscience. One of the crucial parameters known to be affected by the 
interaction of nanoobjects with cells is the intracellular free calcium concentration, 
[Ca2+]i, controlling a plethora of signaling pathways, particularly in neuronal cells 
[8,9]. Nontoxic doses of 50 nm SiO2 NPs were found to elicit strong and oscillatory 
increases in [Ca2+]i in a neuronal cell line, GT1–7 cells; these signals are reversible 
even in the continued presence of NPs [10], fully dependent on calcium influx, and 
carried at least partially through Transient Receptor Potential V4 (TRPV4) channels 
even if other, up to now unidentified channels are involved. Indeed, the first and 
critical step of the interaction between these nanoobjects and the cell resides at 
the plasmamembrane and its rich inventory of proteins that mediate the responses 
to the changes in the extracellular environment. Among this inventory, a key role is 
played by ionic channels, and specifically calcium permeable ones, that can activate 
both fast responses and long term intracellular signalling mechanisms [8,9]. In spite 
of their functional relevance, few reports are available regarding the effects of NPs 
on neuronal calcium permeable channels [10]; most of them have been obtained 
by means of a calcium imaging approach that, even if useful for a phenomenological 
description of the process on a population scale, cannot provide a complete and 
detailed biophysical characterization of the properties of the multiple influx 
pathways activated by the NPs. The adequate approach is electrophysiology, but 
data about patch clamp recordings from cells, and particularly neurons, exposed to 
acute applications of NPs are quite scarce and limited; most of them refer to effects 
on a specific current, isolated from the whole cellular response [11-13]. Recently 
[14] single cell patch clamp measurements combined with long term recordings of 
electrical activity with multielectrode arrays have provided evidence that, at 
nontoxic concentrations, SiO2 NPs evoke a transient depolarization of the 
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membrane potential, leading to a modulation of action potential firing, without any 
change in gene expression. Here, a new contribution to the knowledge of the 
interaction of NPs with the neuronal membrane is presented, focusing on the 
molecular targets involved and on the membrane-delimited mechanisms 
responsible of their activation. 
 
3.2 Materials and methods 
 
Materials. Lab-made silica nanoparticles, in the bare form (i.e. SiO2-50 nm NP) and 
functionalized at their surface with amino groups (i.e. NH2-SiO2-55 nm NP) were 
prepared following the procedure reported in [8] and [11], respectively. In brief, in 
both cases SiO2 NPs were prepared by the reverse microemulsion technique, using 
tetraethylorthosilicate (TEOS) as source of silica. For the functionalization, (3-
Aminopropyl) triethoxysilane (APTS) was added to the microemulsion after the 
formation of NP. Microparticles were purchased from Corpuscular Inc., 
www.microspheresnanosphere.com 
 
Characterization of (nano)particles. Size and shape of SiO2 NPs were determined 
by transmission electron microscopy (Jeol 3010, operated at 300 kV). Samples were 
prepared by dropping of aqueous suspensions of the NPs on TEM grids, supporting 
a lacey carbon film, and waiting until dryness. Histograms of the size distribution of 
NPs were obtained by measuring ca. 200 particles, and the mean particle diameter 
(dm) was calculated as dm = dini/ni, where ni was the number of particles of 
diameter di. The results are indicated as dm ± standard deviation. Microparticles 
were imaged by SEM (Zeiss EVO 50), observing an aliquot of the sample fixed on a 
conventional stub through a carbon conducting biadhesive tape.  
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Dynamic light scattering (DLS) measurements, providing hydrodynamic radius 
values, were carried out with a 90Plus Par-ticle Size Analyzer, laser wavelength 660 
nm, detection angle 90°, T = 20 °C). Materials were suspended (0.1 mg mL−1) in the 
relevant aqueous media indicated in Table 1. Measurements were repeated in 
triplicate. In presence of large agglomerates in the micrometer range, in some cases 
significant differences among repeated measurements occurred, because of the 
much more complex scattering behaviour [15]. The same samples were used for -
potential measurements by electrophoretic light scattering (ELS; Zetasizer Nano-ZS 
, Malvern Instruments). Results are reported as mean value ± standard deviation of 
five separate measurements each resulting from 10 runs. 
 
Cell culture. GT1–7 cells, an immortalized line derived from highly differentiated 
mouse gonadotropin-hormone releasing hormone (GnRH) neurons (generously 
donated by Prof. P.L. Mellon), were plated either on glass 32 mm cover-slips coated 
with 100 µg mL−1 poly-l-lysine (for calcium imaging experiments) or, for 
electrophysiological experiments, on uncoated plastic dishes (Falcon, Becton 
Dickinson) at densities of 10,000 cells cm−2. The cells were maintained in Dulbecco’s 
Modified Eagle’s medium (DMEM) supplemented with10% heat-inactivated fetal 
bovine serum (FBS; Lonza), gentamycin (50 µg mL−1), and glutamine (2 mM) at 37 
°C, in a humidified atmosphere of 5% CO2 in air and then switched for 1 day to 0.5% 
FBS supplemented with B27 (Invitrogen), and subsequently for 3-4 days to 0.5% 
FBS, to improve survival and differentiation.  
 
Electrophysiology - Patch clamp. Conventional whole cell patch clamp recordings 
were performed at 22-25 °C in the voltage clamp mode. In a first set of recordings, 
the cells were continuously superfused with a standard physiological Tyrode 
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solution of the following composition (in mM): NaCl, 154; KCl, 4; CaCl2, 2; MgCl2, 1; 
4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid (HEPES), 5; glucose, 5.5; NaOH 
to pH 7.35. Composition of the pipette solution was (in mM): KCl, 15; CaCl2, 3; 
MgCl2, 3; 4(2hydroxyethyl) -1-piperazine ethane sulfonic acid (HEPES), 5; KAsp, 118; 
EGTA, 5, Na2ATP, 5, KOH to pH 7.35.  Pipettes had a resistance of 2-5 MΩ. In a 
second set, in order to abolish or reduce the contribution of currents through K+ 
channels, the extracellular solution had the following composition (in mM): NaCl, 
134; tetraethylammonium chloride (TEACl), 20; KCl, 4; CaCl2, 2; MgCl2, 1; 
4(2hydroxyethyl) 1 piperazine ethane sulfonic acid (HEPES), 5; glucose, 5.5; NaOH 
to pH 7.35. Composition of the pipette solution was (in mM): CsCl, 20; CaCl2, 0.08; 
MgCl2, 1; 4(2hydroxyethyl) 1 piperazine ethane sulfonic acid (HEPES), 10; Aspartic 
Acid, 100; CsOH, 100; Na2ATP, 4; pH 7.35. A few control experiments were 
performed using DMEM as an extracellular medium. 
NPs (sonicated for 20 min prior to the preparation of the suspensions) and other 
agents were dispersed in the solutions at the required concentration. Solutions 
were applied by means of a microperfusion system connected to a set of five 
syringes containing the control and test solutions; the perfusion pipette was located 
at several tens of microns away from the cell to be recorded, in order to minimize 
mechanical perturbations. 
Correction for junction potential was performed analogically. Data were collected 
with an Axopatch 200B amplifier (Molecular Probes, USA) using Clampex 10.2 and 
Axoscope 10.2 software and sampled at 10 kHz and 1 kHz respectively. Current 
voltage (I-V) relationships were obtained from protocols designed to inactivate the 
voltage-dependent inward currents expressed in these cells (see Fig. S-8 of the 
Supplementary Materials, hereafter SM). In the presence of NPs, whole cell 
recordings lasted from 5 to 40 minutes, durations comparable to those obtained in 
control experiments in the absence of NPs.  
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For single channel outside out experiments, patch pipettes, with a resistance of 5-
7 MΩ, were filled with the Cs-aspartate solution used for whole cell experiments. 
In preliminary experiments with the extracellular solution containing 20 mM TEACl, 
we observed gigaseal (2-10 GΩ) rupture very soon after NPs perfusion. In order to 
increase the duration of the experiments, since it has been reported that NPs are 
less agglomerated when they are suspended in DMEM [10], we added MEM 
supplements (Sigma) to the above solution. A control test (by means of dynamic 
light scattering, DLS, see Methods of the SM and Table 1) showed that 
agglomeration was lower in this solution than in Tyrode solution, even if greater 
than previously reported for DMEM [6]. Actually, this condition enhanced the 
stability of the gigaseals, although the duration of the outside out patch recordings 
was significantly shorter in the presence of 20 µg mL-1 of NPs (median and 
interquartile range: MNP = 158 s, IQRNP = [99; 216] s, n = 14 cells) than in the 
presence of pharmacological agents in similar experiments with the TRPV4 agonist 
GSK1016790A (MGSK = 346 s, IQRGSK = [260; 687] s, n = 28 cells, p-value = 0.022, π = 
0.77, Mann-Whitney U test, two-tailed, unpaired). Data were filtered at 1 kHz and 
digitized continuously at a sampling frequency of 1 kHz with PClamp Axoscope 
software. Steady state voltage clamp and ramp protocols from -120 mV to 100 mV 
were applied and digitized at 10 or 20 kHz with PClamp Clampex software. Data 
analysis was performed with OriginPro 9.1 software (OriginLab, USA). To obtain the 
I-V relationship and the reversal potential of the mean current activated by the 
agonists, we subtracted, if not otherwise specified, the average of at least ten 
current traces recorded in control conditions during ramp application (red curves 
in the figure insets), from the average current recorded in the presence of the 
agonist (black curves in the figure insets). Single channel I-V was obtained by 
subtracting the baseline (current ramp during closed or blocked state of the 
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channel, red curves in the insets) from a current ramp recorded during channel 
opening (black curves in the insets). 
Calcium imaging. Cells were loaded with the Fura-2 acetoxymethyl ester (2.5 M, 45 
min, 37 °C) and subsequently shifted to a standard physiological Tyrode solution of 
the following composition (in mM): NaCl, 154; KCl, 4; CaCl2, 2; MgCl2, 1; 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 5; glucose, 5.5; and NaOH 
(pH 7.35). The NPs were sonicated and dispersed in the Tyrode solution at the 
required concentration. The solutions were applied with a microperfusion system. 
Cells were imaged every 3 s at 37 °C using a monochromator system attached to an 
inverted microscope with a 20× objective (SFluor, Nikon). Images were acquired 
using an enhanced CCD camera (PCO) and the Metafluor software (Universal 
Imaging Co.). 
 
Assessment of lipid peroxidation. GT1–7 cells were seeded at the initial density of 
35,000 cm-2 in 96 well plates in DMEM supplemented 10% FBS (Lonza). The medium 
was changed with DMEM plus 0.5% FBS supplemented with B27 (Invitrogen) for 24 
hrs and substituted with DMEM 0.5% FBS for three days. Lipid peroxidation was 
analysed using the Click-iT® Lipid Peroxidation Imaging kit (ThermoFisher). The 
Click-iT® Lipid Peroxidation Imaging Kit-Alexa Fluor® 488 leverages copper-
catalyzed click chemistry and the linoleamide alkyne (LAA) reagent (alkyne-
modified linoleic acid) for detection of lipid peroxidation-derived protein 
modifications in fixed cells. Details are given in Methods of the SM. 
 
Statistical data analysis. All samples were first tested for normality (Shapiro-Wilk 
test) and for homogeneity of variance (Levene’s test). Mean and standard error of 
the mean (SEM), rather than median (or trimmed mean) and interquartile range 
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(IQR), depending on the skewness of data distribution, were used as measures of 
central tendency and dispersion respectively, as detailed along the text. When 
possible, statistical significance was assessed by parametric tests, otherwise non-
parametric alternatives were used as specified case by case. In any case, all 
statistical tests were among unpaired samples, two-tailed and a p-value < 0.05 was 
considered statistically significant. Sample size was chosen to ensure a statistical 
power π at least equal to 0.8 or to satisfy a particular statistical sensitivity criterion. 
In particular, the power actually achieved (in the case of null hypothesis rejection) 
or the required effect size as a measure of statistical sensitivity (in the case of 
rejection failure) are provided for each test. Single channel current amplitudes are 
represented as mean ± standard deviation (SD), estimated by fitting the amplitude 
histograms to a sum of Gaussian functions (OriginPro 9.1). 
 
3.3 Results  
 
Silica particles  
 
The nanoparticles mainly considered in this work were of bare silica, highly 
homogeneous in spherical shape and in diameter, of 50 ± 2 nm, of the type already 
used in previous investigations [7,10,14]. These nanoparticles will be labeled as 
SiO2-50 nm NPs. Moreover, selected cell tests were also  carried out using two other 
types of SiO2 spherical particles: i) nanoparticles functionalized with –NH2 groups, 
in order to impart different surface properties, namely in terms of -potential, with 
only a quite limited change in size [11] (55 ± 3 nm; hereafter: NH2-SiO2-55 nm NPs), 
and ii) commercial microparticles about 2 m in size [10]. TEM and SEM images of 
the three types of particles are shown in Fig. S-1 of SM. The material features 
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relevant for this work (-potential, size and dispersion/agglomeration state in the 




SiO2 NPs elicit long lasting inward currents in GT1–7 cells 
 
In the voltage clamp mode, the holding potential was set at -50 mV (close to the 
reversal potential for Cl- ions with standard Tyrode extracellular and K+ aspartate 
intracellular solutions, see Materials and methods), in order to exclude any 
contribution of Cl- ions to the NP-induced currents. In these conditions the inward 
currents could be univocally ascribed to influx of cations into the cell. In 34 cells 
perfusion with SiO2-50 nm NPs (20 µg mL-1) induced the activation of an inward 
current, characterized by a noisy behavior (Fig. 1A,C); peak current density, 
expressed as median and interquartile range, was: M = -7.80 pA pF-1, IQR = [-14.80; 
-4.35] pA pF-1 (n = 34 cells). Information about the currents was obtained by 
subtracting the current-voltage (I-V) relationship recorded in control conditions 
from the one recorded during the response. The I-V curves of the NP-activated 
currents of Fig. 1A,C are shown respectively in Fig. 1B,D. In most cases, the I-V 
curves showed a more or less marked outward rectification; the reversal potential 
(Vrev) was analyzed in 16 cells and was M = -1.7 mV, IQR = [-12.4; +8.7] mV (Table 
2). Openings of large conductance single channels were clearly detectable in most 
of the cells (19 out of 34 cells, Figure 1C, inset). The amplitude histogram of the 
elementary events is shown in Fig. 1E. The currents were only partially reversible 
after NP removal, at least for the duration of the recordings (up to 30 minutes). 
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When the cells were challenged with 2 µm SiO2 microparticles (to assess the role of 
size), no current was recorded (n = 5 cells, Table 2 and Fig. 1F). Similarly, perfusion 
with NH2-SiO2-55 nm NPs (to assess the role of surface charge) failed to induce an 
inward current in 7 out of 12 cells (Fig. 1F); in 5 cells, either sporadic events and/or 
low amplitude inward currents could be observed (Table 2 and Fig. S-2 in the SM). 
These findings are in agreement with previous data [10] obtained with a calcium 
imaging approach, and provide evidence for a lack of nonspecific perturbation of 
the cell membrane following exposition to the SiO2 NPs. The above protocol was 
repeated with a lower concentration of the same SiO2 NPs (0.5 µg mL-1): in 5 out of 
29 cells, no detectable change in the current baseline was observed; in the other 
24 cells, the NPs elicited currents of similar time course, but with a significantly 
lower peak current density (Table 2; p-value = 0.0008, π = 0.99, Mann-Whitney U 
test). An example is shown in Fig. S-3 of the SM. 
It has been previously shown [10] that the calcium signals could be also recorded 
when the NPs were dispersed in DMEM medium, in which the agglomeration is 
sharply reduced (Table 1). This finding was confirmed in electrophysiological 
experiments: when dissolved in DMEM, SiO2-50 nm NPs (20 µg mL-1) elicited and 
inward current similar to those observed in Tyrode solution (n = 5 cells). A 
representative recording is shown in Fig. S-4 of the SM.  
In order to better characterize the inward current, a further set of experiments was 
performed on cells bathed in an external solution containing 20 mM 
tetraethylammonium (TEA) and internally perfused with a pipette solution in which 
K+ was substituted with Cs+ (see Materials and methods), to block outward currents 
through K+-selective channels. Fig. 2A,C shows two typical experiments out of 31 
similar recordings. In these conditions the I-V relationships of NP-activated currents 
were in most cases linear (Fig. 2B); Vrev was M = -2.8 mV, IQR = [-10.0; +5.5] mV (n 




Figure 1. SiO2-50 nm NPs activate inward currents in GT1–7 cells. (A,C) Two examples of whole cell 
currents recorded following administration of 20 µg mL-1 of SiO2-50 nm NPs. Voltage clamp 
recordings, Vhold = -50 mV. Inset in (C): a large conductance event observed during a whole cell 
recording. (B,D) I-V relationships obtained from the experiments in (A,C). The red curves were 
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obtained subtracting the currents activated by the voltage ramps applied before NP administration 
(gray) from those recorded during the response (black). (E) Amplitude histogram of the large 
conductance events shown in the inset of (C): the resulting amplitude is 17.2 pA. (F) Stimulation with 
either SiO2 microparticles (diameter 2 µm) or NH2-SiO2-55 nm NPs failed to induce an inward current; 
subsequent administration of plain SiO2-50 nm NPs elicited a response. 
 
Median peak current density was significantly lower than in Tyrode solution (Table 
2; p-value = 0.001, π = 0.99, Mann-Whitney U test; since the same control group of 
peak amplitudes in Tyrode solution has been used twice, p-values have been 
corrected for multiple comparisons). The response was only partially reversible. 
Single channel opening events could again be resolved (Fig. 2C). The amplitude 
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Effects of channel blockers 
 
The currents activated by the NPs, both in physiological solutions and in the 
presence of K+ channel blockers, showed some peculiar features, such as an 
irregular evolution in time, a marked noisy behavior and the occurrence of single 
channel unitary events of amplitude of about 10 pA in whole cell configuration. 
These features point to a complex process involving the activation of multiple 
channel types. It has been shown [10] that the NPs-induced calcium signal could be 
reduced by TRPV4 blockers. As for openings of the large conductance channels 
recorded in whole cell configuration, potential candidates are, among others, 
members of the connexin (Cx) and/or pannexin (Panx) families. Both connexins and 
pannexins form high conductance multimeric membrane channels. In addition, Cxs 
assemble to form vertebrate gap junctions for direct intercellular communication. 
Cx and Panx families share similar membrane topology and in part pharmacologic 
and gating properties, but not sequence homology. Cx and Panx plasma membrane 
channels allow the exchange of ions and signaling molecules between the 
cytoplasm and the extracellular medium, including calcium ions, ATP and large size 
molecules and play important roles in health and desease, such as 
neuroinflammation and neuropathic pain [16-21]. Among connexins, GT1–7 cells 
express at least Cx26 and Cx43 [22], two proteins that can form gap junctions as 
well as hemichannels. Panxs are widely expressed in the nervous system [18, 23-
27] but to our knowledge no data are currently available for GT1–7 neuronal cells. 
Interestingly, in a different experimental model (cultured cortical astrocytes), it has 







Figure 2. Inward currents activated by SiO2-50 nm NPs in the presence of block of K+ selective 
channels. (A,C) Two examples of whole cell currents recorded following administration of 20 µg mL-
1 of SiO2 NPs. Voltage clamp recordings, Vhold = -50 mV. Inset in (C): large conductance events 
observed during a whole cell recording. (B) I-V relationships obtained from the experiment in (A). 
The red curve was obtained subtracting the current activated by the voltage ramps applied before 
NP administration (gray) from the one recorded during the response (black). (D) Amplitude 







In order to evaluate the involvement of these channels, we used a pharmacological 
approach. We preliminary analyzed the effects of these blockers on NP-induced 
calcium signals by means of calcium imaging experiments on cell populations. As a 
first step we tested the activity of Gd3+, a known inhibitor of TRPVs and other 
calcium permeable channels [29] and of several connexins [30, 31]. Its effectiveness 
on pannexins is controversial: some Authors [32] reported lack of blockade of dye 
uptake through Panx1, while others [33] ascribed a reduction in ATP release from 
lymphocytes to Gd3+ block of Panx1. Since it is known that polyvalent ions can 
induce nanoparticle agglomeration in suspension [34] we preliminarily checked the 
aggregation effects by Dynamic Light Scattering at different concentrations of Gd3+. 
Concentrations in the range 50-100 µM are used by some Authors [30, 33, 35, 36]. 
As can be seen in Table 1, agglomeration was strongly increased by 100 µM Gd3+, 
above the detection range of the instrument. At 10 µM, a more detailed analysis 
revealed a bimodal distribution: while a very small fraction of extremely 
agglomerated NPs was present, the majority were even less agglomerated than in 
normal Tyrode (Table 1). For these reasons we employed 10 µM Gd3+, a 
concentration still compatible with the blocking activity on TRPV and Cx channels 
[31, 37]. In the presence of 10 µM Gd3+, NPs failed to induce a detectable increase 
of [Ca2+]i (4 experiments, 354 cells). Upon blocker removal and in the continued 
presence of the NPs, we observed a strong [Ca2+]i increase (Fig. 3A, upper and low). 
A second approach was to combine Ruthenium Red (RR), another blocker of several 
types of TRP channels including TRPVs [38], and carbenoloxone (CBX), inhibitor of 
Cxs and Panx1 channels [16, 32, 39]. Specifically, we used 50 µM CBX and 5 µM RR 
[28, 40. 41]. No relevant change in [Ca2+]i levels was detected upon addition of the 
drugs to the medium. On the other hand, the [Ca2+]i increase induced by SiO2-50 




Figure 3. Effects of channel blockers on the increases in [Ca2+]i and on the ionic currents activated 
by SiO2-50 nm NPs. (A) Gd3+ (10 µM) completely abolished the NP-induced increase in [Ca2+]i. Upper: 
Average response (105 cells) from one experiment representative of 4 (total 354 cells). Lower: three 
individual traces from the same experiment. (B) The combination of 5 µM RR and 50 µM CBX strongly 
reduced the NP-induced increase in [Ca2+]i. Upper: the comparison of the average of  457 cells from 
6 control experiments in which the NPs were administerd in the absence of the blockers (black) and 
the average of 693 cells from 6 experiments in which cells were preincubated with the blockers prior 
to NP administration (gray). Lower: two representative traces from one control experiment and one 
with the blockers. (C) Frequency histograms of the areas between the curve of [Ca2+]i response to 
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NPs and the reference baseline. Black bars: areas measured in control condition (SiO2 NPs alone). 
Transparent gray bars: areas measured during NP administration in the presence of CBX and RR 
blockers. In most of the tested cells NPs did not induce any calcium signal when administered after 
CBX and RR preincubation. (D) Reversible block of the NP-activated inward current by 5 µM RR and 
50 µM CBX. (E) Reversible block of the NP-activated inward current by 10 µM Gd3+. (F) I-V 




For this reason we performed a quantitative analysis by evaluating the area under 
the curves representing the time courses of the cytosolic calcium concentration 
after NP administration. Responses induced by the NPs in the presence of RR and 
CBX (693 cells from 6 different experiments) were compared with a control group 
(response in the sole presence of NPs; 457 cells from 6 different experiments). The 
average [Ca2+]i increases in the two conditions are compared in Fig. 3B, upper; 
individual traces from one control experiment and one performed in the presence 
of the blockers are in Fig. 3B, lower. For both conditions, areas were evaluated 
within an integration time interval of 10 minutes starting from the onset of the 
averaged response and represented by frequency histograms in Fig. 3C. Statistical 
analysis confirmed that the combined administration of 50 µM CBX and 5µM RR 
exerted a strong and significant reduction in [Ca2+]i increase following NP 
administration (Mann-Whitney U Test, p-value = 1.4·10-126, π = 0.99, effect size r = 
0.71). Further analytical and statistical details are provided in Methods of the SM. 
The same blockers were tested in whole cell patch clamp experiments, with the 
same intracellular and extracellular solutions as in Figure 2. Fig. 3D shows that in 
the presence of CBX and RR the current was completely and reversibly abolished (n 
= 5 cells). Fig. 3E,F shows an example (out of 11 cells) of reversible block of the NP-




Biophysical characterization of NPs-activated channels: TRPV4 
 
In order to shed more light on the biophysical properties of the NP activated 
channels, we performed experiments in the outside-out patch configuration. To 
confirm that NPs activate TRPV4 channels, we used GSK1016790A, a selective 
TRPV4 agonist [42] with Cs+-aspartate solution in the pipette and TEA chloride 
solution with added MEM supplements in the bath (see Materials and methods). 
Fig. 4A shows the simultaneous activation of TRPV4 channels at Vhold= -50 mV in 
response to 500 nM GSK1016790A. The I-V curve, shown in Figure 4B, is outwardly 
rectifying with a Vrev = -8 mV, as expected for the cationic TRPV4 current [43-45]. 
Examples of single channel inward currents and the corresponding amplitude 
histograms are plotted in Fig. 4C (same experiment as in Fig. 4A). Current 
amplitudes from the traces were respectively -2.2, -1.9 and -1.7 pA, in agreement 
with previous studies. Fig. 4D shows an example of single channel I-V obtained from 
another outside-out experiment, in the presence of a lower concentration (25 nM) 
of the agonist. The resulting outward rectifying I-V curve shows a Vrev of -4 mV and 
current amplitudes of -1.8 pA at -50 mV and of +8.1 pA at +100 mV. Moreover, we 
obtained similar results for both mean patch current and single channel unitary 
current in experiments in which we applied RR to block the GSK1016790A activated 
currents (Fig. S-5A,B of the SM). Finally, current amplitudes at -50 mV and +100mV 
and reversal potential were respectively -2.3 ± 0.4 pA, +9.5 ± 0.7 pA and -2.4 ± 4.2 
mV (n = 9 cells). In conclusion, in our experimental conditions, TRPV4 single channel 
conductance for outward and inward currents values are respectively 90-100 pS 
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Figure 4. SiO2-50 nm NPs open TRPV4 channels in outside-out patches. (A) Currents activated by 
the TRPV4 specific agonist GSK1016790A (500 nM) at Vhold= -50 mV. (B) I-V relationship of the patch 
average current obtained subtracting the red trace to the black trace shown in the inset. (C) 
Examples of TRPV4 single channel currents and the corresponding amplitude histograms. (D) Single 
channel I-V relationship obtained subtracting the red trace (inset, baseline) from the black trace 
recorded in the presence of GSK1016790A (25 nM). (E) Currents activated by 20 µg mL-1 SiO2 NPs at 
Vhold = -50 mV. (F) I-V relationship of the patch average current activated by SiO2 NPs obtained 
subtracting the red trace from the black trace shown in the inset. (G) Single channel I-V relationship 
obtained subtracting the red trace (baseline) from the black trace shown in the inset. (H) Ruthenium 
red (5 µM) blocked NP-activated TRPV4 channels. 
 
 
Subsequently we challenged outside-out patches with 20 µg mL-1 SiO2 NPs. Fig. 4E 
shows the activation of a cationic inward current at Vhold = -50 mV. Importantly, this 
result obtained on isolated patches provides strong evidence that NPs act via a 
membrane-delimited mechanism to activate ionic channels. 
Furthermore, we obtained the I-V relationship and the reversal potential of the 
average patch NP-activated current (Fig. 4F). The resulting curve showed a Vrev = 
4.5 mV; Fig. 4G shows the single channel I-V relationship obtained from the same 
patch (i-50 = -1.8 pA, i100 = 6.3 pA, Vrev = 5 mV). The NP-activated inward current was 
blocked by RR (Fig. 4H). Figure S-5C,D of the SM shows the I-V relationship of 
respectively the mean patch current and the single channel current blocked by RR.  
Finally, amplitude at -50 mV and +100 mV and reversal potential of the single 
channel currents were respectively of -2.15 ± 0.2 pA, 11.0 ± 1.1 pA and 3.2 ± 2.4 mV 
(n = 11 cells, Table 3). These values do not significantly differ from those obtained 
for TRPV4 (Welch’s t-test, p-value = 0.67, statistical sensitivity = 1.17 pA at π = 0.8 
for comparison at -50 mV, p-value = 0.25, statistical sensitivity = 4.06 pA at π = 0.8 
for comparison at +100 mV), suggesting that TRPV4 channels are actually one the 
calcium-permeable channel types that are activated, via a membrane-delimited 
mechanism, by SiO2-50 nm NPs in GT1–7 neuronal cells. 
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Large conductance nonselective channels 
 
Whole cell and calcium imaging experiments showed that Gd3+ or RR+CBX block 
almost completely the NP-activated inward currents and calcium influx. These data 
point to the involvement of connexins and pannexins as the main large-
conductance calcium-permeable channels activated in response to NPs. In the 
absence of NPs in the external solution, large conductance nonselective channel 
activity was detected in 5 out of 42 outside-out experiments. An example is shown 
in Fig. S-6 of the SM. 
On the other hand, large conductance channel activity in response to NPs perfusion 
was measured in the majority of the experiments (in 3 out of 4 with 0.5 µg mL-1 and 
in 13 out 14 with 20 µg mL-1). Fig. 5A shows an example of the channel activation in 
the presence of 0.5 µg mL-1 NPs. Here and in the trace with an expanded time scale 
(Fig. 5B), the activation of unitary single channel events of -12 pA was suddenly 
followed by a steep activation of additional inward currents of about -67 pA and 
then of -34 pA. Fig. 5C shows the single channel I-V relationship obtained during the 
opening of the channel of unitary current amplitude of -12 pA: the conductance 
was 233 pS and the reversal potential +0.5 mV. Finally, the best fit of the amplitude 
histogram distribution of the single channel trace shown in the inset (Fig. 5D; same 
events as shown at the end of the record of Fig. 5B) indicates a fully open state of -
34 pA (about 680 pS; see below) and two current sub-levels. In a second set of 
experiments we analyzed the responses to 20 µg mL-1 NPs. Fig. 5E shows a series of 
bursts of single channel currents recorded in the presence of  20 µg mL-1 NPs and 
of the TRPV4 antagonist HC-067047 [46] in the bath solution (10 µM), which well 
illustrates several sub-conductance states and loop-gating events, i.e. transitions 





Figure 5. SiO2-50 nm NPs open large conductance channels in outside-out patches. (A) Currents 
activated by 0.5 µg mL-1 SiO2 NPs at Vhold = -50 mV. (B) Single channels currents recorded between 
and during the last 4 voltage ramps of (A) in more expanded scales. Red lines indicate the main 
current levels. (C) Single channel I-V relationship obtained by subtracting from the second current 
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ramp (inset, black trace) of (B) the first one (inset. red trace). The dotted red line represents the 
regression line obtained by fitting the curve from -50 mV to +40 mV. (D) Amplitude histogram, fitted 
by the sum of 4 gaussian curves, of the single channel trace shown in the inset. (E) Single channel 
currents activated in response to 20 µg mL-1 SiO2 NPs at Vhold = -50 mV and (F) the corresponding 
amplitude histogram. (Arrows indicate single channel events of about -20 pA). (G) I-V relationship 
of the channel in (E), obtained by subtracting the baseline from a current ramp recorded during 
channel opening (respectively red and black trace in the inset).  
 
stable intermediate conductance states with a slow, measurable time course [47, 
48].  
The best fit of the amplitude histogram distribution (Fig. 5F) of the single channel 
trace indicates a main open state of -15.9 pA, but single channel events of -20 pA 
and even larger could be detected (arrows in Fig. 5E). Fig. 5G, obtained from the 
same experiment as in Fig. 5E, shows the single channel I-V relationship. The curve 
was fitted with two regression lines yielding a conductance state of 300 pS (blue 
line) and another of 220 (red line). In 5 experiments, NPs activated also channels of 
higher conductance (see also above, Fig. 5B) and with different biophysical 
properties. Fig. 6A shows a current trace, recorded in the presence of 20 µg mL-1 
NPs and 5 µM RR. The I-V relationship in Fig. 6B shows a strong outward 
rectification for Vm > 50 mV and Vrev = -7.8 mV. In the expanded traces shown in the 
lower part of Fig. 6A single channel openings could be observed, with a current 
amplitude of -29 pA (687 pS) at Vm = -50 mV (red lines). 
In conclusion, the data provide evidence that SiO2 NPs activate most frequently 
channels with a conductance in the range of 200-250 pS and in the range of 300-
350 pS (Table 3). These data are in agreement with those reported in previous 
papers for Cx43 and Cx26 [49-53]. In addition, we also recorded nonselective 
channels with an outwardly rectifying I-V relationship, with a very large 
conductance in the range of 600-700 pS at -50 mV (Table 3), properties comparable 







Figure 6. SiO2-50 nm NPs open Panx-like channels in outside-out patches. (A) Currents activated by 
20 µg mL-1  SiO2 NPs at Vhold = -50 mV in the presence of 5 µM RR. Lower traces are single channels 
currents recorded between and during the voltage ramps in more expanded scales. (B) I-V 
relationship obtained by subtracting the baseline (red trace, inset) from the averaged current 










SiO2 NPs induce lipid peroxidation in GT1-7 cells 
 
Production of free radicals, and in particular lipid peroxidation, has been reported 
to be activated by the interaction of several kinds of NPs with different cell types 
[56-58]; this pathway may be in turn involved in the activation of some of the 
channels we described in the previous sections. To investigate this potential 
mechanism, GT1–7 were treated with SiO2-50 nm NPs (20 µg mL-1, 30 minutes), and 
the changes in lipid peroxidation were evaluated by means of the Click-iT® Lipid 
Peroxidation Imaging kit (see Materials and methods). As shown in Fig. 7A, the 
treatment triggered a significant increase (p-value = 0.003) in lipid peroxidation 
over the basal value, while cell preincubation with 1 mM of the antioxidant N-
acetyl-L-cysteine (NAC) significantly reduced (p-value = 0.045) the response 
(Welch’s F-test, π = 0.98, Games-Howell post hoc test, n = 17 for each condition, 
from 3 or 4 technical replicates in 5 biological replicates). 
These protocols were performed by adding the NPs to the culture medium in the 
culture dish, differently from all the other experiments in which the NPs were 
administered by microperfusion. A set of control tests (Methods and Fig. S-7 in the 










Preincubation with NAC affects the calcium increases induced by SiO2 
NPs 
 
To evaluate the effects of NAC on calcium signals induced by SiO2 NPs we performed 
further calcium imaging experiments in which GT1–7 cells were challenged with 20 
µg mL-1 SiO2 after 30 min of preincubation with 1 mM NAC. Specifically, we recorded 
[Ca2+]i time course from 434 NAC-preincubated cells (from 7 experiments) and 
compared the responses elicited by NPs with the same set of control traces already 
used to assess the effect of RR and CBX. NAC preincubation caused a strong 
reduction of NP-induced calcium signals, as shown by the average traces in Fig. 7B; 
Fig. 7C shows 4 representative traces from 2 different experiments (one in control 
conditions and one with NAC preincubation). The area between each trace and its 
baseline was evaluated by the same approach previously described; Fig. 7D shows 
the frequency distributions of the areas measured in the two experimental 
conditions. Similarly to what observed with RR/CBX blockers, the effect of NAC as 
compared to the control condition was striking, leading to a nearly complete 
suppression of the response in most of the observed cells (Mann-Whitney U Test, 
p-value = 9.1·10-82, π = 0.99, effect size r = 0.64). Further analytical and statistical 




Figure 7. SiO2-50 nm NPs induce lipid peroxidation and this pathway is strongly involved in NP-
activated calcium influx. (A) 30 min preincubation of GT1–7 cells with 1 mM NAC prevented the 
increase in lipid peroxidation induced by 20 µg mL-1 SiO2 NPs (*p-value = 0.045, **p-value = 0.003, 
Welch’s F-test and Games-Howell post hoc test, error bars = s.e.m.). (B) Preincubation with NAC 
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strongly reduced the calcium influx induced by NPs as can be seen from the comparison between 
the average of 434 cells from 7 experiments with NAC (gray trace) and the average of the same 
control traces already used as reference for RR and CBX blockers (black trace, 457 traces from 6 
experiments). (C) Two representative traces from one control experiment compared with two from 
one experiment with NAC. (D) Frequency histograms of the areas between the curve of [Ca2+]i 
response to NPs and the reference baseline. Black bars: areas measured in control condition (SiO2 








The detailed and quantitative assessment of the physiopathological responses 
elicited by nanoparticles in cells and tissues is the prerequisite for determining 
which properties (in terms of composition, surface, size) have to be selected in view 
of a safe and effective use of these tools in biomedical applications. In neurons, 
interaction of the NPs with the plasmamembrane can represent a critical factor 
profoundly affecting cell functionality, particularly by modulating the activity of 
ionic channels. In spite of their functional relevance, few reports are available 
regarding the effects of NPs on neuronal channels, in particular at the single 
channel level, due to the challenges posed by the technique: most refer to 
inhibition of voltage-dependent Na+ and K+ channels [11, 12, 59], while increases in 
INa and IK by ZnO NPs have been reported at a relatively high concentration (100 µg 
mL-1) [60]. As reported in the Introduction, a previous work [10] provided evidence 
that SiO2-50 nm NPs, at nontoxic doses, activate in the GT1–7 neuroendocrine cell 
line strong and long lasting increases in [Ca2+]i, at least in part dependent on the 
activation of the calcium permeable channel TRPV4, an integrator of different 
physical and chemical stimuli [61], and only marginally affected by blockers of 
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voltage dependent calcium channels. Therefore, the object of the present work was 
to provide direct evidence, using the patch clamp electrophysiological approach, 
for the involvement of TRPV4 and to identify the other channels responsible of the 
NP-activated calcium influx. 
In whole cell experiments we have found that SiO2-50 nm NPs (0.5 and 20 µg mL-1) 
elicit inward currents showing a noisy behavior, with partial reversibility (Figs. 1, 2, 
S-3). The reversal potential, near 0 mV, suggests the involvement of nonselective 
conductances. The striking observation of single unitary macroscopic events even 
in the whole cell configuration pointed to the activation of large conductance 
channels. A pharmacological approach, by means of blockers of TRPV4 channels 
and of the connexin and pannexin families of large conductance nonselective 
channels allowed to dissect the contribution of the different channel types (Fig. 3). 
By combining calcium imaging on cell populations with whole cell and single 
channel recordings evidence is provided that the three major components of the 
inward currents elicited by the interaction of the NPs with the neuronal plasma 
membrane are carried by TRPV4 channels and Cx and Panx-like channels (Figs. 4, 5, 
6). All three classes of channels described above are known to be involved in a wide 
spectrum of physiological and pathological processes [25, 46] and characterized by 
multiple activation mechanisms. In the present case the most relevant is likely 
related to the production of reactive species, since we have shown that lipid 
peroxidation is significantly increased after 30 minutes of NP exposure and that 
preincubation with the antioxidant NAC strongly reduced the NP-induced [Ca2+]i 
increase (Fig. 7). The detection and measurement of lipid peroxidation is one of the 
evidence most frequently cited to support the involvement of free-radical reactions 
in cellular responses [62]. ROS are involved in the activation of TRPV4 [63]; 
moreover, ROS production has been observed downstream of TRPV4-mediated 
calcium influx [64-67], thus providing a potential amplification mechanism. In 
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addition, some Cxs and Panxs have been reported to open in response to 
generation of ROS and other reactive species [18, 68, 69]. 
A relevant issue in the interpretation of these data is the finding that their activation 
has been observed also in excised membrane patches, pointing to membrane-
delimited pathways. One explanation is based on the existence of 
plasmamembrane, constitutively active oxidases that generate oxides/peroxides in 
the extracellular medium [70, 71]; a recent paper [72] has reported that SiO2 NPs 
can generate ̇ HO in the presence of H2O2. Therefore, channels present in an excised 
patch can be activated by the reactive species produced either locally or in the 
surrounding environment, derived from the whole cell population. Interestingly, 
the Authors reported that in contrast with bare SiO2 NPs, aminated NPs did not 
catalyze ROS production: this is in agreement with a previous observation that 
aminated NPs failed to induce detectable increases in [Ca2+]i [10] and to activate 
inward currents in most cells tested. Additionally, more than one mechanism may 
coexist, in particular for TRPV4: as discussed above, its activation could lead to 
intracellular ROS production, thus explaining the strong contribution of this 
pathway to the observed cellular responses. The obvious candidate is 
mechanotransduction, following membrane stretch due to the interaction with the 
NP. TRPV4 is a polymodal channel, that can give an integrated response to different 
chemical and physical stimuli [73]. It is involved in the transduction of cell stretch 
and mechanical pressure, even if it is still controversial whether it is activated 
directly by deformation of the membrane or by the ensuing release of some 
membrane component that in turn acts on the channel [74-76]. Mechanosensitivity 
has been reported also for Panx channels [77].  
The data presented in this paper can be related to the findings of Ref.14, that show 
that in primary sensory neurons these nanoparticles elicited the same modulation 
of electrical excitability as in GT1-7 cells. The picture has to be broadened to 
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encompass other neurologically relevant nanomaterials. Interestingly, one of such 
materials, graphene, has attracted the interest of several groups for its potential 
biomedical applications, and it has been shown to affect astrocyte function and 
morphology [78] and neuronal excitability, at concentrations that do not impair cell 
viability. The effects on neurons are mediated by modulation of several types of 
ionic channels in hippocampal and cortical neurons, such as synaptic excitatory 
and/or inhibitory ones [79,80] or of K+ currents by an indirect mechanism, due to 
the depletion of extracellular K+ ions because of ion adsorption on the graphene 
surface [81]. The understanding of the biophysical mechanisms underlying these 
interactions is only at the beginning, and future research will provide useful 




In the present paper we report the detailed electrophysiological characterization of 
the ionic currents activated by the interaction of nanoparticles with the neuronal 
plasmamembrane and identify the major channel types involved. Combining whole 
cell and single channel recordings with calcium imaging we show that the response 
can be ascribed to two major components carried respectively by TRPV4 and large 
conductance channels and point to the involvement of free radicals production as 
one of the key actors in this process.  
A peculiar feature of the results presented in this paper is that they have been 
obtained at NP concentrations that we have previously shown to be nontoxic [10, 
14, 82]; a key question is whether the same molecular actors may underlie toxicity 
at higher doses, given the potential amplification pathways described above. In this 
light, recently [83] it has been reported that SiO2 NPs inhibit TRPV4 following its 
activation with the agonist GSK1016790A in airway epithelial cells; however, these 
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findings were obtained with smaller (10 nm) particles with a -potential of 20 mV; 
of greater relevance, the concentrations used in native cell (100-3000 µg mL-1) have 
been shown to be well above the threshold for toxicity [82]. It is quite reasonable 
that at such high doses the interaction of the NPs with the membrane involves 
radically different mechanisms. In any case, the information presented here may 
be of general value, particularly for cells of the nervous system, since a similar 
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Oxaliplatin induced peripheral neurotoxicity is characterized by an acute cold-
induced syndrome characterized by cramps, paresthesias/dysesthesias in the distal 
limbs and perioral region, that develops rapidly and lasts up to one week affecting 
nearly all the patients as well as by long-lasting symptoms. It has been previously 
shown that pharmacological or genetic ablation of TRPA1 responses reduces 
oxaliplatin-induced peripheral neurotoxicity in mouse models. In the present 
report, we show that treatment with concentrations of oxaliplatin similar to those 
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found in plasma of treated patients leads to an acidification of the cytosol of mouse 
dorsal root ganglia neurons in culture and this in turn is responsible for sensitization 
of TRPA1 channels, thereby providing a mechanistic explanation to toxicity of 
oxaliplatin. Reversal of the acidification indeed leads to a significantly reduced 
activity of TRPA1 channels. Last, acidification occurs also in vivo after a single 





Chemotherapy-induced peripheral neurotoxicity is a dose-limiting toxicity of 
several anti-cancer agents, including platinum compounds, anti-tubulins and 
proteasome inhibitors. Management of peripheral neuropathy remains one of the 
most important unmet clinical needs in oncology practice since it compromises the 
quality of life and may limit the effectiveness of treatment (if doses need to be 
adjusted). 
OHP induced peripheral neurotoxicity (OIPN) is characterized by an acute cold-
induced syndrome characterized by cramps, paresthesias/dysesthesias in the distal 
limbs and perioral region, that develops rapidly and lasts up to one week affecting 
nearly all the patients1,2,3. In addition to these acute symptoms, most patients 
develop a chronic sensory neurotoxicity with enduring characteristics like ataxia, 
dysesthesias, paresthesias, burning and lancinating pain, that spreads from toes 
and fingers with a stocking-and-glove distribution4. The chronic symptoms are 
shared with other platinum-containing chemotherapeutics (e.g. cisplatin, 
carboplatin), while acute toxicity is a peculiarity of OHP. No therapies are available 
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to treat OIPN and patients often suffer from pain and sensory symptoms long after 
the end of the therapy5. 
DRG are thought to be the main target of OIPN, although the exact mechanism by 
which this occurs is still unknown. Since it is well established that intracellular 
calcium is a crucial second messenger that can induce short and long-term changes 
in the peripheral nervous system, the hypothesis that intracellular calcium-related 
events might play an important role in the onset of OIPN has been raised6,7, but the 
mechanism by which changes in calcium signalling would occur are so far unknown. 
Hyper-excitability of neurons through triggering of voltage-operated sodium 
channels, which is not in contradiction with the Ca2+-hypothesis, has also been 
postulated as a triggering event8,9. 
Transient receptor potential channels are non-selective cation channels that detect 
a vast array of signals. Given that they play an important role in DRG neurons10, it 
is not surprising that some of its family members may be involved in OIPN11. For 
example, OHP-treated TRPA1-/- animals display reduced cold hypersensitivity12, an 
effect which is also observable in TRPM8-/- animals13. 
In the present study, we set to investigate the relationship between OHP and TRPA1 
activation in DRG neurons. We now report that OHP, in DRG neurons, induces 
cytosolic acidification and TRPA1 sensitization. This sensitization could be reversed 
if pH was restored to physiological pH, suggesting that it is acidification which leads 
to TRPA1 sensitization. Furthermore, acidification of intracellular pH was also 
observed in DRG cells excised from acutely or chronically OHP-treated animals, 
when measured within 24 hours after injection. In conclusion, our data 
demonstrate that OHP-induced cytosolic acidification is a key step in TRPA1 
sensitization and may be related to acute toxicity.  
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4.2 Materials and Methods  
 
Animals and husbandry. BALB/c male mice aged 5-10 weeks upon arrival were 
employed (Envigo, San Pietro al Natisone, Italy) both for DRG culture preparation 
and in vivo studies. Animals were maintained as previously reported14. Care and 
husbandry of animals were in conformity with the institutional guidelines in 
compliance with national and international laws and policies. The study plan was 
approved by the animal Ethics Committee of the University of Milano Bicocca and 
of the Università del Piemonte Orientale.  The procedures were approved by the 
local animal-health and ethical committee (Università del Piemonte Orientale) and 
were authorized by the national authority (Istituto Superiore di Sanità; 
authorization number N. 22/2013).  All mice were euthanized under deep 
isoflurane-induced anaesthesia for cell cultures and with CO2 for in vivo 
experiments. 
 
Chemicals. For in vivo studies OHP solution was prepared as reported by Renn and 
collaborators15 and used as previously described14. 
For in vitro studies, OHP (5 mg/mL stock solution, Sigma-Aldrich Inc., Italy), cisplatin 
(5 mg/mL stock solution, Sigma-Aldrich Inc., Italy), sodium oxalate (10 mg/mL stock 
solution, Sigma-Aldrich Inc., Italy), capsaicin (1 mM stock solution, Sigma-Aldrich 
Inc., Italy), icilin (10 mM stock solution, Sigma-Aldrich Inc., Italy), BCTC (10 mM, 
stock solution, Sigma-Aldrich Inc., Italy), HC-030031 (50 mM stock solution, Sigma-
Aldrich Inc., Italy), AITC (allyl isothiocyanate; 50 mM stock solution; Sigma-Aldrich 
Inc., Italy), BCECF ((2',7'-Bis-(2-Carboxyethyl)-5-(and-6)-Carboxyfluorescein, 
Acetoxymethyl Ester, 100 mM stock solution, Life Technologies, Italy), DIDS (4,4'-
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Diisothiocyano-2,2'-stilbenedisulfonic acid; Sigma-Aldrich Inc., Italy)  and nigericin 
(20 mM stock solution,  Life Technologies, Italy) were used. These compounds, with 
the exception of capsaicin (reconstituted in 100% EtOH), were dissolved in 100% 
dimethyl sulfoxide (DMSO) and stored at -20 °C, according to manufacturers’ 
specifications. Working concentrations of these drugs were freshly prepared for 
each experiment by diluting DMSO or EtOH to 0.1% in milliQ (MilliPore) water. 
 
Experimental design for the in vivo study. For the evaluation of pH in chronically 
OHP-treated animals, animals (n=12 in two separate experiments) were injected 
intravenously in the tail vein with OHP 3.5 mg/Kg (10 mL/Kg) twice a week for 4 
weeks, while control mice (n=12) were left untreated. The neurotoxicity of this 
chronic schedule and its capacity to mimic Human OIPN have already been reported 
in detail15. In a second experiment that evaluated the acute effect of OHP, eight 
animals (in two separate experiments) were injected intravenously in the tail vein 
with a single dose of OHP 3.5 mg/Kg (10 mL/Kg). Animals were sacrificed after 24 
hours to investigate acute effects. 
 
Isolation and Primary Cell Culture of Mouse DRG Neurons. DRG obtained from 
adult BALB/c mice (5/10-wk-old) were excised and collected in a dish containing 
cold F12 (Nutrient Mixture F12 Ham) medium (Sigma Aldrich Inc.). Working under 
a dissecting microscope and using fine forceps, the surrounding membranes were 
gently teased away from each DRG; nerves and sheath were cut. All de-sheathed 
DRG were then transferred into a sterile 35 mm dish containing collagenase from 
Clostridium hystoliticum 0.125% (Sigma Aldrich Inc.) and DNase (Sigma) in F12 
(Nutrient Mixture F12 Ham) medium and incubated at 37 °C for 1 h. After 
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incubation, DRG were triturated using a 1000 µl tip. Myelin and nerve debris were 
eliminated by centrifugation through a bovine serum albumin (BSA) cushion. Cell 
pellets were re-suspended in Bottenstein and Sato medium (BS) (30% F12 (Nutrient 
Mixture F12 Ham medium), 40% DMEM (Dulbecco’s Modified Eagle’s medium 
(Sigma Aldrich Inc., Italy), 30% Neurobasal A medium (Life Technologies, Italy), 100 
X N2 supplement (Life Technologies, Italy), penicillin 10 U/mL and streptomycin 100 
mg/mL (Sigma Aldrich Inc., Italy), supplemented with Recombinant Human -NGF, 
Recombinant Murine GDNF and Recombinant Human NT3 (Peprotech, USA) and 
plated onto 24 mm glass coverslips pre-coated with laminin (Sigma Aldrich Inc., 
Italy).  
 
Real Time Quantitative PCR (QRT-PCR) . Total RNA was isolated from DRG using 
TRI-Reagent® and reverse transcribed according to the manufacturer’s instructions 
(Im-Prom-II™ Reverse Transcription System, Promega, WI, USA). cDNA was then 
stored at -20°C until further used. qRT-PCRs were performed on 96-well plates 
(CFX96™ Real-Time PCR Detection Systems, Bio-Rad Inc), in triplicate and 
florescence intensity assessed using the CFX96™ Real-Time PCR Detection Systems 
(Bio-Rad Inc.). After an initial denaturation step at 95°C (10 min), each primer set 
was used (through 40 cycles of amplification) as follows: mouse TRPV1 5’-
CCTGCATTGACACCTGTGAG-3’ forward, 5’-AGAAGATGCGCTTGACAAATC-3’ reverse; 
mouse TRPM8 5’-TGGAGCCAAAAACTTTGCTT-3’ forward, 5’-
TCATCAGGCCGTAGTGAGTG-3’ reverse and mouse TRPA1 5’-
TGTCACCCCTTCACATAGCT-3’ forward, 5’-GTGGACATCAAAGCCGTGTT-3’ reverse; 
60°C annealing temperature. Transcripts were normalized to the expression of 
Ribosomal Protein S18 mRNAs, for each gene, the threshold cycle (Ct) was 
calculated. The Ct of treated cells was compared to the Ct generated by the control 
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cells and ΔCt was calculated as the difference between Ct values, determined using 
the equation 2-ΔCt. 
 
Cell lines. Human colorectal carcinoma LS180, HCT116, LoVo, HT29, HCT15 cell lines 
and SW620 colon cancer cells derived from metastatic site cell lines were obtained 
from ATCC (Rockville, MD, USA) and were cultured and grown according to the data 
sheets.   
To evaluate viability, the 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium 
Bromide (MTT) assay was used. Briefly, cells were plated at concentrations 2.5 × 
104 per well in 24 well plates and treated with OHP and Na+ oxalate. At the end of 
the treatments, the MTT reagent was added to cells at a final concentration of 0.25 
mg/mL (Sigma-Aldrich Inc., Milan, Italy), for 90 min at 37°C. Reactions were stopped 
and the crystals were solubilized by adding isopropyl alcohol/HCL (1:1; vol:vol, 
Sigma-Aldrich Inc., Milan, Italy), before reading the absorbance at 570 nm, using 
the multi-plate reader Victor3 V (PerkinElmer, Milan, Italy). pH determinations with 
BCECF on LoVo and LS180 was performed as described in the relevant section 
below. 
 
Fura-2 Ca2+ measurements and image analysis. For Ca2+ imaging, DRG cultures 
grown onto 24 mm round cover-slips were loaded with 5 M Fura-2 AM in presence 
of 0.02% of Pluronic-127 (both from Life Technologies) and 10 M sulfinpyrazone 
(Sigma Adrich Inc., Italy) in Krebs–Ringer buffer (KRB, 135 mM NaCl, 5 mM KCl, 0.4 
mM KH2PO4, 1 mM MgSO4, 5.5 mM glucose, 20 mM HEPES, pH 7.4) containing 2 
mM CaCl2 (30 min, room temperature). Cells were washed and incubated with KRB 
for other 15 min to allow de-esterification of Fura-2. During the experiments the 
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coverslips were mounted into acquisition chamber and places on the stage of a 
Leica DMI6000 epifluorescent microscope equipped with S Fluor ×40/1.3 objective. 
Cells were alternatively excited at 340/380 nm by the monochromator Polychrome 
IV (Till Photonics, Germany) and the fluorescent signal was collected by a CCD 
camera (Hamamatsu, Japan) through bandpass 510 nm filter; the experiments were 
controlled and images analysed with MetaFluor (Molecular Devices, Sunny-vale, 
CA, USA) software. Data in traces are expressed as 340/380 ratio while to quantify 
the differences in the amplitudes of Ca2+ transients the ratio values were 
normalized according to the formula F/F0 (referred to as normalized Fura-2 ratio, 
“Norm. Fura ratio”). 
To obtain the size of the neurons, images of fluorescent Fura-2 loaded neurons 
excited at 380 nm were analysed using ImageJ software (National Institutes of 
Health, Bethesda, MD, USA, http://imagej.nih.gov/ij). The size was estimated by the 
average soma diameter, calculated by measuring and averaging the length of the 
minimum and maximum Feret diameters of the neuronal cell body. TRPA1-positive 
neurons were determined by their ability to respond to icilin, without any prior 
selection. The diameter of these neurons is depicted in Suppl. Figure S2. 
 
Measurement of intracellular pH in DRG cultures by epifuorescence microscopy 
with BCECF. DRG cultures or colorectal cancer cells grown onto 24 mm round cover-
slips were incubated with 1 μM BCECF (Life Technologies, Italy) in Krebs–Ringer 
buffer (KRB, 135 mM NaCl, 5 mM KCl, 0.4 mM KH2PO4, 1 mM MgSO4, 5.5 mM 
glucose, 20 mM HEPES, pH 7.4) containing 2 mM CaCl2 (15 min, room temperature). 
Subsequently, cells were washed and re-suspended in KRB (pH 7.4). A Leica 
DMI6000 epifluorescent microscope equipped with S Fluor ×40/1.3 objective was 
used. Cells were alternatively excited at 490/450 nm (monochromator Polychrome 
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IV, Till Photonics, Germany) and the fluorescent signals were collected every 10 
seconds (Hamamatsu, Japan); the experiments were controlled and images 
analysed with MetaFluor (Molecular Devices, Sunny-vale, CA, USA) software. 
Finally, intracellular pH was calculated by comparing 525/610 nm emission 
fluorescence ratios with in vivo calibration curves obtained by pH equilibration 
using the proton ionophore nigericin (20 M) and Intracellular pH Calibration Buffer 
Kit (pH 7.5-5.5, Life Technologies). 
 
Measurement of intracellular pH in DRG by flow cytometry with BCECF. After in 
vivo treatment and dissociation, DRG cells were incubated with 1 μM BCECF (Life 
Technologies, Italy) in Krebs–Ringer buffer (KRB, 135 mM NaCl, 5 mM KCl, 0.4 mM 
KH2PO4, 1 mM MgSO4, 5.5 mM glucose, 20 mM HEPES, pH 7.4) containing 2 mM 
CaCl2 (15 min, room temperature). Cells were washed, re-suspended in KRB (pH 7.4) 
and used for flow cytometry (FACSCanto I, Becton Dickinson,). Excitation was 
performed at 488 nm, using an air-cooled, 20-mW solid-state laser, the emission 
fluorescence was collected and the FITC and PE median fluorescence values and CV 
were determined using FACS Diva software. Approximately 10,000 cells were 
collected in a user-defined gate. A calibration curve was then prepared by 
suspending cells in high [K+] buffers (pH 5.5-6.5-7.5) containing 20 µM of the proton 
ionophore nigericin (Intracellular pH Calibration Buffer Kit, Life Technologies). 
Finally, intracellular pH was calculated by comparing FITC/PE nm emission 
fluorescence ratios with the values obtained by the calibration curve. 
 
Electrophysiology. Cell attached patch clamp recordings were performed at 22-
25°C on control and OHP-treated neurons with a mean soma diameter < 25 m. 
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Prior to the gigaseal formation, cells were continuously superfused with a standard 
physiological solution of the following composition (in mM): NaCl 154; KCl 4; CaCl2 
2; MgCl2 1; 4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid (HEPES) 5; glucose 
5.5; NaOH to pH 7.4. The patch electrodes prepared from borosilicate glass 
capillaries (World Precision Instruments) had a resistance of 5-7 MΩ. In most 
experiments the pipette solution contained (in mM): CsCl 130, TEACl 20, DIDS 1; 4-
(2-hydroxyethyl)-1-piperazine ethane sulfonic acid (HEPES) 10, EGTA 2, BCTC 3 M, 
Icilin 1 µM, CsOH to pH 7.4. In a set of experiments, we added 2 mM CaCl2 in the 
absence of EGTA in the patch pipette solution. After seal formation (2-10 DRG cells 
were perfused with a solution containing KCl 150, MgCl2 2, CaCl2 1, EGTA 1.1, HEPES 
5, KOH to pH 7.4, in order to set the membrane potential near 0 mV and to prevent 
intracellular calcium loading. Data were collected and filtered at 1 kHz with an 
Axopatch 200B amplifier (Molecular Devices, USA) and digitized continuously at a 
sampling frequency of 1 kHz with PClamp Axoscope software (Molecular Devices, 
USA). Steady state voltage clamp protocols were applied and digitized at 10 or 20 
kHz with PClamp Clampex software Data analysis was performed with OriginPro 
(OriginLab, USA) and PClamp Clampfit software. 
 
Statistical analysis. Data are presented as mean ± SEM or Median and IQR. Data 
points in the single channel current-voltage graphs represent mean ± S.D., 
estimated by fitting the amplitude histograms to a sum of Gaussian functions 
(OriginPro 9.1, OriginLab USA). The normality of data distributions was assessed 
using Shapiro–Wilk test. Parametric (unpaired t-test and One-way analysis of 
variance (ANOVA) followed by Tukey’s post-hoc) or non parametric (Mann-Whitney 
U test and One-way Kruskal-Wallis H test followed by Dunn’s post-hoc) statistical 
analysis was used for comparisons of data. All statistical assessments were two-
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sided and a value of P < 0.05 was considered statistically significant. Statistical 
analyses were performed using GraphPad Prism software (GraphPad Software, Inc., 
USA). In in vitro experiments, the n number was calculated on the number of cells, 
and the number of independent experiments (defined as cultures from separate 




Toxicity of OHP in dorsal root ganglia neuronal cultures. 
 
Most in vitro studies so far performed to elucidate the mechanism of neurotoxicity 
have used concentrations of OHP in the range of 5-50 µg/mL16,17. In the present 
work, three different concentrations (0.1, 1, 10 µg/mL) of OHP were initially tested. 
Briefly, DRG neurons were exposed for 6 or 48 hours to OHP. Experiments were 
carried out after 48 hours of the treatment. Therefore, for the 6 hours exposure, 
cells were washed and grown for a further 42 hours in normal medium in the 
absence of OHP before the experiments. Immunostainings with GAP4317 showed 
well-developed neurites when cells were exposed for only 6 hours with the lowest 
concentration of OHP (0.1 µg/mL), while other treatments showed a marked 
reduction both in neurite length and in the number of surviving neurons (Suppl. 
Figure S1). The concentration of 0.1 µg/mL for 48 hours leads only to minor 
alterations and was therefore also carried forward for calcium-signalling 
characterization together with the 6 hour treatment. It should be noted that the 




OHP modifies responses to capsaicin and icilin  
 
We first set out to investigate whether the above treatment conditions might affect 
TRPV1, TRPM8 and TRPA1 responses, in analogy to what observed by others with 
more aggressive protocols. DRG neurons exposed to OHP for 6 hours (0.1 µg/mL) 
challenged with capsaicin (TRPV1 agonist; 200 nM) showed a reduced Ca2+-
response compared to controls (median of CTRL: 1.98; median of OHP: 1.28; ****P= 
1.4·10-5). The reduction was more evident for neurons exposed for 48 hours to OHP 
(0.1 µg/mL; median of CTRL: 1.98; median of OHP: 0.37; P****<10-6; Figure 1a). 
Conversely, only a minority of the control DRG neurons responded to icilin (TRPA1 
and TRPM8 agonist; 1 µM) with very small Ca2+-rises (Figure 1b). DRG neurons pre-
exposed for 6 hours to OHP, instead, unmasked a large icilin-induced Ca2+-rise 
(median of CTRL: 0.05; median of OHP: 0.92; ****P<10-6). DRG neurons treated for 
48 hours with OHP also displayed an icilin-induced Ca2+-rise although this was 
reduced compared to the shorter treatment (median of CTRL: 0.05; median of OHP: 
0.23; P=4·10-6). Therefore, although the effect was evident both after 6 and 48 
hours, the shortest treatment was chosen for all other experiments. 
Responses to ATP were not affected by OHP in either treatment duration (Figure 
1a, 1b), suggesting that cells were healthy and that our results were not a 
manifestation of an experimental artefact. Nonetheless, given the possibility that 
part of the effects elicited by OHP for 48 hours might have been attributed to 
neuronal suffering, we decided to focus our attention on the shorter treatment. 
Given that OHP unmasked a response to icilin, we also investigated the neurons 
that were responsible for this response by measuring their average soma diameter 
(Suppl. Figure 2a for distributions). Briefly, our cell cultures were characterized by 






Figure 1. Calcium responses to capsaicin (a) and icilin (b).  DRG neurons treated with OHP (0.1 
μg/mL) for 6 or 48 hours or untreated (CTRL) were loaded with Fura2-AM and placed in an 
extracellular solution containing 2 mM calcium. Traces are the average of the cells indicated in the 
corresponding bar graphs, obtained from 3 independent experiments. Box and whisker plots show 
median and IQR of peak of calcium changes. Kruskal-Wallis H test followed by Dunn’s post-hoc. 




of 13.8 µm, n=278) and similar values were observable in OHP-treated neurons 
(13.1 µm, n= 223). The few cells that responded to icilin in control conditions (albeit 
with very small Ca2+-rises) had a median soma diameter of 13.1 µm (n= 55) while 
the cells that responded to icilin in OHP-treated cultures had a median of 12.5 µm 
(n=172). There was no statistically significant difference between the groups 
(Kruskall Wallis test, P= 0.86, Suppl. Figure 2b). This would suggest that the 
observed unmasking of a Ca2+-response to icilin might be relevant to the clinical 
manifestations. 
 
Icilin responses are mediated by TRPA1 and not by TRPM8 
 
Icilin has been reported to be an agonist of both TRPM8 and TRPA1 receptors19,20. 
To discriminate between the two, we used the specific inhibitors of TRPM8 (BCTC) 
or TRPA1 (HC-030031). As it can be observed in Figure 2a, icilin induced a response 
in OHP-treated DRG neurons both in the presence (3 µM; median: 0.71) or absence 
of BCTC (median: 1.01) suggesting that the TRPM8 was not involved. On the 
contrary, the response to icilin was completely abolished in the presence of HC-
030031 (10 µM; median: 0.02) in OHP-treated neurons. In accord, in our conditions, 
preliminary experiments showed that menthol elicited very small responses (data 
not shown), suggesting that TRPM8 does not contribute to the icilin-response. This 
might be due to a number of factors, including the temperature at which we 
perform experiments. 
Allyl isothiocyanate (AITC) is another well-known agonist of TRPA1 and we 
therefore evaluated whether the potentiation of the response by OHP treatment 
could be unmasked also by activation of the channel by this compound. As shown 
in Suppl. Figure 3, in control cells AITC induced only a modest response (median: 
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0.09), while in OHP-treated neurons the response was significantly potentiated 
(median: 0.39). The potentiated response was sensitive to HC-030031 (10 µM; 
median: 0.06). 
These data would therefore suggest that, in our model, OHP modulates the 
response to TRPA1. 
 
Sodium Oxalate or cisplatin do not mimic the effect of OHP 
 
We next tested whether treatment for 6 hours with the close analogue cisplatin or 
sodium oxalate were able to mimic the sensitization of TRPA1. As it can be observed 
(Figure 3a), cisplatin (0.1 µg/mL; median: 0.05), unlike OHP (median: 0.81), was 
unable to potentiate the response to icilin in DRG neurons. Similarly, sodium 
oxalate, at the same molar concentration (0.3 µg/mL), was also unable to unmask 
a TRPA1-dependent Ca2+-response (median: 0.14) (Figure 3b). We also evaluated 
whether sodium oxalate was able to modify the response to OHP and, to our 
surprise, co-treatment with equimolar concentrations of OHP and sodium oxalate 
led to the abolishment of the icilin response (median OHP: 0.82, median co-
treatment: 0.10). Oxalate can chelate Ca2+-ions, although it is unlikely that the low 
concentrations used (0.3 µg/mL; 2.2 µM) are able to mask Ca2+-responses, also in 
light of the mM concentrations of Ca2+ in the extracellular medium. To verify that 
indeed oxalate does not affect Ca2+-responses, we evaluated ATP-induced Ca2+-
mobilization in the same cells. As observed in the Suppl. Figure S4, the ATP induced 
Ca2+-responses were not different in control, OHP-treated, and oxalate-treated cells 





Figure 2. OHP increases icilin responses by a TRPA1-dependent mechanism. DRG neurons were 
treated with OHP (0.1 μg/mL) for 6 hours, loaded with 5 μM Fura2-AM and placed in an extracellular 
solution containing 2 mM calcium. Cells were pre-treated with BCTC (TRPM8 antagonist; a) or HC-
030031 (TRPA1 antagonist; b) before being challenged with icilin. Traces are the average of the cells 
indicated in the corresponding bar graphs, obtained from 6 independent experiments. Box and 
whisker plots show median and IQR of peak calcium responses in the presence or in the absence of 





The antagonistic effect of oxalate was unexpected and we therefore evaluated 
whether this also occurred for the cytotoxic effect of OHP. To this end, we treated 
6 different colorectal cancer cell lines with OHP (3 µg/mL) in the presence or 
absence of equimolar concentrations of oxalate (9 µg/mL) for 24, 48 or 72 hours. 
The concentration of OHP was chosen based on the IC50 obtained in preliminary 
experiments for the 48h treatment. OHP was cytotoxic to the same degree in the 
presence or absence of oxalate (Suppl. Figure S5), suggesting that this antagonism 
is specific for TRPA1 calcium response in DRG neurons. 
 
OHP does not modify mRNA levels for TRPA1 or TRPV1 
 
After the 6 hour treatment with OHP, DRG cells are maintained for a further 42 
hours in culture before experiments. Therefore, it is possible that gene expression 
changes may be responsible for the effects observed. Treatment with OHP did not 
induce any change in mRNA levels for TRPA1 (1.0± 0.1 of control; n=6), TRPV1 (1.1 
± 0.1 of control; n=6) or TRPM8. We also recently performed a microarray analysis 
with a validation set to investigate gene expression changes upon OHP treatment 
in vivo in DRG cells14. When interrogating the microarray results for these two 
genes, we confirmed that no significant changes occurred for either TRPA1 
(|log2FC| 0.142) or TRPV1 (|log2FC| 0.016) in vivo. Similarly, RT-PCR data of the 
confirmation dataset performed on mRNA from DRG cells from a different set of 
animals confirmed that no significant changes occurred in these animals for these 





Figure 3. Icilin responses induced by cisplatin (a) or sodium oxalate (b). DRG neurons were treated 
with OHP (0.1 μg/mL), cisplatin (CIS; 0.1 μg/mL), or sodium oxalate (0.3 μg/mL) alone or in 
combination with OHP (0.1 μg/mL) for 6 hours. Traces are the average of the cells indicated in the 
corresponding bar graphs, obtained from 4 independent experiments. Box and whisker plots show 
median and IQR of peak of calcium changes after the addition of 1µM icilin. Kruskal-Wallis H test 




pH changes occur upon OHP treatment in vitro and in vivo 
 
If changes in channel expression cannot account for the change in icilin-response 
observed, i.e. the same number of channels are present in control and OHP-primed 
neurons, other explanations might account for the results observed. It is well known 
that TRP channels are multimodal receptors, able to detect a number of chemical 
and physical agents. In this respect, it has been reported that intracellular pH 
changes are able to modulate in opposite directions the effect of TRPV1 and 
TRPA121, which would be compatible with our Ca2+-signalling results (Figure 1). 
To investigate this aspect, we made use of BCECF, a specific ratiometric fluorescent 
pH probe22,23. As it can be observed (Figure 4a), a significant median drop from 7.23 
to 6.49 occurred in cells exposed to OHP (****P < 10-6). Paralleling the results 
obtained in calcium signalling (Figure 3), such changes did not occur upon exposure 
for the same length of time with either oxalate (7.55) or cisplatin (7.51). In line with 
what observed for calcium signalling, while devoid of any effect per se, oxalate was 
nonetheless able to revert the effect of OHP (7.36; Figure 4a). 
While our protocol is translational (6-hour treatment followed by 42 hour recovery) 
it fails to disclose when this pH change takes place, i.e. in the first 6 hours or 
afterwards. To dissect the two, we then performed experiments at 6 hours. As 
shown in Figure 4b, 6 hours treatment with OHP was sufficient to reduce pH 
significantly (medians: control 7.37 and OHP 6.83). The effect on pH at 6 hours was 
paralleled by the sensitization to icilin (Figure. 4c, median of CTRL: 0.08; median of 
OHP: 0.28) and the reduction of the capsaicin response (Figure. 4d, median of CTRL: 






Figure 4. Effects of OHP, cisplatin or sodium oxalate on intracellular pH. (a) pH evaluation in 
cultured DRG neurons treated with OHP (0.1 μg/mL), cisplatin (CIS; 0.1 μg/mL) or sodium oxalate 
(0.3 μg/mL) alone or in combination with OHP (0.1 μg/mL) for 6 hours. Box and whisker plots show 
median and IQR of pHi values. For each treatment the number of cell is indicated in the 
corresponding bar; data are from 7 independent experiments. Kruskal-Wallis test followed by 
Dunn’s post-hoc. ****P < 10-6, **P= 0.0078; +++P= P < 10-6 OHP vs. CIS, sodium oxalate and 
OHP+sodium oxalate; (b) pH evaluation of cultured DRG neurons treated with OHP (0.1 μg/mL) in 
the presence or absence of HC.030031 (10 µM) for 6 hours. Box and whisker plots show median and 
IQR of pHi values. For each treatment the number of cell is indicated in the corresponding bar; data 
are from 2 independent experiments. Kruskal-Wallis test followed by Dunn’s post-hoc. ****P < 10-
6; (c,d) Ca2+-responses to icilin (1 µM; c) or capsacin (200 nM, d) in cells treated for 6 hours with the 
indicated compounds (OHP 0.1 µg/ml and oxalate 0.3 µg/ml). Box and whisker plots show median 
and IQR of peak of calcium changes after the addition of compounds. Kruskal-Wallis test followed 
by Dunn’s post-hoc. ****P < 10-6, *P= 0.031, ++++P<10-6; (e) pH evaluation in the indicated colorectal 
cancer cells treated with OHP (0.1 μg/mL) for 6 hours and determined at 48 hours. Box and whisker 
plots show median and IQR of pHi values. For each treatment the number of cell is indicated in the 
corresponding bar; data are from 2 independent experiments. Kruskal-Wallis test followed by 
Dunn’s post-hoc. ****P < 10-6; (f) freshly excised DRG cells from control or acutely or chronically 
OHP-treated BALB/c mice were loaded with 5 μM BCECF and placed in an extracellular physiological 
solution. Ratiometric measurements of pHi and calibration curves were obtained by flow cytometry. 
Graphs show the mean ± S.E.M from n=16 controls, n= 12 chronic treatment, or n=8 acutely treated 
animals. One-way analysis of variance (F=19.38) followed by Tukey’s post-hoc. **** P< 10-6. 
 
 
To confirm that the effects observed at this time-point were linked to those 
observed at 48 hours, we also co-treated for 6 hours DRG cultures with OHP and 
oxalate and tested the recovery of TRPV1 responses. As observed in Figure 4d, 
oxalate led to a partial recovery of TRPV1 responses, linking the two observations 
(median of oxalate: 0.36; median of OHP + oxalate: 0.25). 
To understand whether pH changes were up-stream or down-stream of TRPA1-
sensitization, we treated DRG cultures with OHP in the presence of HC-030031. In 
this manner, we tested whether acidification is the result of TRPA1 activation. As 
shown in Figure 4b, HC-030031 had no effect on OHP-induced acidification 
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(median: 6.84 compared to OHP 6.83), strongly suggesting that cytosolic 
acidification is an up-stream effect. 
To investigate whether these OHP-induced pH changes were specific for DRG 
neurons or could be observed also in other cells, we tested, with the 48 hours 
protocol (6 hours treatment and further 42 hours in normal medium), two different 
colorectal cancer cells, LoVo and LS180. In both cells, OHP-treatment (0.1 µg/ml) 
led to a significant decrease in pH (medians for LoVo: control 7.12, OHP 6.81; for 
LS180 control 7.26 OHP 6.91) albeit of smaller entity compared to that observed in 
DRG neurons (Figure. 4e). This strengthens the notion that in DRG neurons, TRPA1 
sensitization is down-stream of acidification, as these cells do not express TRPA1. 
All the above data was obtained on DRG neurons or on cancer cell lines in culture, 
and, to test the relevance of these pH changes we felt necessary to explore the pH 
of DRG cells from OHP-treated animals. Briefly, BALB/c mice were treated either 
with OHP (3.5 mg/Kg) twice a week for four weeks14 or only once (3.5 mg/Kg). 
Twenty-four hours after the last treatment, animals were sacrificed, DRG dissected, 
dissociated and FACS analysis with BCECF was performed as described in the 
materials and methods section.  The average pH of cells (Figure 4f) from control 
animals was 7.22 + 0.05 (n=16). The average pH of cells from animals treated 
chronically with OHP was 6.80 + 0.07 (n=12) while average pH from animals treated 
once with OHP was 6.72 + 0.03 (n=8). These data therefore correlate with what 






Restoration of physiological pH suppresses TRPA1 hyper-sensitivity 
 
The above data would suggest that OHP acidifies the pH of DRG cells, both in vitro 
and in vivo, and this in turn modifies the activity of pH-sensitive channels, including 
TRPA1. If this were the case, it would be expected that experimental manipulations 
that restore pH of DRG neurons would normalize the channel activity. 
To investigate this, we decided to perform electrophysiological patch clamp 
experiments in the cell attached mode, the recording configuration that less 
interferes with the intracellular milieu composition. In all experiments, DRG 
neurons were perfused with a bath solution containing 150 mM KCl and low [Ca2+] 
(see methods), to set the membrane potential near zero and reduce the calcium 
load. Figure 5a shows two records of 30 s long showing the channel activity in an 
OHP treated neuron in the presence of icilin (1 µM in the presence of BCTC) and of 
2 mM of CaCl2 in the pipette solution at Vm= 40 mV (upper trace) and -40 mV (lower 
trace). Single channel currents were outwards at positive voltages and inwards at 
negative voltages as expected for a non-selective cationic channel. Figure 5b shows 
the I-V relationship obtained from the same experiment. Single channel 
conductance (γ) and reversal potential (Vr) were respectively of 109.3 ± 6.7 pS and 
of 3.9 ± 1.6 mV for outward currents and of 32.9 ± 3.3 pS and of -5.9 ± 3.4 mV for 
inward currents. Furthermore, the channel activity (NPo, were N is the number of 
channels in the patch and Po the open probability) was voltage-dependent, with 
high open probability at negative potentials and a voltage-dependent inactivation 
at positive potentials (Figure 5c). These channel properties are in good agreement 
with previously published data, and confirm that in OHP-treated neurons icilin 
robustly activates TRPA1 channels24,25,26,27,28,29. 
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We next addressed the characterization of the channel biophysical properties in the 
absence of divalent ions in the pipette, with the purpose to attenuate calcium-
dependent inactivation25,28, a prerequisite for long duration experiments. Figure 5d 
shows a 30 s recording of the patch currents from an OHP treated neuron in the 
presence of 1 µM of icilin at Vm= 40 mV (upper trace) in which at least three 
channels were active. Moreover, the red open circles of Figure 5e represent the 
single channel current amplitudes recorded at different membrane potentials. In 
this condition, the fitted regression line yields a γ and a Vr respectively of 107.8 ± 
7.6 pS and of 4.2 ± 2.0 mV. The lower trace of Figure 5d was obtained from an 
untreated neuron again in the presence of icilin in the pipette. Single channel 
current amplitudes at different Vm are represented as black open circles in Figure 
5e. The values of the elementary conductance and the reversal potential were very 
similar for the two patches (γ 113.2 ± 5.0 pS and Vr =2.0 ± 1.4 mV). Moreover, Figure 
5f compares the channel activity NPo at Vm= 40 mV of the traces in D. We also 
obtained similar values in two other untreated (NPo = 0.002 and 0.004) and treated 
neurons (NPo = 0.13 and 0.05). This result suggests that NPo is of one to two orders 
of magnitude greater in OHP-treated neuron compared to control. 
Last, we assessed if the NPo increase observed in treated neurons was dependent 
on the OHP-induced pHi acidification. For this purpose, we added to the bathing 
solution 10 µM of the K+/H+ exchanger nigericin. In our ionic conditions, the 
insertion in the membrane of the ionophore should activate a net movement of H+ 
outside the cell that will set the pHi value close to the extracellular one. To validate 
this approach, using BCECF we evaluated the effect of nigericin on intracellular pH 
in DRG neurons pre-treated for 6 hours with OHP and then left for 42 hours in the 
same experimental conditions (i.e. high extracellular potassium, low calcium 
extracellular solution). As shown in Suppl. Figure S6, the addition of nigericin led to 
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an alkalinisation of intracellular pH, from approx. 6.8 to 7.5. We hypothesized that 
the change from an acidic to a slightly alkaline pH, should decrease TRPA1 channel 
activity, if the original hypothesis were true. We observed such effect in all the 
three neurons tested. In the experiment shown in Figure 5g and in another one, a 
complete inactivation of the channel occurred after about 2 min of nigericin 
perfusion. From the amplitude analysis of single channel recording obtained at 
different membrane potentials we obtained the I-V relationship (Figure 5f) for 
which the elementary conductance and the reversal potential were again very close 
to the expected values for TRPA1 channel (γ 121.1 ± 7.0 pS and Vr =-8.4 ± 1.8 mV). 
A complete channel inactivation after 7 min of nigerin perfusion was also observed 





Figure 5. Restoration of physiological pH suppresses TRPA1 hyper-sensitivity to icilin in cell-
attached patches. Single channel recordings at two different membrane potentials of a TRPA1 
channel obtained in the presence of 2 mM CaCl2 in the patch pipette from an OHP treated DRG 
neuron (a). i-V plot with linear regressions (b) and NPo (c) for the same channel shown in (a). In this 
experiment and in all other shown in the figure, the patch pipette contained 1 µM icilin. (d) Two 
example of TRPA1 channel activity recorded in the absence of divalent ions in the patch pipette from 
an OHP-treated (upper trace) or untreated neuron (lower trace). i-V plot with linear regressions (e) 
and NPo (f) for the channels shown in (d). Red symbols and line refer to treated neuron. (g) Single 
channel traces from an OHP-treated neuron before and during nigericin perfusion, that induces a 
pHi shift towards a slightly alkaline value. (h) Elementary currents recorded for the channels shown 





In the present contribution we show that therapeutically-relevant OHP 
concentrations18 induce an acidification of intracellular pH both in cultured DRG 
neurons and in DRG cells from treated animals. This pH change leads to a 
sensitization of TRPA1 channels which can be reversed by restoring pH to 
physiological level. Remarkably, acidification occurs even after a single injection of 
OHP in animals, suggesting its relevance for the occurrence of acute OIPN. This is 
strengthened by the observation that equi-molar concentrations of cisplatin, in 
vitro, are unable to induce any pH change. 
It should be noticed that, while we do not see an effect of cisplatin at low 
concentrations on pH, higher concentrations (that we have not investigated) may 
be able to elicit an effect on DRG neurons. Indeed, this has been shown previously 
on colorectal cancer cells at approx 100-fold the concentrations used in the present 
study (20-30µM)30, 31 . 
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This may be indicative of the fact that all platinum containing drugs share this effect 
but have different potencies. Indeed, while it could be envisaged that its the oxalate 
molecule from oxaliplatin that is responsible for the effect observed, we believe 
this is not the case as: (i) the concentration of released oxalate would be too low; 
(ii) oxalate surprisingly reverts the effect of oxaliplatin; and (iii) cisplatin, at 100-fold 
higher concentrations, can elicit similar effects. It is interesting to speculate that 
the different relative potencies between the cytotoxic and pH effect may be 
responsible for the different neurotoxic potential of the drugs. In the present 
contribution, we indeed provide evidence that the effect on pH also occurs in 
colorectal cancer cells, at lower concentrations compared to the cytotoxic effect, 
thereby possibly dis-joining the two effects.  
It should be noticed that the concentrations in vitro in the present manuscript are 
lower than those of previous reports attempting to elucidate the mechanism of 
OIPN16,17, and therefore they are not in contradiction. Nonetheless, we believe that 
these lower concentrations more closely resemble those found in plasma of 
patients and of mice treated with OHP32 compared to higher concentrations used 
in the literature. 
In our hands, equimolar concentrations of oxalate were also unable to induce 
intracellular pH changes. Yet, to our surprise, co-treatment of equimolar 
concentrations of oxalate were able to abolish OHP-induced pH changes. At 
present, no explanation can be put forward for this, although it demonstrates that 
OHP-induced pH acidification occurs via a specific and saturable mechanism. It 
should be noted that oxalate antagonized the change in pH (and the relative 
sensitization of the channel), but did not antagonize the cytotoxic effects of OHP in 
any of the 6 colorectal cell lines tested, suggesting that the site of interaction might 
represent an exploitable pharmacological target in DRG to reduce OIPN. However, 
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since oxalate is per se toxic, it is unlikely that it could be directly used for OIPN 
prevention. In fact, oxalate is mainly nephrotoxic33, and, at high doses, 
neurotoxic11,34. 
Our data are partly in contrast with earlier evidence that oxalate and OHP produce 
similar neurotoxic effects in rodents34. It should be nonetheless noticed that 
whether these two agents act via the same mechanism has never been 
investigated.  
In the present contribution we have focused on TRPA1, a TRP channel that has been 
shown earlier to be involved in OIPN. For example, pharmacological inhibition of 
TRPA1 abolishes OHP-induced mechanical and cold-hypersensitivity and this effect 
is also abolished in TRPA1-null mice12,35,36. Furthermore, hypersensibility has also 
been shown upon pre-treatment in vitro in DRG neurons, in agreement with our 
data12,36. Remodelling of TRPA1 expression has been postulated as one the 
mechanisms that may underlie this hypersensitivity13,16, but our data, obtained 
both in vitro and in vivo, failed to detect any mRNA change related to this channel14 
and this report. It has also been recently pointed out that while channel remodelling 
may explain chronic OIPN, it is unlikely that protein changes may explain 
hypersensitivity occurring within hours of exposure36. 
Our observation that intracellular pH acidification hyper-sensitizes the TRPA1 
channel is supported by earlier data that report intracellular pH-dependent 
activation of this channel37,38. Indeed, this was postulated to be the mechanism by 
which humans detect some of the sensations from carbonated beverages39. Yet, it 
is likely that intracellular pH changes do not affect solely this channel, as other 
channels may also be affected. Indeed, TRPM8, the other TRP family member that 
has been postulated to be responsible for acute OIPN, has also been demonstrated 
to display pH sensitivity, although in this context acidification led to a decreased 
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sensitivity40. This observation is supported by the modest icilin-dependent BCTC-
sensitive response in OHP-treated DRG neurons we observed. Also, TRPV1 has been 
shown37 to be affected negatively by intracellular pH acidification, which is in 
agreement with the data obtained in the present manuscript (Figure 1). 
In conclusion, our results suggest the OHP-induced cytosolic acidification as one of 
the key factors involved in the positive modulation of TRPA1 channels activity and 








The Authors wish to acknowledge Fondazione Cariplo (2013.0842; grant to PM, AG), 
AIRC (Trideo 2014, Ref. 15942 grant to VC) and the Università del Piemonte 









1. Argyriou, A.A. et al. Peripheral neurotoxicity of oxaliplatin in combination with 5-
fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 
colorectal cancer patients. Ann Oncol. 23, 3116-3122 (2012). 
2. Argyriou, A.A. et al. Clinical pattern and associations of oxaliplatin acute 
neurotoxicity: a prospective study in 170 patients with colorectal cancer. Cancer 
119, 438-444 (2013). 
3. Lucchetta, M. et al. Incidence of atypical acute nerve hyperexcitability symptoms 
in oxaliplatin-treated patients with colorectal cancer. Cancer Chemother 
Pharmacol. 70, 899-902 (2012). 
4. Lehky, T.J., Leonard G.D., Wilson R.H., Grem J.L. & Floeter M.K. Oxaliplatin-induced 
neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve. 29, 
387-392 (2004). 
5. Wolf S., Barton D., Kottschade L., Grothey A. & Loprinzi C. Chemotherapy-induced 
peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 44, 
1507-1515 (2008). 
6. Scholz, J. & Woolf C.J. Can we conquer pain? Nat Neurosci. 5, 1062-7 (2002). 
7. Marmiroli, P. et al. Calcium-related Neurotoxicity of Oxaliplatin: Understanding the 
Mechanisms to Drive Therapy. Curr Med Chem. 22, 3682-3694 (2015). 
8. Grolleau, F. et al. A possible explanation for a neurotoxic effect of the anticancer 
agent oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol. 85, 
2293-2297 (2001). 
9. Adelsberger, H. et al.  The chemotherapeutic oxaliplatin alters voltage-gated Na(+) 
channel kinetics on rat sensory neurons. Eur J Pharmacol. 406, 25-32 (2000). 




11. Kawashiri, T. et al. L type Ca²+ channel blockers prevent oxaliplatin-induced cold 
hyperalgesia and TRPM8 overexpression in rats. Mol Pain. 31, 8-7 (2012). 
12. Zhao, M. et al. Acute cold hypersensitivity characteristically induced by oxaliplatin 
is caused by the enhanced responsiveness of TRPA1 in mice. Mol Pain. 28, 8-55 
(2012). 
13. Descoeur, J. et al. Oxaliplatin-induced cold hypersensitivity is due to remodelling 
of ion channel expression in nociceptors. EMBO Mol Med. 3, 266-278 (2011). 
14. Marmiroli, P., et al. Susceptibility of different mouse strains to oxaliplatin 
peripheral neurotoxicity: Phenotypic and genotypic insights. PLoS One. 12, 
e0186250 (2017). 
15. Renn, C.L. et al. Multimodal assessment of painful peripheral neuropathy induced 
by chronic oxaliplatin-based chemotherapy in mice. Mol Pain. 26, 7-29 (2011). 
16. Ta, L.E., Espeset, L., Podratz, J. & Windebank, A.J. Neurotoxicity of oxaliplatin and 
cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. 
Neurotoxicology. 27, 992-1002 (2006). 
17. Anand, U., Otto, W.R. & Anand, P. Sensitization of capsaicin and icilin responses in 
oxaliplatin treated adult rat DRG neurons. Mol Pain. 24, 6-82 (2010). 
18. Ehrsson ,H., Wallin, I. & Yachnin, J. Pharmacokinetics of oxaliplatin in humans. Med 
Oncol. 19, 261-265 (2002). 
19. Rawls, S.M., Gomez, T., Ding, Z. & Raffa, R.B. Differential behavioral effect of the 
TRPM8/TRPA1 channel agonist icilin (AG-3-5). Eur J Pharmacol. 575, 103-4 (2007). 
20. Bandell, M. Noxious cold ion channel TRPA1 is activated by pungent compounds 
and bradykinin. Neuron. 41, 849-857 (2004). 
21. Wang, Y.Y. et al. A TRPA1-dependent mechanism for the pungent sensation of 
weak acids. J Gen Physiol. 137, 493-505 (2011). 
22. Lanz, E., Slavík, J., Kotyk, A. 2',7'-bis-(2-carboxyethyl)-5(6)-carboxyfluorescein as a 
dual-emission fluorescent indicator of intracellular pH suitable for argon laser 
confocal microscopy. Folia Microbiol (Praha) 44, 429-434 (1999). 
162 
 
23. Franck, P. et al. Measurement of intracellular pH in cultured cells by flow cytometry 
with BCECF-AM. J Biotechnol. 46, 187-195 (1996). 
24. Macpherson, L.J. et al. Noxious compounds activate TRPA1 ion channels through 
covalent modification of cysteines. Nature. 445, 541-545 (2007). 
25. Cavanaugh, E.J., Simkin, D. & Kim, D. Activation of transient receptor potential A1 
channels by mustard oil, tetrahydrocannabinol and GAP reveals different 
functional channel states. Neuroscience. 154, 1467-1476 (2008). 
26. Karashima, Y. et al.  Modulation of the transient receptor potential channel TRPA1 
by phosphatidylinositol 4,5-biphosphate manipulators. Pflugers Arch. 457, 77-89 
(2008). 
27. Karashima, Y. et al. Agonist-induced changes in Ca (2+) permeation through the 
nociceptor cation channel TRPA1. Biophys J. 98, 773-783 (2010). 
28. Nilius, B., Prenen, J. & Owsianik, G. Irritating channels: the case of TRPA1. J Physiol. 
589, 1543-1549. 
29. Takahashi, N. et al. TRPA1 underlies a sensing mechanism for O2. Nat Chem Biol. 
28, 701-711. 
30. Milosavljevic, N. et al. Nongenomic effects of cisplatin: acute inhibition of 
mechanosensitive transporters and channels without actin remodeling. 70, 7514-
22 (2010). 
31. Rebillard, A. et al. Cisplatin-induced apoptosis involves membrane fluidification via 
inhibition of NHE1 in human colon cancer cells. Cancer Res. 67, 7865-74.  
32. Pestieau, S.R., Belliveau, J.F., Griffin, H., Stuart, O.A. & Sugarbaker, P.H. 
Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies. J Surg Oncol. 
76, 106-114 (2001). 
33. Trinchieri, A., Castelnuovo, C., Lizzano, R. & Zanetti G. Calcium stone disease: a 
multiform reality. Urol Res. 33, 194-198 (2005). 
34. Sakurai, M. et al. Oxaliplatin-induced neuropathy in the rat: involvement of oxalate 
in cold hyperalgesia but not mechanical allodynia. Pain. 147, 165-174 (2009). 
163 
 
35. Nassini, R. et al. Oxaliplatin elicits mechanical and cold allodynia in rodents via 
TRPA1 receptor stimulation. Pain. 152, 1621-31 (2011). 
36. Nakagawa, T. & Kaneko, S. Roles of Transient Receptor Potential Ankyrin 1 in 
Oxaliplatin-Induced Peripheral Neuropathy. Biol Pharm Bull. 40, 947-953 (2017). 
37. Dhaka, A. et al. TRPV1 is activated by both acidic and basic pH. J Neurosci. 29, 153-
158 (2009). 
38. Miyake, T. et al. Cold sensitivity of TRPA1 is unveiled by the prolyl hydroxylation 
blockade-induced sensitizationto ROS. Nat Commun. 7, 12840 (2016). 
39. Wang, Y.Y., Chang, R.B. & Liman, E.R. TRPA1 is a component of the nociceptive 
response to CO2.  J Neurosci. 30, 12958-12963 (2010). 
40. Andersson, D.A., Chase, H.W. & Bevan, S. TRPM8 activation by menthol, icilin, and 






BR designed and performed most of the experiments; MD performed the 
electrophysiological experiments; AP and CC-S performed in vitro experiments; AC 
performed in vivo experiments; RR performed in vivo experiments; VAC performed 
in vivo experiments; DL performed and supervised in vitro experiments; GC 
supervised in vivo experiments and contributed to design of the experimental plan; 
PM supervised and contributed to design of the experimental plan; CD designed, 
supervised and analyzed electrophysiological experiments; AAG designed the 









Contribution of hyperpolarizing ion channels to 







Oxaliplatin (OHP), a platinum-based chemotherapeutic agent, causes peripheral 
neurotoxicity (OIPN) characterized by an acute cold-induced syndrome 
accompanied by cramps, paresthesias/dysesthesias in the distal limbs and perioral 
region. No therapies are available to treat OIPN and patients often suffer from pain 
and sensory symptoms long after the end of the therapy. The molecular and cellular 
mechanisms that produce OIPN are not fully understood; however, one common 
mechanism appears to be changes in ion channels expression and/or function in 
primary afferent sensory neurons. 
Here we have combined different electrophysiological approaches in order to 
investigate, in mice DRG neurons, the impact of OHP treatment on the molecular 
165 
 
targets that are known to participate in the processing of noxious stimuli as well as 
in the tuning of cold perception. Recently, we found that therapeutically-relevant 
OHP concentrations (0.1 µg mL-1) lead to an acidification of the DRG cytosol neurons 
that modulate the activity of TRPA1 and TRPV1 channels. It is likely that other 
different classes of channels could be affected by this alteration in pH homeostasis. 
In particular, single channels recordings suggest the involvement of the two pore 
domain K+ (K2P) channel family members. These are background channels that 
contribute to the regulation of neuronal excitability hyperpolarizing the membrane 
potential of peripheral nerve terminals and that are tightly regulated by different 
stimuli, including variations of internal pH.  
In light of this, the hyperexcitability underlying the OINP can be explained as the 
resultant effect of multiple regulations on different targets in response to the OHP 
alteration of pH homeostasis. This provides useful insights for the understanding of 
the pathogenesis behind this neuropathy in order to propose effective therapeutic 
pain management. 
 




Chemotherapy-induced peripheral neurotoxicity remains the most common side 
effect of several anticancer agents including vinca alkaloids, taxanes, platin 
derivates, bortezomib and thalidomide 13. The relevant clinical hallmark of OHP is 
an acute sensory neuropathy characterized by alterations of sensitivity, 
dysesthesias, paresthesias and cramps, which are predominantly located in the 
extremities and in the face and, in most patients, last for hours or even days after 
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the first OHP injection. In addition, almost all patients that experience this acute 
cold-induced syndrome, develop chronic symptoms that are common to other 
platinum-based chemotherapies 16,37. Currently, there have not been developed 
sufficiently effective agents for the prevention or treatment of OHP-induced 
peripheral neurotoxicity (OIPN) and thus  patients' quality of life is affected long 
after the end of the therapy 13,15. 
Even if there is an increasing knowledge of the cellular and molecular mechanisms 
by which anticancer agents induce such neurotoxicity, the pathogenesis of OIPN 
remains poorly understood. In this sense, OHP is known to induce hyperexcitability 
by remodelling the expression and/or altering the function of some molecular 
targets that participate in the transduction of the thermal sensation at a peripheral 
level 37. Among them, transient receptor potential (TRP) channels are generally 
accepted as primary receptors for the detection of both physiological and noxious 
temperatures 92,93. Cumulative genetic and pharmacological evidences suggest the 
involvement of cold-activated TRP members in the onset of OIPN 37,94. However, 
there are other channels that modulate thermosensation. For instance, 
hyperpolarizing background K+ channels (K2P channels) work as regulators of the 
excitability of primary afferent fibers, and thus of pain signalling by tuning the 
excitation elicited by several stimuli including temperature 80,95,96. In accordance 
with this idea, it has been proposed that all three components of the TREK-family 
channels (TREK-1, TREK-2 and TRAAK), which are widely expressed in DRG and TG, 
are also implicated in the mediation of cold hypersensitivity following the 
treatment with OHP37,77. 
Interestingly, a recent report has shown that therapeutically-relevant OHP 
concentrations induce cytosolic acidification in both cultured DRG neurons and DRG 
cells from treated animals 97. In this line, the excitability of neurons is particularly 
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sensitive to intracellular pH (pHi) and/or extracellular pH (pHo) alterations since 
many surface channels, transporters and receptors present intra and/or extra pH-
sensitive moieties 55. In fact, as a consequence of the OHP-induced pH changes, a 
reversible hypersensitization of TRPA1 channels is observed 97. In the present study, 
we have investigated the involvement of K2P channels in this context since these 
channels also respond to, among other stimuli, intracellular pH 98–100and strongly 
collaborate with TRP channels to generate the sensation of heat, cold and thermal 
pain 93. We address this issue by means of an integrated approach that combines 
electrophysiological recordings in OHP-treated mice DRGs at both single cell level 
by using the patch clamp technique, and at population level by using multielectrode 
arrays (MEAs), as well as quantitative real-time polymerase chain reaction (qRT-
PCR). 
 
5.2 Material and methods  
 
Animals. BALB/c male mice aged 5–10 weeks upon arrival were employed (Envigo, 
San Pietro al Natisone, Italy) both for DRG culture preparation and in vivo studies. 
Animals were maintained as previously reported14. Care and husbandry of animals 
were in conformity with the institutional guidelines in compliance with national and 
international laws and policies. The study plan was approved by the animal Ethics 
Committee of the University of Milano Bicocca and of the Università del Piemonte 
Orientale. The procedures were approved by the local animal-health and ethical 
committee (Università del Piemonte Orientale) and were authorized by the national 
authority (Istituto Superiore di Sanità; authorization number N. 22/2013). All mice 
were euthanized under deep isoflurane-induced anaesthesia for cell cultures and 




Chemicals. For in vivo studies OHP solution was prepared as reported by Renn and 
collaborators 101and used as previously described 102.For in vitro studies, OHP (5 
mg/mL stock solution, Sigma-Aldrich Inc., Italy), capsaicin (1 mM stock solution, 
Sigma-Aldrich Inc., Italy), DIDS (4,4′-Diisothiocyano-2,2′-stilbenedisulfonic acid; 
Sigma-Aldrich Inc., Italy), AA ( Arachidonic acid; Sigma-Aldrich Inc., Italy) and 
nigericin (20 mM stock solution, Life Technologies, Italy) were used. These 
compounds, with the exception of capsaicin an AA (reconstituted in 100% EtOH and 
in water, respectively), were dissolved in 100% dimethyl sulfoxide (DMSO) and 
stored at −20 °C, according to manufacturers’ specifications. Working 
concentrations of these drugs were freshly prepared for each experiment by 
diluting DMSO or EtOH to 0.1% in milliQ (MilliPore) water. 
 
Experimental design for the in vivo study. For the evaluation of  the expression of 
TREK and TRAAK channels in chronically OHP-treated animals, animals (n=12 in two 
separate experiments) were injected intravenously in the tail vein with OHP 3.5 
mg/Kg (10 mL/Kg) twice a week for 4 weeks, while control mice (n=12) were left 
untreated. The neurotoxicity of this chronic schedule and its capacity to mimic 
Human OIPN have already been reported in detail 101.In a second experiment that 
evaluated the acute effect of OHP, eight animals (in two separate experiments) 
were injected intravenously in the tail vein with a single dose of OHP 3.5 mg/Kg (10 




Isolation and Primary Cell Culture of Mouse DRG Neurons. DRG excised from adult 
BALB/c mice and (5/10-wk-old) were collected in a dish containing cold F12 
(Nutrient Mixture F12 Ham) medium (Sigma Aldrich Inc.). The DRG, accurately de-
sheathed, were transferred into a sterile 35 mm dish containing collagenase from 
Clostridium hystoliticum 0.125% (Sigma Aldrich Inc.) and DNase (Sigma) in F12 
(Nutrient Mixture F12 Ham) medium and incubated at 37 °C.  After 1 h incubation , 
DRG were triturated using a 1000 µl tip. Myelin and nerve debris were eliminated 
by centrifugation through a bovine serum albumin (BSA) cushion. Cell pellets were 
re-suspended in Bottenstein and Sato medium (BS) (30% F12 (Nutrient Mixture F12 
Ham medium), 40% DMEM (Dulbecco’s Modified Eagle’s medium (Sigma Aldrich 
Inc., Italy), 30% Neurobasal A medium (Life Technologies, Italy), 100 X N2 
supplement (Life Technologies, Italy), penicillin 10 U/mL and streptomycin 100 
mg/mL (Sigma Aldrich Inc., Italy), supplemented with Recombinant Human β-NGF, 
Recombinant Murine GDNF and Recombinant Human NT3 (Peprotech, USA) and 
plated onto 24 mm glass coverslips pre-coated with laminin (Sigma Aldrich Inc., 
Italy). 
 
Real Time Quantitative PCR (QRT-PCR) . Total RNA was isolated from DRG using 
TRI-Reagent® and reverse transcribed according to the manufacturer’s instructions 
(Im-Prom-II™ Reverse Transcription System, Promega, WI, USA). Until using, cDNA 
was stored at -20°C. qRT-PCRs were performed on 96-well plates (CFX96™ Real-
Time PCR Detection Systems, Bio-Rad Inc), in triplicate and florescence intensity 
assessed using the CFX96™ Real-Time PCR Detection Systems (Bio-Rad Inc.). The 
initial denaturation step was set at 95°C for 10 min,  followed by 40 cycles of 
amplification using this set of primers: TREK-1 5’-TCACTCTGACGACCATTGGA-
3’forward, 5’-GAGGATCCAGAACCACACCA-3′ reverse; mouse TREK-2 5’-
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CATCTGTGTGAGTCCCCAGG-3′ forward, 5’-GACTGCTGCTGTTGGAAGAG-3′ reverse 
and mouse TRAAK 5’-GTGTGAGCCAGAAGAGCCT-3′ forward, 5′-
GGTTGCTGCTATTGGTCCAG-3′ reverse; 60°C annealing temperature. Transcripts 
were normalized to the expression of Ribosomal Protein S18 mRNAs, for each gene, 
the threshold cycle (Ct) was calculated. The Ct of treated cells was compared to the 
Ct generated by the control cells and ΔCt was calculated as the difference between 
Ct values, determined using the equation 2-ΔCt. 
 
Electrophysiology - Multielectrode Arrays (MEAs). Extracellular DRG action 
potentials were recorded by means of a commercial 60-channel multi-electrode 
array (MEA) setup. An external T-control unit (TC02) kept the temperature of the 
socket surface at 310 K. The digitalized output-data coming from the USB-ME64 
unit were acquired, monitored and recorded on a PC through MC_Rack software 
(Version 4.6.2, Multi Channel Systems MCS GmbH). A channel was considered 
active for the analysis if it recorded at least 5 spikes in 60 s (time window of agonist 
application). Neuronal firing activity was evoked by 50 s applications of 1 µM 
capsaicin and later, after 16 min washing, of 40 mM KCl using continuous perfusion 
system (2 mL/min flux). Threshold was fixed at ±5 standard deviations from baseline 
noise (typically around 15 µV peak-to-peak). In general, according to the technical 
specifications of the device, one electrode does not correspond to a single cell. 
Rather, each electrode can detect all the electrical signals originating in the spatial 
region surrounding it, within a radius of tens of micrometers. NeuroExplorer (Nex 
Technologies, USA) was used to make raster plot from each channel. Only upward 
(positive) and downward (negative) spike cutouts from each of the available 
recording electrodes were stored. These waveforms consisted of 1 ms pre-spike 




Electrophysiology - Patch-clamp Cell attached patch clamp recordings were 
performed at 22–25 °C on control and OHP-treated neurons with a mean soma 
diameter < 25 μm. During gigaseal formation DRG neurons were continuously 
superfused with a standard physiological solution of the following composition (in 
mM): NaCl 154; KCl 4; CaCl2 2; MgCl2 1; 4-(2-hydroxyethyl)-1-piperazine ethane 
sulfonic acid (HEPES) 5; glucose 5.5; NaOH to pH 7.4. The resistance of patch 
electrodes, prepared from borosilicate glass capillaries (World Precision 
Instruments), was  5–7 MΩ. In most experiments, pipette solution composition was 
(in mM): CsCl 130, TEACl 20, DIDS 1; 4-(2-hydroxyethyl)-1-piperazine ethane 
sulfonic acid (HEPES) 10, EGTA 2, BCTC 3 μM, Icilin 1 μM, CsOH to pH 7.4. In a second 
set of experiments, the pipette solution composition was (in mM): KCl 150, TEACl 
20, DIDS 1; 4-(2-hydroxyethyl)-1-piperazine ethane sulfonic acid (HEPES) 10, EGTA 
2, CsCl 1, BCTC 3 μM, KOH to pH 7.4. Once the seal was obtained (2–10 GΩ), cells 
were perfused with a solution containing KCl 150, MgCl2 2, CaCl2 1, EGTA 1.1, HEPES 
5, KOH to pH 7.4, in order to set the membrane potential near 0 mV and to prevent 
intracellular calcium loading. Inside out experiments were performed on untreated 
DRG neurons. As describe above, standard physiological solution was used during 
gigaseal formation, and high potassium bath solution, once the seal was obtained 
and the patch excised. Pipettes were filled with the same 150 mM KCl pipette 
solution above described. Data were collected and filtered at 1 kHz with an 
Axopatch 200B amplifier (Molecular Devices, USA) and continuously digitized at 1 
kHz sampling frequency with PClamp Axoscope software (Molecular Devices, USA). 
Steady state voltage clamp protocols were applied and digitized at 10 or 20 kHz 
with PClamp Clampex software Data analysis was performed with OriginPro 




Statistical Analysis. Data are presented as mean ± SEM or median and IQR, 
depending on the skewness of data distribution. Data points in the single channel 
current-voltage graphs represent mean ± SD, estimated by fitting the amplitude 
histograms to a sum of Gaussian functions (OriginPro 9.1, OriginLab USA). The 
normality of data distributions was assessed using Shapiro–Wilk test. Parametric 
(unpaired t-test and One-way analysis of variance (ANOVA) followed by Tukey’s 





OHP effect on expression of TREK and TRAAK mRNA in DRG neurons 
  
OHP promotes hyperexcitability by remodelling ion channel expression in cold-
sensing nociceptors. Descoeur and collaborators (2011) 37 showed a drastic 
decrease of the expression of TREK and TRAAK channels in mice after four days post 
treatment with a single dose of OHP, just at the peak of pain hypersensitivity 37. To 
investigate the effect of the treatment with OHP on the expression of TREK / TRAAK 
channels on DRG neurons, in our experimental conditions, we performed RT-PCR 
both in vitro and in vivo. In in vitro experiments, the mRNA levels were measured 
after a 6-h treatment with OHP, as well as, after removing the treatment, 42 hours 
later. In in vivo experiments, BALB/c mice were treated either with OHP (3.5 mg/Kg) 
twice a week for four weeks or only once (3.5 mg/Kg). Twenty-four hours after the 
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last treatment, animals were sacrificed, DRG dissected, and their mRNA levels 
measured as described in the materials and methods section.   
We observed that the acute treatment with OHP induce a significant increase in the 







Fig 1. A Oxaliplatin affects in vitro the transcription of TREK-1, TREK-2 and TRAAK channels. The 
mRNA levels  were measured after the 6 hour treatment with OHP and after 48 hours (upon 6 hour 
treatment with OHP), by RT-PCR. Values for both conditions were normalized against the expression 
of the same transcripts as evaluated in control (untreated) samples. Data show a significant increase 
of all K2P channels considered in this analysis after 6 hour treatment (*p-value˂0.05, Bonferroni-
adjusted). B These data were confirmed by the analysis performed on mRNA from DRG cells from a 







OHP effect on electrical activity in DRG neurons  
 
The magnitude of the K+ leak current is a primary determinant of neuronal resting 
Vm 92. An increase of TREK/TRAAK channel expression and activity is expected to 
induce membrane hyperpolarization and decreased excitability. To provide such 
information on electrical activity elicited by OHP, we performed extracellular 
recordings from DRG neurons on MEAs. 
Previous studies have shown that DRG neurons, even if representing a 
heterogeneous population of different sensory cells, have a very limited and 
sporadic spontaneous electrical activity 89. For this reason, we evoked transitory 
activity in these primary cultures by adding 1 µM capsaicin and 40 mM KCl (Fig. 
2).Full recordings sampled at 25 kHz were filtered using a voltage threshold (see 
Methods) in order to extract extracellular action potential (EAP) waveforms from 
raw data and build raster plots showed in Fig. 2a. 
Three different time points were investigated, after 6-h treatment with OHP, 30 h 
and 42 h later, after removing the treatment (from now on they will be indicated as 
24h and 48h respectively). We measured the average number of EAPs in a temporal 
window of 50 s both for capsaicin and KCl. Within these temporal borders, active 
channels changed their firing rate according to Fig. 2a. 
For capsaicin, the average firing rate under control conditions, expressed as median 
and interquartile range, was respectively Mf = 0.701 Hz, IQRf = [0.258; 1.148] Hz at 
6 h (65 different channels, from n=4 independent experiments), Mf = 1.062 Hz, IQRf 
= [0.506; 1.583] Hz at 24 h (54 different channels, from n=2 independent 
experiments) and Mf = 0.621 Hz, IQRf = [0.346; 1.566] Hz at 48 h (76 different 
channels, from n=2 independent experiments). While for treated neurons the 
average firing rate was Mf = 0.255 Hz, IQRf = [0.137; 0.484] Hz at 6 h (61 different 
channels, from n=4 independent experiments), Mf = 0.458 Hz, IQRf = [0.236; 0.935] 
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Hz at 24 h (64 different channels, from n=2 independent experiments), and Mf = 
0.580 Hz, IQRf = [0.350; 1.917] Hz at 48 h (76 different channels, from n=2 
independent experiments) . The OHP-treatment elicited a statistically significant 
median decrease in firing rate compared to the control electrical activity, both at 6 
h ( p = 1.173·10-4, Fig. 2B) and at 24 h (p = 5.646·10-5,Fig. 2B). No significant 
differences was observed at 48 h. For this reason, an analysis of statistical power 
was conducted to determine the minimum detectable effect in our experimental 
conditions. In particular, statistical sensitivity was computed in terms of absolute 
(difference in firing rate, Δf) and relative (Cohen’s d) effect needed for having a 
significant p-value with a level of α = 0.05 and a power of π = 0.8 (results of such an 
analysis are reported in Table 1). 
For KCl, the average firing rate under control conditions, expressed as median and 
interquartile range, was respectively Mf = 0.188 Hz, IQRf = [0.098; 0.288] Hz at 6 h 
(30 different channels, from n=4 independent experiments), Mf = 0.078 Hz, IQRf = 
[0.039; 0.145] Hz at 24 h (11 different channels, from n=2 independent 
experiments) and Mf = 0.163 Hz, IQRf = [0.111; 0.530] Hz at 48 h (7 different 
channels, from n=2 independent experiments). While for treated neurons the 
average firing rate was Mf = 0.128 Hz, IQRf = [0.065; 0.179] Hz at 6 h (18 different 
channels, from n=4 independent experiments), Mf = 0.076 Hz, IQRf = [0.041; 0.344] 
Hz at 24 h (12 different channels, from n=2 independent experiments) and Mf = 
0.308 Hz, IQRf = [0.185; 0.422] Hz at 48 h (14 different channels, from n=2 
independent experiments) 
In this case, the effect induced by OHP led to significant differences only in the 6-
hour after-treatment group (p = 0.022, Fig. 2C). Even for this agonist a statistical 








Capsaicin (1 µM) Effect size  
(Cohen’s d) 
Pooled Sd Effect size 
(Δf) 
6 h 0.468 1.481 0.693 
24 h 0.515 1.588 0.818 







KCl  (40 M) Effect size 
(Cohen’s d) 
Pooled Sd Effect size 
(Δf) 
6 h 0.874 0.089 0.078 
24 h 1.258 0.192 0.241 







Fig. 2. A Three representative raster plots for each condition (control and OHP treated neurons) and 
each time point considered during the application of 1 µM capsaicin and 40 mM KCl. On the right 
side of each raster is the channel identifier. Symbols + and – represent the direction (upward or 
downward respectively) of the EAPs detected. B Box plots show median and IQR of mean spike 
frequency (Hz) in the presence of capsaicin (at 6 h p = 1.173·10-4, Mann-Whitney U test, mctrl = 61 
and mOHP = 65 different channels, from n=4 independent experiments; at 24 h p = 5.646·10-5, Mann-
Whitney U test, mctrl = 54 and mOHP = 64 different channels, from n=2 independent experiments; at 
48 h p = 0.806, Mann-Whitney U test, mctrl = 76 and mOHP = 76 different channels, from n=2 
independent experiments Mann-Whitney U test). C Box plots show median and IQR of mean spike 
frequency (Hz) in the presence of KCl (at 6 h  p = 0.022, mctrl = 30 and mOHP = 18 different channels, 
from n=4 independent experiments; at 24 h p = 0.975, mctrl = 11 and mOHP = 12 channels, from n=2 
independent experiments; at 48 h p= 0.975, mctrl = 7 and mOHP = 14  different channels, from n=2 







OHP effect on TREK-2 channel  
 
Riva et al. (2018)97 showed that OHP-induced intracellular acidification sensitize 
TRPA1 channels activity. This effect was abolished by using the K+/H+ exchanger 
nigericin to clamp pHi to physiological levels, the effect of the ionophore being to 
mediate H+ equilibration across the plasma membrane. On the other hand, a large 
amount of literature claims that intracellular protons influence TREK channels in 
different ways: TREK1 and TREK2 are both activated by acidification; while TRAAK 
is stimulated by alkalinization from pH 7.3, but without undergoing to any 
modification by cytoplasmic acidosis 103. In light of this, we hypothesized that the 
reduced excitability in OHP-treated neurons depends on an increase of TREK1 and 
TREK2 channels activity that make the resting membrane potential more 
hyperpolarized.  
To obtain a more direct evidence on the involvement of TREK channels, we 
performed single-channel patch clamp experiments in the recording configuration 
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that less interferes with the intracellular composition, i.e. the cell attached mode. 
To achieve a stable membrane potential near zero without inducing intracellular 
free calcium increases, we perfused DRG neurons with a bath solution containing 
150 mM KCl and low [Ca2+]. Furthermore, the pipette solution contained TEA 
chloride, CsCl and DIDS (see Material and methods) to exclude any contribution of 
other K+-selective channels (inward-rectifying (Kir), voltage-gated (KV), and calcium-
activated K+ channels (KCa)) and Cl--selective channels, which are known to be 
expressed in DRGs (ref). 
Interestingly, in most cell attached patches (6 out of 11 cells) we observed a similar 
modulation as it is described for TRPA1 by Riva et al. (2018)97, of a channel 
characterized by two different current levels at positive membrane potentials (+40 
mV). Figure 3A shows the channel activity in an OHP-treated neuron before and 
during the perfusion of the high potassium solution containing 10 μM nigericin. 
With the ionic solution used in the experiments, nigericin activates a net efflux of 
H+ and stabilizes the intracellular pH near 7.4. The channel activity (NPo, were N is 
the number of channels in the patch and Po the open probability) changes from 
NPo= 0.57 ± 0.19 to NPo= 0.08 ± 0.11 following the perfusion with nigericin, 
evidencing a high sensitivity of this channel to acidic intracellular pH. In the insets 
(FIG 3A), as well as in the trace with an expanded scale shown in Figure 3B, it can 
be observed the small current level (S) and the larger one (L) more clearly. From the 
best fit of the amplitude histogram distribution of the single channel trace shown 
in Figure 3C there can be extracted the values for S and L, 1.68 pA and 5.21 pA at 
Vm=+40 mV, respectively.   
Figure 3D, from the same experiment, shows the single channel I-V relationship 
obtained by plotting the mean amplitudes of the two current levels at different 
membrane potentials. Single channel slope conductance (γ) and negative reversal 
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potential (Vrev) values were, for the small phenotype, 15 ± 1.5 pS and -49 ± 7.5 mV, 
respectively, while 62 ±6 pS and -35 ±4 mV for the large one, on the basis of linear 
regression of current versus voltage. The biophysical properties described above 
are in agreement with previously published data for TREK2 channels 104. 
Furthermore, Vrev values are less negative than expected for a K+ selective channel, 
suggesting that the channel is slightly permeable to cesium ions 78. On the other 
hand, in our ionic conditions the actual reversal potential is very difficult to evaluate 
from the current-voltage relationship. To overcome this difficulty and to better 
characterize the I-V properties and shape we performed a series of experiments 
replacing 130 mM CsCl with 150 mM KCl in the pipette solution. These conditions 
would allow us to observe the inward rectifying behaviour that characterises TREK2 
channels 104,105The red and blue traces in figure 3E represent examples of the 
channel activity recorded in a OHP-treated neuron during a voltage ramp from -120 
mV to 100 mV. To obtain the I-V relationship and the reversal potential of the 
channel, we subtracted the recorded trace representing the closed state of the 
channel (baseline; black trace in Fig 3E) to the red one. The resulting curve in figure 
3G (red trace) show that the channel is weakly inward rectifier with a Vrev = 0mV. 
Finally, we performed inside-out experiments in an untreated neuron in which we 
added arachidonic acid (AA; 10 µM), which is known to be a potent activator of 
TREK2 106. Although the open state shows high background noise, the inward 
rectifying behaviour of currents activated by the agonist can be observed (Fig. 3F). 
This evidence is well illustrated in Figure 3G. Here, the average current obtained 
from a series of ten ramp currents recorded during the administration of AA is 
showed (black trace) and superimposed with the I-V curve obtained in cell-attached 
experiments (red curve). 
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In conclusion, these data provide evidence that expressed cell-membrane TREK2 
channels are functional at 48 h post OHP-treatment and that their activity is 





Fig 3. A Single channel recording at Vhold=+40 mV from an OHP treated DRG neuron, before and 
during nigericin perfusion. Insets show a magnification in three different time recording points (2 
min before nigericin perfusion; 1 and 4 min after nigericin perfusion, respectively). B Single channel 
recorded in cell attached configuration at Vhold=+40 mV from an OHP treated DRG neuron. The two 
different levels of conductance could be observed: the smaller one (S) and the larger one (L). C 
Amplitude histograms of the two conductance levels shown in B. D I-V plot with linear regressions, 
for the channels shown in B. E I-V curve obtained from another experiment recorded in cell attached 
mode with high K+ solution in the pipette. The black trace is the baseline level, while the blue and 
red traces representing I-V currents during the channel opening. F three examples of I-V recorded 
in inside out configuration during the stimulation with Arachidonic Acid (2 µM) in symmetrical K+ 
concentrations. G merge of the average of 10 I-V curve recorded in the presence of Arachidonic Acid 







The data presented in this work show that therapeutically-relevant OHP 
concentrations 97 induce a transiently overexpression of TREK-1, TREK-2 and TRAAK 
both in cultured DRG neurons and in DRG cells from treated animals. Moreover, 
MEA recordings provide evidence for a parallel decrease in the firing rate of both 
capsaicin- and KCl-triggered action potentials. Specifically, statistical significance 
emerged when comparing OHP-treated and control groups at 6 h and 24 h after-
treatment in capsaicin-induced firing rates and at 6 h after-treatment in those KCl-
induced. 
Interestingly, power analysis revealed that the lack of statistical significance at 48 h 
after-treatment time point in capsaicin-induced firing rates cannot be ascribed to a 
lack of sensitivity (i.e. insufficient sample size). In other words, notwithstanding the 
impossibility of accepting the null hypothesis of no difference in frequency rates at 
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this time point, a biologically relevant effect can be ruled out. On the contrary, 
when considering the effect on firing triggered by KCl administration at 24 and 48 
hours, a type II error (false negative) can be suspected. According to Table 2, the 
reduction in the estimated statistical sensitivity does not allow us to exclude the 
presence of an effect similar to the one detected after the first 6 hours. Therefore, 
more experiments are needed in order to increase the sample size of these two 
conditions and the accuracy of the related firing rate measurement. 
In this regard, the lack of effect at 48 h after capsaicin triggering may be related to 
the restoring of expression similar to control conditions. These findings suggest that 
the K+ leak current are likely to be transiently augmented in our experimental 
models. This could lead in turn in a shift of Vm towards the potassium Nernst 
potential (EK) making the cells less excitable, that is larger depolarizations are 
required to initiate action potentials.  
The most effective way to identify and characterize individual TREK channels 
involved in the responses OHP-induced is by recording single-channel openings 
from cell-attached patches. These recordings have evidenced that the activity of a 
channel with biophysical properties that can be associated with those described in 
literature for TREK-2 channels 78,104,107, was enhanced by OHP-treatment. In a 
previous work 97 we reported that the same concentrations of OHP, are able to 
induce an acidification of intracellular pH that, in turn, leads to a sensitization of 
TRPA1 channels. By restoring pH to physiological level the hyperactivity of this 
channel could be reversed. In this line, we performed cell attached recordings 
following the same experimental procedures reported in Riva et al97. A modulation 
of the TREK-2 channel activity similar to that recorded for TRPA1 in the previous 
work was observed. However, the contribution of the other members of the family, 
in particular TRAAK and TREK1, is not excluded 37,78,107. In this regard, the 
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characterization of this family of channels is limited by the lack of specific agonist 
and antagonist. The identification of TREK-2 has been possible thanks to its unique 
biophysical properties, widely described in literature 99.  
This is, to our knowledge, the first description of transient increase in the levels of 
the expression of TREK and TRAAK channels after OHP treatment. The decrease 
showed by Descoeur and collaborators 37 is related to a different time point, after 
four days post treatment with a single dose and higher dose of OHP. 
In conclusion, the transient overexpression of the background K+ channels could be 
interpreted as a tentative of neurons to restore the homeostasis condition. In 
detail, the hyperpolarizing currents carried by K2P channels counteract the 
depolarization triggered by the positive modulation of non-selective cationic 
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The central idea of my thesis project during these three years has been to study the 
role of specific ionic channels and to identify the main mechanisms in which they 
are involved regarding two cases of neurotoxicity, which were widely documented 
but not completely understood: 1) the potential neurotoxicity induced by SiO2 NP 
and 2) the one induced by OHP.  
The control of Ca2+ homeostasis is a key point for neuronal physiological and 
pathological processes. Any single step in neuronal functioning is linked to a tight 
control of intracellular Ca2+ levels and all the mechanisms involved in its 
regulation48. In both cases of neurotoxicity I studied, a dysregulation of Ca2+ 
signalling appears to be a critical starting point 10,15,16.  
The two papers by Distasi et al. from 2018 and 2019 (corresponding to Chapters 2 
and 3 of this thesis, respectively) give together a detailed electrophysiological 
characterization of the Ca2+ signals elicited by the interaction of 50 nm SiO2 NPs 
with the neuronal plasma membrane. 
Combining patch-clamp recordings from single neuroendocrine cells (GT1-7) 
together with population recordings by means of MEAs (Chapter 2) we have 
correlated oscillatory and reversible changes in [Ca2+]i in GT1-7, as previously 
described by Gilardino et al. (2015)10 for the modulation of the electrical activity 
elicited by the same non-toxic doses of 50 nm SiO2 NPs. Three major classes of 
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channel types are involved: TRPV4 channels, Cx and Panx-like channels. All of these 
components are known to be involved in a wide spectrum of physiological and 
pathological processes and characterized by multiple activating mechanisms60,62,70.   
In the last decade, research on the potential toxic effects of NPs have focused on 
targets such as cell genome108, as well as mitochondria and the following 
interruption of the respiratory chain function23–25.  
Ultrastructural and ICP-MS provide evidence that these SiO2 NPs could be 
internalized by the activation of an endocytic process after the interaction with 
plasma membrane. These findings suggest the possibility that also intracellular 
organelles could represent potential targets. In contrast, the time course of 
internalization is slower than the onset of the calcium signals 10. Further evidences 
that confirm we are describing a membrane-delimited pathway are 1) the fast 
transient increase in the firing rate of action potentials recorded with MEA early 
after the administration of SiO2 NPs, and that 2) the activation of three classes of 
channels involved has been also observed in excised membrane patches. 
The direct role of Ca2+ in controlling the transcriptional events were the rational for 
carrying out the analysis of the whole transcriptome. Interestingly, SiO2 NPs do not 
induce transcriptional changes, in our experimental conditions, at any of the 
analyzed time points (30 min, 1, 6 and 24 hrs). In addition, evidences for DNA 
damage induced by SiO2 NPs are limited, and confined to relatively high doses (in 
most cases over 100 µg mL-1) 109.However, it cannot be excluded a transcriptional 
or genotoxic effect of these NPs whether a prolonged time window is considered, 
as described for other nanoparticles 109,110. Furthermore, NPs toxicity can be 
influenced by the presence of serum. The different biomolecules which compose 
the serum may form a complex adsorption layer surrounding the NPs, the so-called 
protein corona, that may strongly modify the interaction of NP-membrane and 
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consequently the cellular uptake, cytotoxicity and genotoxicity. It has been 
described that the toxic doses can change even of a few orders of magnitude when 
evaluated in the presence or in the absence of serum 109. In our experimental 
conditions, even in the absence of FBS, the lack of effects on expression profile are 
paralleled by a lack in reduction of cell survival. 
Several reviews report that NPs induce cytotoxicity by increasing ROS production 
that, in turn, activate subsequent pathways such as the oxidation of proteins that 
leads to their aggregation, the oxidation of mitochondrial DNA, and also the 
perturbation of Ca2+ homeostasis4. A recent paper has reported that the generation 
of ROS can be stimulated by SiO2 NPs in the extracellular environment111; however, 
no specific evidence for neuronal cells can be found in the literature. In this line, we 
showed (Chapter 3) that lipid peroxidation is significantly increased after 30 
minutes exposures with NPs and that the NP-induced [Ca2+]i increases were 
strongly reduced when the cells were preincubated with the antioxidant NAC. This 
observation points out that the most relevant mechanism by which SiO2 NPs elicit 
the activation of TRPV4 channels and Cx and Panx-like channels is likely related to 
the production of ROS. As described in the section 1.5 of the Introduction section, 
all these channels are activated by ROS. In the case of TRPV4, a potential 
amplification mechanism may be involved, since ROS production has been also 
observed downstream the TRPV4-mediated Ca2+ influx63,112. This is also supported 
by the fact that the same NPs when functionalized with amine groups did not 
catalyze the production of ROS. This result is in solid agreement with the lack of 
detectable increases in [Ca2+]i by aminated NPs10 and the lack of inward currents in 
most cells tested (Chapter 3). 
However, our explanation does not exclude the possibility that more than one 
mechanism may coexist. TRPV4, as well as the other two components, is activated 
197 
 
by different chemical and physical stimuli, so for example, mechanotransduction, 
following membrane stretch due to the interaction with the NP, represents a 
possible candidate73,113.  
These findings are not limited to the GT1-7 experimental model. 
Electrophysiological recordings in current clamp mode (Chapter 2) have evidenced 
that 50 nm SiO2 NPs elicit similar depolarizing responses also on primary adult 
neurons. Since each cell type expresses a different set of membrane proteins 
depending on its needs, in addition to TRPV4, connexin and pannexin-like channels, 
likely other calcium permeable channels may contribute to the onset of these 
responses NP-induced in DRG. In particular, TRPV1, TRPA1 and TRPM2, highly 
expressed channels in these neurons, are known to be activated by oxidizing 
agents114–116.  
As described in the Introduction section (Chapter 1) TRP channels are an 
heterogenous class of ion channels that detect a wide variety of external 
environment stimuli. For this reason, they are considered cellular sensors that 
mediate a broad range of pato-physiological processes68.  
The peripheral nervous system is one of the regions of the NS more sensible to 
structural and functional injury in response to toxicants because it is only partially 
protected by BBB. In detail, the BBB in this area just comprises capillaries with 
fenestrated walls that allow the free passage of molecules between the 
bloodstream and the extracellular fluid18. This feature explains, in part, why sensory 
neurons located in DRG and TG  are common targets of chemotherapeutic agents 
like platinum-based drugs11.  
Although the pathomechanism by which these chemotherapeutic agents induce 
peripheral neurotoxicity was considered multifactorial, alteration of Ca2+ signalling 
seems to be one of the most important factors. Especially in the onset of the OHP-
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induced acute syndrome, in which changes in the expression of ion channels and/or 
their function in primary afferent sensory neurons have been reported15.  
The involvement of TRPV1, TRPA1, TRPM8, known as the main receptors 
participating in the transduction and generation of pain, was confirmed in OIPN 54. 
Among them, we have focused on TRPA1 (Chapter 4). Reported Ca2+ imaging data 
indicate that therapeutically relevant OHP concentrations induce, in our conditions, 
an hypersensitization of this channel. Although the remodelling of TRPA1 
expression has been postulated as one of the mechanisms that may underlie this 
hypersensitivity117, our data, obtained by both in vitro and in vivo assays, failed to 
detect any mRNA change related to this channel. The same observation was 
recently obtained by Marmiroli et al. (2017)102. In light of this, we have correlated 
the positive modulation of the activity of TRPA1 channels after the treatment with 
OHP with an alteration of a fundamental parameter for maintaining of neuronal 
homeostasis, the pHi. The ionization state and, therefore, the structure and 
function of virtually all proteins of the cells depends on pH. Intracellular and 
extracellular moieties of membrane proteins (such as channels, transporters, 
receptors and even ATPase pumps) provide them extreme sensitivity to pH 
changes. Thus, a straight correlation between the excitability of the neurons and 
alterations of this functional parameter exists55. In this regard, the resultant hyper-
excitability observed in DRG neurons can be interpreted as the effect of multiple 
adjustments on different molecular targets whose activity is altered by changes in 
the pH induced by OHP.  
Apart from TRPA1, we have evidenced (Chapter 5) the involvement of other 
molecular targets belonging to TREK-family channels that are widely expressed in 
DRG and TRG, and also implicated in the mediation of cold hypersensitivity 
following the treatment with OHP77,117.  
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Cell attached recordings showed in Chapter 4 and in Chapter 5 have confirmed that 
the observed sensitization of TRPA1 and TREK-2-like channels can be reversed by 
restoring pH to physiological levels. Moreover, these findings are also supported by 
previous data reporting intracellular pH-dependent activation for both TRPA1118 
and TREK-278,119. 
Interestingly, in contrast to what happens to TRPA1, OHP promotes a significant 
increase in the mRNA levels of TREK / TRAAK channels that, in our experimental 
conditions, is limited to the period right after the OHP treatment (6 h). Such changes 
in transcript expression are confirmed  also in vivo. Finally, MEA recordings provide  
evidence for a parallel decrease in the firing rate of action potentials. Since the 
augmentation of K+ leak currents moves Vm closer to potassium Nernst potential 
(EK), the cells become less excitable and a larger depolarization is required to 
generate an action potential. The members of this class of channels work as 
regulators of the excitability of primary afferent fibers and, thus, of pain signalling 
by tuning the excitation elicited by several stimuli, including temperature77,117.  
 
In this regard, the transient overexpression of the background K+ channels could be 
interpreted as a tentative of neurons to restore a condition of homeostasis. In 
detail, the hyperpolarizing currents curried by K2P channels are counteracting the 
high depolarization triggered by hyperactivity of TRPA1 OHP-induced.  
 
To study the mechanisms involved in these two cases of neurotoxicity, we have 
worked under the threshold for toxicity, which were established previously by 
testing the cell viability. The information presented here may be valuable, 
particularly for contributing to current knowledge on this subject mainly regarding 
cells of the nervous system, as some evidence and mechanistic suggestions are 




1 ) The fact that the same NPs can elicit quite similar responses in more than one 
neuronal cell model, showing different functional properties and different 
expression of membrane channels, provides evidence that the mechanisms 
involved may be quite general. Therefore, it could be interesting to study whether 
analogous responses can be observed with different types of nano-objects on 
selected cellular models and whether the molecular players involved are the same. 
Several other reports are available regarding the perturbation of neuronal 
excitability and synaptic transmission (ref) induced by NPs but, to our knowledge, 
this is the first detailed electrophysiological description of the changes in electrical 
activity of neurons following exposure to a nanoparticle, and of its evolution in 
time. 
More information on the specific channels and mechanisms responsible for the 
observed effects would be useful for a better design of safe and efficient tools for 
nanomedicine.   
 
 
2) At present, no explanation for the pH homeostasis alteration can be done. We 
observed that oxalate antagonized the change in pH (Chapter 4), without any 
negative impact on the cytotoxic effects of OHP (in any of the 6 colorectal cell lines 
tested). This finding suggests that OHP-induced pH acidification occurs via a specific 
and saturable mechanism.  
A recent report120 shows that OHP creates adducts with neuronal haemoglobin (HB) 
that acts as a proton-buffer, as reported for the red blood cells121. However, more 




The pHi homeostasis is a complex process. At any instant in time, the rate of pHi 
change depends on the total intracellular buffering power and the balance between 
acid-loading and acid-extruding rates and the way to alter steady-state pHi is to 
alter the fundamental kinetics of JE and JL53. 
Therefore, it could be interesting to study whether OHP directly interferes with the 
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NPs = nanoparticles 
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SiO2 NP = silica nanoparticles 
OHP = Oxaliplatin 
NMs = Nanomaterials 
ISO = The International Organization for Standardization 
CNS = Central nervous system 
QDs = Quantum dots (QDs) 
CIPN = Chemotherapy-induced peripheral neuropathy  
TNF-α = tumor necrosis factor alpha  
NF-kB = nuclear factor kappa B 
b-FGF = basic fibroblast growth factor  
VEGF = vascular endothelial growth factor  
BBBs = blood–brain barriers  
mtDNA = mitochondrial DNA  
ROS = reactive oxygen species 
PM10 = particulate matter 10 
DNA = deoxyribonucleic acid 
ATP = adenosine triphosphate 
TRP = transient receptor potential channels 
NaV = voltage-gated sodium channels 
K2P = two-pore domain potassium channels 
BCSFB = blood–cerebrospinal fluid barrier 
CSF = cerebrospinal fluid  
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BMECs = brain microvessel endothelial cells  
ISF = interstitial fluid  
NVU = neurovascular unit  
EC = endothelial cells  
NADPH = nicotinamide adenine dinucleotide phosphate  
ER = endoplasmic reticulum  
FADH2 = Flavin adenine dinucleotide 
NOX = nicotinamide adenine dinucleotide phosphate oxidases  
O2− = superoxide anion 
SOD = superoxide dismutase 
H2O2 = hydrogen peroxide 
OH = hydroxyl radicals 
MPT = mitochondrial permeability transition  
PTP = permeability transition pores  
PMCA = plasma membrane Ca2+ ATPase 
NCX = sodium-calcium exchanger 
VOCCs = Voltage-operated Ca2+ channels  
NMDA = N-methyl-D-aspartate 
NMDARs = NMDA receptors  
ROCs = receptor-operated channels  
SMOCs = second-messenger-operated channels  
SR = sarcoplasmatic reticulum  
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Ins(1,4,5)P3 = inositol-1,4,5-trisphosphate  
cADPR = cyclic ADP ribose  
NAADP = nicotinic acid adenine dinucleotide phosphate  
S1P = sphingosine-1-phosphate  
RYR = ryanodine receptors 
Ins (1,4,5) P3R = inositol (1,4,5) trisphosphate receptors 
CICR = Ca2+-induced Ca2+ release  
V-ATPase = vacuolar H+-ATPase 
NHE = Na+-H+ exchangers  
NCBTs = Na+-coupled HCO3- transporters  
PtdIns (4,5) P2 = phosphatidylinositol (4,5) bisphosphate  
PLCs = phospholipases C  
GPCRs = G protein–coupled receptors  
DAG = diacylglycerol  
PUFAs = polyunsaturated fatty  
AA = arachidonic acid  
SOCE = store-operated Ca2+ entry  
CCE = capacitative Ca2+ entry  
ALS-G = guamanian amyotrophic lateral sclerosis  
GJs = Gap junctions 
HCs = hemichannels  
Cx = connexin  
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EL = extracellular loops 
CL = cytoplasmic loop 
CT = cytoplasmic C-terminal tail  
NAD+ = nicotinamide adenine dinucleotide 
ODDD = oculodentodigital dysplasia  
Panx = pannexin 
KV = voltage-gated potassium channels 
Kir = inwardly rectifying potassium channels 
SF = selectivity filter 
LDH= lactate dehydrogenase  
MEAs = Multielectrode arrays  
APC = automated patch-clamp  
NAC = N-acetyl-L-cysteine  
BCTC = 4-(3-Chloro-2-pyridinyl)-N-[4-(1,1-dimethylethyl)phenyl]-1-
piperazinecarboxamide 
OIPN = oxaliplatin-induced peripheral neuropathy  
TEOS = tetraethylorthosilicate  
HRTEM = high resolution transmission electron microscopy  
DLS =dynamic light scattering  
GnRH = gonadotropin-hormone releasing hormone  
DMEM = Dulbecco’s modified eagle’s medium  
NGF = nerve growth factor 
GDNF = glial derived neurotrophic factor 
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NT3 = neurotrophin-3 factor 
TEM = transmission electron microscopy 
ICP-MS = inductively coupled plasma mass spectrometry  
EAPs = extracellular action potentials  
SEM = scanning electron microscope 
LAA = linoleamide alkyne  
CCD = charge-coupled device camera 
CBX = carbenoxolone 
RR = ruthenium red 
BCECF = 2',7'-Bis-(2-Carboxyethyl)-5-(and-6)-Carboxyfluorescein, Acetoxymethyl 
Ester 
DIDS = 4,4′-Diisothiocyano-2,2′-stilbenedisulfonic acid 
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